,category,ID,term,adj_pval,genes
GO:0006438,BP,GO:0006438,valyl-tRNA aminoacylation,0.315787566,"VARS,VARS2"
GO:0010796,BP,GO:0010796,regulation of multivesicular body size,0.315787566,"RILP,SNF8"
GO:0035315,BP,GO:0035315,hair cell differentiation,0.415792792,"SPINK5,HES5,PDZD7,TRIOBP"
GO:0071625,BP,GO:0071625,vocalization behavior,0.415792792,"NRXN2,MYH14,SHANK2"
GO:0051036,BP,GO:0051036,regulation of endosome size,0.415792792,"RILP,SNF8"
GO:0097107,BP,GO:0097107,postsynaptic density assembly,0.470631081,"NRXN2,SHANK2"
GO:0098698,BP,GO:0098698,postsynaptic specialization assembly,0.470631081,"NRXN2,SHANK2"
GO:0060563,BP,GO:0060563,neuroepithelial cell differentiation,0.470631081,"HES5,BMP2,PDZD7,TRIOBP"
GO:0060122,BP,GO:0060122,inner ear receptor cell stereocilium organization,0.470631081,"HES5,PDZD7,TRIOBP"
GO:0042634,BP,GO:0042634,regulation of hair cycle,0.470631081,"SPINK5,HPSE,FA2H"
GO:0032728,BP,GO:0032728,positive regulation of interferon-beta production,0.470631081,"TICAM1,IRF5,POLR3D"
GO:0030948,BP,GO:0030948,negative regulation of vascular endothelial growth factor receptor signaling pathway,0.470631081,"DAB2IP,HGS"
GO:0042491,BP,GO:0042491,inner ear auditory receptor cell differentiation,0.470631081,"HES5,PDZD7,TRIOBP"
GO:0033690,BP,GO:0033690,positive regulation of osteoblast proliferation,0.470631081,"BMP2,HPSE"
GO:0050850,BP,GO:0050850,positive regulation of calcium-mediated signaling,0.470631081,"P2RX5,P2RX3,CALM3"
GO:0051154,BP,GO:0051154,negative regulation of striated muscle cell differentiation,0.470631081,"YBX1,CTDP1,BMP2"
GO:0106074,BP,GO:0106074,aminoacyl-tRNA metabolism involved in translational fidelity,0.470631081,"VARS,VARS2"
GO:0060119,BP,GO:0060119,inner ear receptor cell development,0.470631081,"HES5,PDZD7,TRIOBP"
GO:0032536,BP,GO:0032536,regulation of cell projection size,0.470631081,"KEL,CDHR2"
GO:0060088,BP,GO:0060088,auditory receptor cell stereocilium organization,0.470631081,"PDZD7,TRIOBP"
GO:1904861,BP,GO:1904861,excitatory synapse assembly,0.470631081,"NRXN2,SHANK2"
GO:0002829,BP,GO:0002829,negative regulation of type 2 immune response,0.470631081,"IFNL1,IL27RA"
GO:0048839,BP,GO:0048839,inner ear development,0.470631081,"MAFB,HES5,BMP2,MYO15A,PDZD7,TRIOBP"
GO:0042059,BP,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,0.470631081,"DAB2IP,CBLC,HGS"
GO:0002093,BP,GO:0002093,auditory receptor cell morphogenesis,0.470631081,"PDZD7,TRIOBP"
GO:0097106,BP,GO:0097106,postsynaptic density organization,0.470631081,"NRXN2,SHANK2"
GO:0099084,BP,GO:0099084,postsynaptic specialization organization,0.470631081,"NRXN2,SHANK2"
GO:1903543,BP,GO:1903543,positive regulation of exosomal secretion,0.470631081,"SNF8,HGS"
GO:0032648,BP,GO:0032648,regulation of interferon-beta production,0.470631081,"TICAM1,IRF5,POLR3D"
GO:0042058,BP,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,0.470631081,"DAB2IP,CBLC,HGS,SHKBP1"
GO:0009615,BP,GO:0009615,response to virus,0.470631081,"IFNLR1,TICAM1,IFNL1,IRF5,IKBKG,CCDC130,POLR3D,BATF3"
GO:0007379,BP,GO:0007379,segment specification,0.470631081,"MAFB,HES5"
GO:1903541,BP,GO:1903541,regulation of exosomal secretion,0.470631081,"SNF8,HGS"
GO:0032608,BP,GO:0032608,interferon-beta production,0.470631081,"TICAM1,IRF5,POLR3D"
GO:0010951,BP,GO:0010951,negative regulation of endopeptidase activity,0.470631081,"CST1,SPINK5,SPINT1,ITIH4,DNAJB6,RENBP,BIRC5"
GO:0060711,BP,GO:0060711,labyrinthine layer development,0.470631081,"VASH1,SPINT1,DNAJB6"
GO:0022010,BP,GO:0022010,central nervous system myelination,0.470631081,"HES5,FA2H"
GO:0032291,BP,GO:0032291,axon ensheathment in central nervous system,0.470631081,"HES5,FA2H"
GO:0099068,BP,GO:0099068,postsynapse assembly,0.470631081,"NRXN2,SHANK2"
GO:0006418,BP,GO:0006418,tRNA aminoacylation for protein translation,0.470631081,"VARS,VARS2,PARS2"
GO:0030534,BP,GO:0030534,adult behavior,0.470631081,"ZFHX2,EFNB3,NRXN2,SHANK2,ARCN1"
GO:0060074,BP,GO:0060074,synapse maturation,0.470631081,"PALM,DAB2IP"
GO:2000726,BP,GO:2000726,negative regulation of cardiac muscle cell differentiation,0.470631081,"CTDP1,BMP2"
GO:0007605,BP,GO:0007605,sensory perception of sound,0.470631081,"MYO15A,MYH14,PDZD7,TRIOBP,BIRC5"
GO:0010524,BP,GO:0010524,positive regulation of calcium ion transport into cytosol,0.470631081,"P2RX5,P2RX3,CALM3"
GO:0043039,BP,GO:0043039,tRNA aminoacylation,0.470631081,"VARS,VARS2,PARS2"
GO:0010466,BP,GO:0010466,negative regulation of peptidase activity,0.470631081,"CST1,SPINK5,SPINT1,ITIH4,DNAJB6,RENBP,BIRC5"
GO:0006450,BP,GO:0006450,regulation of translational fidelity,0.470631081,"VARS,VARS2"
GO:1990182,BP,GO:1990182,exosomal secretion,0.470631081,"SNF8,HGS"
GO:0043038,BP,GO:0043038,amino acid activation,0.470631081,"VARS,VARS2,PARS2"
GO:0042472,BP,GO:0042472,inner ear morphogenesis,0.470631081,"MAFB,MYO15A,PDZD7,TRIOBP"
GO:0043583,BP,GO:0043583,ear development,0.470631081,"MAFB,HES5,BMP2,MYO15A,PDZD7,TRIOBP"
GO:1901184,BP,GO:1901184,regulation of ERBB signaling pathway,0.470631081,"DAB2IP,CBLC,HGS,SHKBP1"
GO:0051797,BP,GO:0051797,regulation of hair follicle development,0.470631081,"SPINK5,HPSE"
GO:0060117,BP,GO:0060117,auditory receptor cell development,0.470631081,"PDZD7,TRIOBP"
GO:0097734,BP,GO:0097734,extracellular exosome biogenesis,0.470631081,"SNF8,HGS"
GO:0051148,BP,GO:0051148,negative regulation of muscle cell differentiation,0.470631081,"YBX1,CTDP1,BMP2"
GO:0060113,BP,GO:0060113,inner ear receptor cell differentiation,0.470631081,"HES5,PDZD7,TRIOBP"
GO:1901185,BP,GO:1901185,negative regulation of ERBB signaling pathway,0.470631081,"DAB2IP,CBLC,HGS"
GO:0006516,BP,GO:0006516,glycoprotein catabolic process,0.470631081,"NEU4,HPSE"
GO:0032509,BP,GO:0032509,endosome transport via multivesicular body sorting pathway,0.470631081,"RILP,SNF8"
GO:0060713,BP,GO:0060713,labyrinthine layer morphogenesis,0.470631081,"SPINT1,DNAJB6"
GO:0006914,BP,GO:0006914,autophagy,0.470631081,"TICAM1,TECPR2,MCOLN1,SNF8,IKBKG,DAP,ATP6V0B,PGA3,HGS,TMEM150B"
GO:0061919,BP,GO:0061919,process utilizing autophagic mechanism,0.470631081,"TICAM1,TECPR2,MCOLN1,SNF8,IKBKG,DAP,ATP6V0B,PGA3,HGS,TMEM150B"
GO:0009100,BP,GO:0009100,glycoprotein metabolic process,0.470631081,"ASGR2,SLC34A1,KRTCAP2,ST3GAL2,NEU4,SDF2L1,POMGNT1,BMP2,HPSE"
GO:0035590,BP,GO:0035590,purinergic nucleotide receptor signaling pathway,0.470631081,"P2RX5,P2RX3"
GO:0071218,BP,GO:0071218,cellular response to misfolded protein,0.470631081,"SDF2L1,DNAJB12"
GO:0140112,BP,GO:0140112,extracellular vesicle biogenesis,0.470631081,"SNF8,HGS"
GO:1905208,BP,GO:1905208,negative regulation of cardiocyte differentiation,0.470631081,"CTDP1,BMP2"
GO:0003130,BP,GO:0003130,BMP signaling pathway involved in heart induction,0.470631081,BMP2
GO:0003133,BP,GO:0003133,endodermal-mesodermal cell signaling,0.470631081,BMP2
GO:0003134,BP,GO:0003134,endodermal-mesodermal cell signaling involved in heart induction,0.470631081,BMP2
GO:0005986,BP,GO:0005986,sucrose biosynthetic process,0.470631081,FBP2
GO:0006050,BP,GO:0006050,mannosamine metabolic process,0.470631081,RENBP
GO:0006051,BP,GO:0006051,N-acetylmannosamine metabolic process,0.470631081,RENBP
GO:0006530,BP,GO:0006530,asparagine catabolic process,0.470631081,ASPG
GO:0021560,BP,GO:0021560,abducens nerve development,0.470631081,MAFB
GO:0021598,BP,GO:0021598,abducens nerve morphogenesis,0.470631081,MAFB
GO:0021599,BP,GO:0021599,abducens nerve formation,0.470631081,MAFB
GO:0021691,BP,GO:0021691,cerebellar Purkinje cell layer maturation,0.470631081,ARCN1
GO:0034342,BP,GO:0034342,response to type III interferon,0.470631081,IFNLR1
GO:0035283,BP,GO:0035283,central nervous system segmentation,0.470631081,MAFB
GO:0035284,BP,GO:0035284,brain segmentation,0.470631081,MAFB
GO:0036324,BP,GO:0036324,vascular endothelial growth factor receptor-2 signaling pathway,0.470631081,DAB2IP
GO:0051040,BP,GO:0051040,regulation of calcium-independent cell-cell adhesion,0.470631081,BMP2
GO:0060128,BP,GO:0060128,corticotropin hormone secreting cell differentiation,0.470631081,BMP2
GO:0060988,BP,GO:0060988,lipid tube assembly,0.470631081,SNX9
GO:0061622,BP,GO:0061622,glycolytic process through glucose-1-phosphate,0.470631081,GALK1
GO:0090675,BP,GO:0090675,intermicrovillar adhesion,0.470631081,CDHR2
GO:0098886,BP,GO:0098886,modification of dendritic spine,0.470631081,SYNPO
GO:1901491,BP,GO:1901491,negative regulation of lymphangiogenesis,0.470631081,VASH1
GO:2000742,BP,GO:2000742,regulation of anterior head development,0.470631081,SSBP3
GO:2000744,BP,GO:2000744,positive regulation of anterior head development,0.470631081,SSBP3
GO:2000978,BP,GO:2000978,negative regulation of forebrain neuron differentiation,0.470631081,HES5
GO:0050954,BP,GO:0050954,sensory perception of mechanical stimulus,0.470631081,"MYO15A,MYH14,PDZD7,TRIOBP,BIRC5"
GO:0042490,BP,GO:0042490,mechanoreceptor differentiation,0.477931208,"HES5,PDZD7,TRIOBP"
GO:0033688,BP,GO:0033688,regulation of osteoblast proliferation,0.484681739,"BMP2,HPSE"
GO:0032729,BP,GO:0032729,positive regulation of interferon-gamma production,0.488023833,"IFNL1,IL27RA,TNFRSF13C"
GO:0045662,BP,GO:0045662,negative regulation of myoblast differentiation,0.488023833,"MBNL3,NMRK2"
GO:0051788,BP,GO:0051788,response to misfolded protein,0.488023833,"SDF2L1,DNAJB12"
GO:2000311,BP,GO:2000311,regulation of AMPA receptor activity,0.488023833,"SHISA9,SHANK2"
GO:0002065,BP,GO:0002065,"columnar,cuboidal epithelial cell differentiation",0.488023833,"HES5,BMP2,PDZD7,TRIOBP"
GO:0060669,BP,GO:0060669,embryonic placenta morphogenesis,0.488023833,"SPINT1,DNAJB6"
GO:0045685,BP,GO:0045685,regulation of glial cell differentiation,0.488023833,"HES5,SPINT1,BMP2"
GO:0033687,BP,GO:0033687,osteoblast proliferation,0.488023833,"BMP2,HPSE"
GO:0042471,BP,GO:0042471,ear morphogenesis,0.488023833,"MAFB,MYO15A,PDZD7,TRIOBP"
GO:0050808,BP,GO:0050808,synapse organization,0.488023833,"PALM,CBLN2,PCDHB16,NRXN2,SYNPO,SHANK2,DAB2IP"
GO:0097066,BP,GO:0097066,response to thyroid hormone,0.488023833,"SLC34A1,GAS2L1"
GO:0002636,BP,GO:0002636,positive regulation of germinal center formation,0.488023833,TNFRSF13C
GO:0005985,BP,GO:0005985,sucrose metabolic process,0.488023833,FBP2
GO:0006059,BP,GO:0006059,hexitol metabolic process,0.488023833,GALK1
GO:0006433,BP,GO:0006433,prolyl-tRNA aminoacylation,0.488023833,PARS2
GO:0014908,BP,GO:0014908,myotube differentiation involved in skeletal muscle regeneration,0.488023833,BCL9
GO:0021571,BP,GO:0021571,rhombomere 5 development,0.488023833,MAFB
GO:0021590,BP,GO:0021590,cerebellum maturation,0.488023833,ARCN1
GO:0021699,BP,GO:0021699,cerebellar cortex maturation,0.488023833,ARCN1
GO:0030047,BP,GO:0030047,actin modification,0.488023833,TRIOBP
GO:0030200,BP,GO:0030200,heparan sulfate proteoglycan catabolic process,0.488023833,HPSE
GO:0031296,BP,GO:0031296,B cell costimulation,0.488023833,TNFRSF13C
GO:0035054,BP,GO:0035054,"embryonic heart tube anterior,posterior pattern specification",0.488023833,BMP2
GO:0042668,BP,GO:0042668,auditory receptor cell fate determination,0.488023833,HES5
GO:0060129,BP,GO:0060129,thyroid-stimulating hormone-secreting cell differentiation,0.488023833,BMP2
GO:0060160,BP,GO:0060160,negative regulation of dopamine receptor signaling pathway,0.488023833,PALM
GO:0060715,BP,GO:0060715,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,0.488023833,DNAJB6
GO:0061366,BP,GO:0061366,behavioral response to chemical pain,0.488023833,P2RX3
GO:0061368,BP,GO:0061368,behavioral response to formalin induced pain,0.488023833,P2RX3
GO:0072138,BP,GO:0072138,mesenchymal cell proliferation involved in ureteric bud development,0.488023833,BMP2
GO:0097116,BP,GO:0097116,gephyrin clustering involved in postsynaptic density assembly,0.488023833,NRXN2
GO:0099010,BP,GO:0099010,modification of postsynaptic structure,0.488023833,SYNPO
GO:1903797,BP,GO:1903797,positive regulation of inorganic anion transmembrane transport,0.488023833,SLC34A1
GO:1905457,BP,GO:1905457,negative regulation of lymphoid progenitor cell differentiation,0.488023833,HES5
GO:2000118,BP,GO:2000118,regulation of sodium-dependent phosphate transport,0.488023833,SLC34A1
GO:2000974,BP,GO:2000974,negative regulation of pro-B cell differentiation,0.488023833,HES5
GO:0048710,BP,GO:0048710,regulation of astrocyte differentiation,0.488023833,"HES5,BMP2"
GO:0070979,BP,GO:0070979,protein K11-linked ubiquitination,0.488023833,"UBE2T,UBE2C"
GO:0032479,BP,GO:0032479,regulation of type I interferon production,0.488023833,"DTX4,TICAM1,IRF5,POLR3D"
GO:0032606,BP,GO:0032606,type I interferon production,0.488023833,"DTX4,TICAM1,IRF5,POLR3D"
GO:0010458,BP,GO:0010458,exit from mitosis,0.488023833,"UBE2C,CTDP1"
GO:0035666,BP,GO:0035666,TRIF-dependent toll-like receptor signaling pathway,0.488023833,"TICAM1,IKBKG"
GO:0071985,BP,GO:0071985,multivesicular body sorting pathway,0.488023833,"RILP,SNF8"
GO:0032481,BP,GO:0032481,positive regulation of type I interferon production,0.488023833,"TICAM1,IRF5,POLR3D"
GO:0002828,BP,GO:0002828,regulation of type 2 immune response,0.488023833,"IFNL1,IL27RA"
GO:0033198,BP,GO:0033198,response to ATP,0.488023833,"P2RX5,P2RX3"
GO:0036258,BP,GO:0036258,multivesicular body assembly,0.488023833,"SNF8,HGS"
GO:0007032,BP,GO:0007032,endosome organization,0.488023833,"RILP,SNF8,HGS"
GO:0010922,BP,GO:0010922,positive regulation of phosphatase activity,0.488023833,"BMP2,CALM3"
GO:0036257,BP,GO:0036257,multivesicular body organization,0.488023833,"SNF8,HGS"
GO:0021700,BP,GO:0021700,developmental maturation,0.488023833,"PALM,SPINK5,HES5,BMP2,DAB2IP,ARCN1"
GO:0002756,BP,GO:0002756,MyD88-independent toll-like receptor signaling pathway,0.488023833,"TICAM1,IKBKG"
GO:0030947,BP,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,0.488023833,"DAB2IP,HGS"
GO:0031295,BP,GO:0031295,T cell costimulation,0.488023833,"EFNB3,TNFRSF14,TNFRSF13C"
GO:0007173,BP,GO:0007173,epidermal growth factor receptor signaling pathway,0.488023833,"DAB2IP,CBLC,HGS,SHKBP1"
GO:0002784,BP,GO:0002784,regulation of antimicrobial peptide production,0.488023833,SPINK5
GO:0002786,BP,GO:0002786,regulation of antibacterial peptide production,0.488023833,SPINK5
GO:0003308,BP,GO:0003308,negative regulation of Wnt signaling pathway involved in heart development,0.488023833,BMP2
GO:0010961,BP,GO:0010961,cellular magnesium ion homeostasis,0.488023833,KEL
GO:0030167,BP,GO:0030167,proteoglycan catabolic process,0.488023833,HPSE
GO:0032286,BP,GO:0032286,central nervous system myelin maintenance,0.488023833,FA2H
GO:0032345,BP,GO:0032345,negative regulation of aldosterone metabolic process,0.488023833,BMP2
GO:0032348,BP,GO:0032348,negative regulation of aldosterone biosynthetic process,0.488023833,BMP2
GO:0038026,BP,GO:0038026,reelin-mediated signaling pathway,0.488023833,DAB2IP
GO:0043328,BP,GO:0043328,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,0.488023833,SNF8
GO:0045632,BP,GO:0045632,negative regulation of mechanoreceptor differentiation,0.488023833,HES5
GO:0046340,BP,GO:0046340,diacylglycerol catabolic process,0.488023833,LIPE
GO:0061209,BP,GO:0061209,cell proliferation involved in mesonephros development,0.488023833,BMP2
GO:0070676,BP,GO:0070676,intralumenal vesicle formation,0.488023833,RILP
GO:0072086,BP,GO:0072086,specification of loop of Henle identity,0.488023833,HES5
GO:0097118,BP,GO:0097118,neuroligin clustering involved in postsynaptic membrane assembly,0.488023833,NRXN2
GO:0097187,BP,GO:0097187,dentinogenesis,0.488023833,SLC34A1
GO:1901490,BP,GO:1901490,regulation of lymphangiogenesis,0.488023833,VASH1
GO:1990743,BP,GO:1990743,protein sialylation,0.488023833,ST3GAL2
GO:2000065,BP,GO:2000065,negative regulation of cortisol biosynthetic process,0.488023833,BMP2
GO:2000622,BP,GO:2000622,"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",0.488023833,SECISBP2
GO:2000623,BP,GO:2000623,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",0.488023833,SECISBP2
GO:2000977,BP,GO:2000977,regulation of forebrain neuron differentiation,0.488023833,HES5
GO:2000981,BP,GO:2000981,negative regulation of inner ear receptor cell differentiation,0.488023833,HES5
GO:0031294,BP,GO:0031294,lymphocyte costimulation,0.488023833,"EFNB3,TNFRSF14,TNFRSF13C"
GO:0060674,BP,GO:0060674,placenta blood vessel development,0.488023833,"VASH1,SPINT1"
GO:0071312,BP,GO:0071312,cellular response to alkaloid,0.488023833,"SLC34A1,CACNA1S"
GO:0009311,BP,GO:0009311,oligosaccharide metabolic process,0.488023833,"ST3GAL2,FBP2,NEU4"
GO:0048024,BP,GO:0048024,"regulation of mRNA splicing, via spliceosome",0.488023833,"MBNL3,JMJD6,DAZAP1"
GO:0050848,BP,GO:0050848,regulation of calcium-mediated signaling,0.488023833,"P2RX5,P2RX3,CALM3"
GO:0045682,BP,GO:0045682,regulation of epidermis development,0.488023833,"SPINK5,HES5,HPSE"
GO:0035966,BP,GO:0035966,response to topologically incorrect protein,0.488023833,"SDF2L1,TATDN2,DNAJB12,DAB2IP,DNAJC4"
GO:0019228,BP,GO:0019228,neuronal action potential,0.488023833,"P2RX3,MYH14"
GO:0035637,BP,GO:0035637,multicellular organismal signaling,0.488023833,"P2RX3,FXYD6,MYH14,CALM3,CACNA1S"
GO:0016197,BP,GO:0016197,endosomal transport,0.488023833,"RILP,SNX9,SNF8,HGS,CALY"
GO:0052548,BP,GO:0052548,regulation of endopeptidase activity,0.488023833,"CST1,SPINK5,SPINT1,ITIH4,DNAJB6,RENBP,DAP,BIRC5"
GO:0033572,BP,GO:0033572,transferrin transport,0.488023833,"MCOLN1,ATP6V0B"
GO:0034122,BP,GO:0034122,negative regulation of toll-like receptor signaling pathway,0.488023833,"TICAM1,DAB2IP"
GO:0003129,BP,GO:0003129,heart induction,0.488023833,BMP2
GO:0006528,BP,GO:0006528,asparagine metabolic process,0.488023833,ASPG
GO:0010986,BP,GO:0010986,positive regulation of lipoprotein particle clearance,0.488023833,GPIHBP1
GO:0031133,BP,GO:0031133,regulation of axon diameter,0.488023833,KEL
GO:0031536,BP,GO:0031536,positive regulation of exit from mitosis,0.488023833,UBE2C
GO:0031944,BP,GO:0031944,negative regulation of glucocorticoid metabolic process,0.488023833,BMP2
GO:0031947,BP,GO:0031947,negative regulation of glucocorticoid biosynthetic process,0.488023833,BMP2
GO:0035519,BP,GO:0035519,protein K29-linked ubiquitination,0.488023833,UBE2T
GO:0042640,BP,GO:0042640,anagen,0.488023833,SPINK5
GO:0044314,BP,GO:0044314,protein K27-linked ubiquitination,0.488023833,UBE2T
GO:0046351,BP,GO:0046351,disaccharide biosynthetic process,0.488023833,FBP2
GO:0051343,BP,GO:0051343,positive regulation of cyclic-nucleotide phosphodiesterase activity,0.488023833,CALM3
GO:0051884,BP,GO:0051884,regulation of timing of anagen,0.488023833,SPINK5
GO:0070934,BP,GO:0070934,CRD-mediated mRNA stabilization,0.488023833,YBX1
GO:0070940,BP,GO:0070940,dephosphorylation of RNA polymerase II C-terminal domain,0.488023833,CTDP1
GO:0072047,BP,GO:0072047,"proximal,distal pattern formation involved in nephron development",0.488023833,HES5
GO:0072081,BP,GO:0072081,specification of nephron tubule identity,0.488023833,HES5
GO:0072733,BP,GO:0072733,response to staurosporine,0.488023833,SLC34A1
GO:0072734,BP,GO:0072734,cellular response to staurosporine,0.488023833,SLC34A1
GO:0090032,BP,GO:0090032,negative regulation of steroid hormone biosynthetic process,0.488023833,BMP2
GO:0140052,BP,GO:0140052,cellular response to oxidised low-density lipoprotein particle stimulus,0.488023833,TICAM1
GO:1900425,BP,GO:1900425,negative regulation of defense response to bacterium,0.488023833,SPINK5
GO:1903772,BP,GO:1903772,regulation of viral budding via host ESCRT complex,0.488023833,SNF8
GO:1904058,BP,GO:1904058,positive regulation of sensory perception of pain,0.488023833,P2RX3
GO:1904970,BP,GO:1904970,brush border assembly,0.488023833,CDHR2
GO:0042092,BP,GO:0042092,type 2 immune response,0.488023833,"IFNL1,IL27RA"
GO:0055026,BP,GO:0055026,negative regulation of cardiac muscle tissue development,0.488023833,"CTDP1,BMP2"
GO:0060402,BP,GO:0060402,calcium ion transport into cytosol,0.488023833,"P2RX5,MCOLN1,P2RX3,CALM3"
GO:0045022,BP,GO:0045022,early endosome to late endosome transport,0.488023833,"RILP,SNF8"
GO:0045687,BP,GO:0045687,positive regulation of glial cell differentiation,0.488023833,"SPINT1,BMP2"
GO:0045861,BP,GO:0045861,negative regulation of proteolysis,0.488023833,"CST1,SPINK5,SPINT1,ITIH4,DNAJB6,RENBP,BIRC5"
GO:0014003,BP,GO:0014003,oligodendrocyte development,0.488023833,"HES5,FA2H"
GO:0072512,BP,GO:0072512,trivalent inorganic cation transport,0.488023833,"MCOLN1,ATP6V0B"
GO:0001892,BP,GO:0001892,embryonic placenta development,0.488023833,"VASH1,SPINT1,DNAJB6"
GO:0001890,BP,GO:0001890,placenta development,0.488023833,"VASH1,SPINT1,DNAJB6,DAZAP1"
GO:0009312,BP,GO:0009312,oligosaccharide biosynthetic process,0.488023833,"ST3GAL2,FBP2"
GO:1900744,BP,GO:1900744,regulation of p38MAPK cascade,0.488023833,"BMP2,DAB2IP"
GO:0002759,BP,GO:0002759,regulation of antimicrobial humoral response,0.488023833,SPINK5
GO:0002775,BP,GO:0002775,antimicrobial peptide production,0.488023833,SPINK5
GO:0002778,BP,GO:0002778,antibacterial peptide production,0.488023833,SPINK5
GO:0006689,BP,GO:0006689,ganglioside catabolic process,0.488023833,NEU4
GO:0009912,BP,GO:0009912,auditory receptor cell fate commitment,0.488023833,HES5
GO:0010966,BP,GO:0010966,regulation of phosphate transport,0.488023833,SLC34A1
GO:0010994,BP,GO:0010994,free ubiquitin chain polymerization,0.488023833,UBE2C
GO:0016198,BP,GO:0016198,axon choice point recognition,0.488023833,EFNB3
GO:0019262,BP,GO:0019262,N-acetylneuraminate catabolic process,0.488023833,RENBP
GO:0021546,BP,GO:0021546,rhombomere development,0.488023833,MAFB
GO:0021578,BP,GO:0021578,hindbrain maturation,0.488023833,ARCN1
GO:0021626,BP,GO:0021626,central nervous system maturation,0.488023833,ARCN1
GO:0021999,BP,GO:0021999,"neural plate anterior,posterior regionalization",0.488023833,SSBP3
GO:0032344,BP,GO:0032344,regulation of aldosterone metabolic process,0.488023833,BMP2
GO:0032347,BP,GO:0032347,regulation of aldosterone biosynthetic process,0.488023833,BMP2
GO:0032696,BP,GO:0032696,negative regulation of interleukin-13 production,0.488023833,IFNL1
GO:0043553,BP,GO:0043553,negative regulation of phosphatidylinositol 3-kinase activity,0.488023833,DAB2IP
GO:0045345,BP,GO:0045345,positive regulation of MHC class I biosynthetic process,0.488023833,IFNL1
GO:0060120,BP,GO:0060120,inner ear receptor cell fate commitment,0.488023833,HES5
GO:0071503,BP,GO:0071503,response to heparin,0.488023833,GPIHBP1
GO:0072049,BP,GO:0072049,comma-shaped body morphogenesis,0.488023833,HES5
GO:2000064,BP,GO:2000064,regulation of cortisol biosynthetic process,0.488023833,BMP2
GO:2000973,BP,GO:2000973,regulation of pro-B cell differentiation,0.488023833,HES5
GO:0032649,BP,GO:0032649,regulation of interferon-gamma production,0.488023833,"IFNL1,IL27RA,TNFRSF13C"
GO:0006487,BP,GO:0006487,protein N-linked glycosylation,0.488023833,"ASGR2,KRTCAP2,ST3GAL2"
GO:0098927,BP,GO:0098927,vesicle-mediated transport between endosomal compartments,0.488023833,"RILP,SNF8"
GO:1903311,BP,GO:1903311,regulation of mRNA metabolic process,0.488023833,"YBX1,GTPBP1,MBNL3,SECISBP2,JMJD6,DAZAP1"
GO:0007416,BP,GO:0007416,synapse assembly,0.488023833,"CBLN2,PCDHB16,NRXN2,SHANK2"
GO:0038127,BP,GO:0038127,ERBB signaling pathway,0.488023833,"DAB2IP,CBLC,HGS,SHKBP1"
GO:0046425,BP,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,0.488023833,"HES5,IFNL1,LRRC3C,HGS"
GO:0052547,BP,GO:0052547,regulation of peptidase activity,0.488023833,"CST1,SPINK5,SPINT1,ITIH4,DNAJB6,RENBP,DAP,BIRC5"
GO:0030890,BP,GO:0030890,positive regulation of B cell proliferation,0.488023833,"TICAM1,TNFRSF13C"
GO:1900449,BP,GO:1900449,regulation of glutamate receptor signaling pathway,0.488023833,"SHISA9,SHANK2"
GO:1904892,BP,GO:1904892,regulation of receptor signaling pathway via STAT,0.488023833,"HES5,IFNL1,LRRC3C,HGS"
GO:0031648,BP,GO:0031648,protein destabilization,0.488023833,"NCLN,BMP2"
GO:2000725,BP,GO:2000725,regulation of cardiac muscle cell differentiation,0.488023833,"CTDP1,BMP2"
GO:0051302,BP,GO:0051302,regulation of cell division,0.488023833,"YBX1,ORC6,CIT,CALM3"
GO:0060401,BP,GO:0060401,cytosolic calcium ion transport,0.488023833,"P2RX5,MCOLN1,P2RX3,CALM3"
GO:0051607,BP,GO:0051607,defense response to virus,0.488023833,"IFNLR1,TICAM1,IFNL1,IRF5,POLR3D"
GO:0034765,BP,GO:0034765,regulation of ion transmembrane transport,0.488023833,"SLC34A1,SHISA9,FXYD6,KEL,SHANK2,CALM3,KCNC3,CACNA1S"
GO:0003307,BP,GO:0003307,regulation of Wnt signaling pathway involved in heart development,0.488023833,BMP2
GO:0014832,BP,GO:0014832,urinary bladder smooth muscle contraction,0.488023833,P2RX3
GO:0014848,BP,GO:0014848,urinary tract smooth muscle contraction,0.488023833,P2RX3
GO:0021814,BP,GO:0021814,cell motility involved in cerebral cortex radial glia guided migration,0.488023833,DAB2IP
GO:0021861,BP,GO:0021861,forebrain radial glial cell differentiation,0.488023833,HES5
GO:0031946,BP,GO:0031946,regulation of glucocorticoid biosynthetic process,0.488023833,BMP2
GO:0032532,BP,GO:0032532,regulation of microvillus length,0.488023833,CDHR2
GO:0032714,BP,GO:0032714,negative regulation of interleukin-5 production,0.488023833,IFNL1
GO:0034128,BP,GO:0034128,negative regulation of MyD88-independent toll-like receptor signaling pathway,0.488023833,TICAM1
GO:0036089,BP,GO:0036089,cleavage furrow formation,0.488023833,SNX9
GO:0040016,BP,GO:0040016,embryonic cleavage,0.488023833,TOP1
GO:0042297,BP,GO:0042297,vocal learning,0.488023833,NRXN2
GO:0043634,BP,GO:0043634,polyadenylation-dependent ncRNA catabolic process,0.488023833,PAPD5
GO:0043654,BP,GO:0043654,recognition of apoptotic cell,0.488023833,JMJD6
GO:0045341,BP,GO:0045341,MHC class I biosynthetic process,0.488023833,IFNL1
GO:0045343,BP,GO:0045343,regulation of MHC class I biosynthetic process,0.488023833,IFNL1
GO:0045359,BP,GO:0045359,positive regulation of interferon-beta biosynthetic process,0.488023833,TICAM1
GO:0048733,BP,GO:0048733,sebaceous gland development,0.488023833,FA2H
GO:0060710,BP,GO:0060710,chorio-allantoic fusion,0.488023833,DNAJB6
GO:0060717,BP,GO:0060717,chorion development,0.488023833,DNAJB6
GO:0060897,BP,GO:0060897,neural plate regionalization,0.488023833,SSBP3
GO:0061476,BP,GO:0061476,response to anticoagulant,0.488023833,GPIHBP1
GO:0090219,BP,GO:0090219,negative regulation of lipid kinase activity,0.488023833,DAB2IP
GO:0097065,BP,GO:0097065,anterior head development,0.488023833,SSBP3
GO:0098596,BP,GO:0098596,imitative learning,0.488023833,NRXN2
GO:1901533,BP,GO:1901533,negative regulation of hematopoietic progenitor cell differentiation,0.488023833,HES5
GO:1903608,BP,GO:1903608,protein localization to cytoplasmic stress granule,0.488023833,YBX1
GO:1903795,BP,GO:1903795,regulation of inorganic anion transmembrane transport,0.488023833,SLC34A1
GO:1903961,BP,GO:1903961,positive regulation of anion transmembrane transport,0.488023833,SLC34A1
GO:1905456,BP,GO:1905456,regulation of lymphoid progenitor cell differentiation,0.488023833,HES5
GO:0010522,BP,GO:0010522,regulation of calcium ion transport into cytosol,0.488023833,"P2RX5,P2RX3,CALM3"
GO:0018279,BP,GO:0018279,protein N-linked glycosylation via asparagine,0.488023833,"ASGR2,ST3GAL2"
GO:0072666,BP,GO:0072666,establishment of protein localization to vacuole,0.488023833,"SNF8,HGS"
GO:1902373,BP,GO:1902373,negative regulation of mRNA catabolic process,0.488023833,"YBX1,SECISBP2"
GO:0051346,BP,GO:0051346,negative regulation of hydrolase activity,0.488023833,"CST1,SPINK5,SPINT1,ITIH4,DNAJB6,DAB2IP,RENBP,BIRC5"
GO:0007212,BP,GO:0007212,dopamine receptor signaling pathway,0.488023833,"PALM,CALY"
GO:0010501,BP,GO:0010501,RNA secondary structure unwinding,0.488023833,"DDX49,DDX51"
GO:0018196,BP,GO:0018196,peptidyl-asparagine modification,0.488023833,"ASGR2,ST3GAL2"
GO:0038066,BP,GO:0038066,p38MAPK cascade,0.488023833,"BMP2,DAB2IP"
GO:0032609,BP,GO:0032609,interferon-gamma production,0.488023833,"IFNL1,IL27RA,TNFRSF13C"
GO:0002291,BP,GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,0.488023833,APBB1IP
GO:0007217,BP,GO:0007217,tachykinin receptor signaling pathway,0.488023833,TACR3
GO:0010992,BP,GO:0010992,ubiquitin recycling,0.488023833,UBE2C
GO:0017185,BP,GO:0017185,peptidyl-lysine hydroxylation,0.488023833,JMJD6
GO:0030388,BP,GO:0030388,"fructose 1,6-bisphosphate metabolic process",0.488023833,FBP2
GO:0032511,BP,GO:0032511,late endosome to vacuole transport via multivesicular body sorting pathway,0.488023833,SNF8
GO:0034127,BP,GO:0034127,regulation of MyD88-independent toll-like receptor signaling pathway,0.488023833,TICAM1
GO:0034144,BP,GO:0034144,negative regulation of toll-like receptor 4 signaling pathway,0.488023833,DAB2IP
GO:0043380,BP,GO:0043380,regulation of memory T cell differentiation,0.488023833,IFNL1
GO:0043633,BP,GO:0043633,polyadenylation-dependent RNA catabolic process,0.488023833,PAPD5
GO:0045080,BP,GO:0045080,positive regulation of chemokine biosynthetic process,0.488023833,TICAM1
GO:0045607,BP,GO:0045607,regulation of inner ear auditory receptor cell differentiation,0.488023833,HES5
GO:0045631,BP,GO:0045631,regulation of mechanoreceptor differentiation,0.488023833,HES5
GO:0045647,BP,GO:0045647,negative regulation of erythrocyte differentiation,0.488023833,MAFB
GO:0048664,BP,GO:0048664,neuron fate determination,0.488023833,HES5
GO:0060316,BP,GO:0060316,positive regulation of ryanodine-sensitive calcium-release channel activity,0.488023833,CALM3
GO:0061052,BP,GO:0061052,negative regulation of cell growth involved in cardiac muscle cell development,0.488023833,CTDP1
GO:0061101,BP,GO:0061101,neuroendocrine cell differentiation,0.488023833,BMP2
GO:0061635,BP,GO:0061635,regulation of protein complex stability,0.488023833,SNF8
GO:0070474,BP,GO:0070474,positive regulation of uterine smooth muscle contraction,0.488023833,TACR3
GO:0071313,BP,GO:0071313,cellular response to caffeine,0.488023833,CACNA1S
GO:0071374,BP,GO:0071374,cellular response to parathyroid hormone stimulus,0.488023833,SLC34A1
GO:0072050,BP,GO:0072050,S-shaped body morphogenesis,0.488023833,HES5
GO:0072282,BP,GO:0072282,metanephric nephron tubule morphogenesis,0.488023833,HES5
GO:0085020,BP,GO:0085020,protein K6-linked ubiquitination,0.488023833,UBE2T
GO:0098597,BP,GO:0098597,observational learning,0.488023833,NRXN2
GO:1903896,BP,GO:1903896,positive regulation of IRE1-mediated unfolded protein response,0.488023833,DAB2IP
GO:2000980,BP,GO:2000980,regulation of inner ear receptor cell differentiation,0.488023833,HES5
GO:0030199,BP,GO:0030199,collagen fibril organization,0.488023833,"ADAMTS14,COL5A3"
GO:0071825,BP,GO:0071825,protein-lipid complex subunit organization,0.488023833,"GPIHBP1,SNX9"
GO:0099601,BP,GO:0099601,regulation of neurotransmitter receptor activity,0.488023833,"SHISA9,SHANK2"
GO:0035967,BP,GO:0035967,cellular response to topologically incorrect protein,0.488023833,"SDF2L1,TATDN2,DNAJB12,DAB2IP"
GO:0052652,BP,GO:0052652,cyclic purine nucleotide metabolic process,0.488023833,"PALM,GUCY2D,CALM3"
GO:0042110,BP,GO:0042110,T cell activation,0.488023833,"MAFB,SPINK5,IFNL1,APBB1IP,EFNB3,JMJD6,TNFRSF14,TNFRSF13C"
GO:0048167,BP,GO:0048167,regulation of synaptic plasticity,0.488023833,"SHISA9,P2RX3,SYNPO,SHANK2"
GO:0009190,BP,GO:0009190,cyclic nucleotide biosynthetic process,0.488023833,"PALM,GUCY2D,CALM3"
GO:0001701,BP,GO:0001701,in utero embryonic development,0.488023833,"YBX1,VASH1,SPINT1,BMP2,DNAJB6,EIF4E2"
GO:0016525,BP,GO:0016525,negative regulation of angiogenesis,0.488023833,"SPINK5,VASH1,DAB2IP,HGS"
GO:0014013,BP,GO:0014013,regulation of gliogenesis,0.488023833,"HES5,SPINT1,BMP2"
GO:0019722,BP,GO:0019722,calcium-mediated signaling,0.488023833,"P2RX5,MCOLN1,P2RX3,CALM3"
GO:0045661,BP,GO:0045661,regulation of myoblast differentiation,0.488023833,"MBNL3,NMRK2"
GO:2000181,BP,GO:2000181,negative regulation of blood vessel morphogenesis,0.488023833,"SPINK5,VASH1,DAB2IP,HGS"
GO:0009896,BP,GO:0009896,positive regulation of catabolic process,0.488023833,"RILP,TICAM1,GTPBP1,SNX9,SNF8,IKBKG,DAB2IP"
GO:0030218,BP,GO:0030218,erythrocyte differentiation,0.488023833,"MAFB,JMJD6,KLF1"
GO:0001514,BP,GO:0001514,selenocysteine incorporation,0.488023833,SECISBP2
GO:0002281,BP,GO:0002281,macrophage activation involved in immune response,0.488023833,TICAM1
GO:0002634,BP,GO:0002634,regulation of germinal center formation,0.488023833,TNFRSF13C
GO:0006002,BP,GO:0006002,fructose 6-phosphate metabolic process,0.488023833,FBP2
GO:0006265,BP,GO:0006265,DNA topological change,0.488023833,TOP1
GO:0006451,BP,GO:0006451,translational readthrough,0.488023833,SECISBP2
GO:0019388,BP,GO:0019388,galactose catabolic process,0.488023833,GALK1
GO:0021603,BP,GO:0021603,cranial nerve formation,0.488023833,MAFB
GO:0030643,BP,GO:0030643,cellular phosphate ion homeostasis,0.488023833,SLC34A1
GO:0030647,BP,GO:0030647,aminoglycoside antibiotic metabolic process,0.488023833,SLC34A1
GO:0030917,BP,GO:0030917,midbrain-hindbrain boundary development,0.488023833,SSBP3
GO:0031943,BP,GO:0031943,regulation of glucocorticoid metabolic process,0.488023833,BMP2
GO:0032287,BP,GO:0032287,peripheral nervous system myelin maintenance,0.488023833,FA2H
GO:0032341,BP,GO:0032341,aldosterone metabolic process,0.488023833,BMP2
GO:0032342,BP,GO:0032342,aldosterone biosynthetic process,0.488023833,BMP2
GO:0034371,BP,GO:0034371,chylomicron remodeling,0.488023833,GPIHBP1
GO:0034382,BP,GO:0034382,chylomicron remnant clearance,0.488023833,GPIHBP1
GO:0034651,BP,GO:0034651,cortisol biosynthetic process,0.488023833,BMP2
GO:0035630,BP,GO:0035630,bone mineralization involved in bone maturation,0.488023833,BMP2
GO:0042538,BP,GO:0042538,hyperosmotic salinity response,0.488023833,TACR3
GO:0043379,BP,GO:0043379,memory T cell differentiation,0.488023833,IFNL1
GO:0044341,BP,GO:0044341,sodium-dependent phosphate transport,0.488023833,SLC34A1
GO:0044848,BP,GO:0044848,biological phase,0.488023833,SPINK5
GO:0044851,BP,GO:0044851,hair cycle phase,0.488023833,SPINK5
GO:0045350,BP,GO:0045350,interferon-beta biosynthetic process,0.488023833,TICAM1
GO:0045357,BP,GO:0045357,regulation of interferon-beta biosynthetic process,0.488023833,TICAM1
GO:0048819,BP,GO:0048819,regulation of hair follicle maturation,0.488023833,SPINK5
GO:0051342,BP,GO:0051342,regulation of cyclic-nucleotide phosphodiesterase activity,0.488023833,CALM3
GO:0060056,BP,GO:0060056,mammary gland involution,0.488023833,BSX
GO:0060242,BP,GO:0060242,contact inhibition,0.488023833,CDHR2
GO:0060896,BP,GO:0060896,neural plate pattern specification,0.488023833,SSBP3
GO:0061004,BP,GO:0061004,pattern specification involved in kidney development,0.488023833,HES5
GO:0070472,BP,GO:0070472,regulation of uterine smooth muscle contraction,0.488023833,TACR3
GO:0071415,BP,GO:0071415,cellular response to purine-containing compound,0.488023833,CACNA1S
GO:0071830,BP,GO:0071830,triglyceride-rich lipoprotein particle clearance,0.488023833,GPIHBP1
GO:0072048,BP,GO:0072048,renal system pattern specification,0.488023833,HES5
GO:0072501,BP,GO:0072501,cellular divalent inorganic anion homeostasis,0.488023833,SLC34A1
GO:0072502,BP,GO:0072502,cellular trivalent inorganic anion homeostasis,0.488023833,SLC34A1
GO:0090030,BP,GO:0090030,regulation of steroid hormone biosynthetic process,0.488023833,BMP2
GO:0090129,BP,GO:0090129,positive regulation of synapse maturation,0.488023833,DAB2IP
GO:0090713,BP,GO:0090713,immunological memory process,0.488023833,IFNL1
GO:0090715,BP,GO:0090715,immunological memory formation process,0.488023833,IFNL1
GO:0097119,BP,GO:0097119,postsynaptic density protein 95 clustering,0.488023833,NRXN2
GO:1900747,BP,GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,0.488023833,DAB2IP
GO:1901844,BP,GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,0.488023833,CALM3
GO:1903867,BP,GO:1903867,extraembryonic membrane development,0.488023833,DNAJB6
GO:0033209,BP,GO:0033209,tumor necrosis factor-mediated signaling pathway,0.488023833,"RELT,IKBKG,TNFRSF14,TNFRSF13C"
GO:0043279,BP,GO:0043279,response to alkaloid,0.488023833,"SLC34A1,TACR3,CACNA1S"
GO:0051928,BP,GO:0051928,positive regulation of calcium ion transport,0.488023833,"P2RX5,P2RX3,CALM3"
GO:0060079,BP,GO:0060079,excitatory postsynaptic potential,0.488023833,"P2RX5,P2RX3,SHANK2"
GO:0007259,BP,GO:0007259,receptor signaling pathway via JAK-STAT,0.488023833,"HES5,IFNL1,LRRC3C,HGS"
GO:0035176,BP,GO:0035176,social behavior,0.488023833,"NRXN2,SHANK2"
GO:0035306,BP,GO:0035306,positive regulation of dephosphorylation,0.488023833,"BMP2,CALM3"
GO:0046426,BP,GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,0.488023833,"LRRC3C,HGS"
GO:0051703,BP,GO:0051703,intraspecies interaction between organisms,0.488023833,"NRXN2,SHANK2"
GO:0070936,BP,GO:0070936,protein K48-linked ubiquitination,0.488023833,"UBE2T,UBE2C"
GO:1902369,BP,GO:1902369,negative regulation of RNA catabolic process,0.488023833,"YBX1,SECISBP2"
GO:1904893,BP,GO:1904893,negative regulation of receptor signaling pathway via STAT,0.488023833,"LRRC3C,HGS"
GO:0097696,BP,GO:0097696,receptor signaling pathway via STAT,0.490719113,"HES5,IFNL1,LRRC3C,HGS"
GO:0051153,BP,GO:0051153,regulation of striated muscle cell differentiation,0.490719113,"YBX1,CTDP1,BMP2"
GO:0048168,BP,GO:0048168,regulation of neuronal synaptic plasticity,0.490719113,"SHISA9,SYNPO"
GO:2000117,BP,GO:2000117,negative regulation of cysteine-type endopeptidase activity,0.490719113,"CST1,DNAJB6,BIRC5"
GO:0006383,BP,GO:0006383,transcription by RNA polymerase III,0.490719113,"SNAPC2,POLR3D"
GO:0006584,BP,GO:0006584,catecholamine metabolic process,0.490719113,"TACR3,AOC2"
GO:0009712,BP,GO:0009712,catechol-containing compound metabolic process,0.490719113,"TACR3,AOC2"
GO:0030490,BP,GO:0030490,maturation of SSU-rRNA,0.490719113,"UTP14A,PDCD11"
GO:0032781,BP,GO:0032781,positive regulation of ATPase activity,0.490719113,"DNAJB6,HSCB"
GO:0002328,BP,GO:0002328,pro-B cell differentiation,0.490719113,HES5
GO:0007168,BP,GO:0007168,receptor guanylyl cyclase signaling pathway,0.490719113,GUCY2D
GO:0010960,BP,GO:0010960,magnesium ion homeostasis,0.490719113,KEL
GO:0030259,BP,GO:0030259,lipid glycosylation,0.490719113,ST3GAL2
GO:0030432,BP,GO:0030432,peristalsis,0.490719113,P2RX3
GO:0032353,BP,GO:0032353,negative regulation of hormone biosynthetic process,0.490719113,BMP2
GO:0034650,BP,GO:0034650,cortisol metabolic process,0.490719113,BMP2
GO:0042758,BP,GO:0042758,long-chain fatty acid catabolic process,0.490719113,LIPE
GO:0043497,BP,GO:0043497,regulation of protein heterodimerization activity,0.490719113,DAB2IP
GO:0043569,BP,GO:0043569,negative regulation of insulin-like growth factor receptor signaling pathway,0.490719113,BMP2
GO:0051006,BP,GO:0051006,positive regulation of lipoprotein lipase activity,0.490719113,GPIHBP1
GO:0051124,BP,GO:0051124,synaptic growth at neuromuscular junction,0.490719113,SHANK2
GO:0060159,BP,GO:0060159,regulation of dopamine receptor signaling pathway,0.490719113,PALM
GO:0070471,BP,GO:0070471,uterine smooth muscle contraction,0.490719113,TACR3
GO:0097428,BP,GO:0097428,protein maturation by iron-sulfur cluster transfer,0.490719113,HSCB
GO:0098598,BP,GO:0098598,learned vocalization behavior or vocal learning,0.490719113,NRXN2
GO:1902093,BP,GO:1902093,positive regulation of flagellated sperm motility,0.490719113,TACR3
GO:1902548,BP,GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus,0.490719113,DAB2IP
GO:0042303,BP,GO:0042303,molting cycle,0.490719113,"SPINK5,HPSE,FA2H"
GO:0042633,BP,GO:0042633,hair cycle,0.490719113,"SPINK5,HPSE,FA2H"
GO:1901343,BP,GO:1901343,negative regulation of vasculature development,0.491958902,"SPINK5,VASH1,DAB2IP,HGS"
GO:0090596,BP,GO:0090596,sensory organ morphogenesis,0.492284756,"MAFB,FJX1,MYO15A,PDZD7,TRIOBP"
GO:0042552,BP,GO:0042552,myelination,0.495767883,"HES5,KEL,FA2H"
GO:0045843,BP,GO:0045843,negative regulation of striated muscle tissue development,0.495767883,"CTDP1,BMP2"
GO:0007219,BP,GO:0007219,Notch signaling pathway,0.495767883,"YBX1,DTX4,HES5,BMP2"
GO:0048635,BP,GO:0048635,negative regulation of muscle organ development,0.495767883,"CTDP1,BMP2"
GO:0007272,BP,GO:0007272,ensheathment of neurons,0.495767883,"HES5,KEL,FA2H"
GO:0008366,BP,GO:0008366,axon ensheathment,0.495767883,"HES5,KEL,FA2H"
GO:0034101,BP,GO:0034101,erythrocyte homeostasis,0.495767883,"MAFB,JMJD6,KLF1"
GO:0001819,BP,GO:0001819,positive regulation of cytokine production,0.495767883,"TICAM1,IFNL1,IRF5,HPSE,POLR3D,IL27RA,TNFRSF13C"
GO:1901862,BP,GO:1901862,negative regulation of muscle tissue development,0.495767883,"CTDP1,BMP2"
GO:0002921,BP,GO:0002921,negative regulation of humoral immune response,0.495767883,SPINK5
GO:0006048,BP,GO:0006048,UDP-N-acetylglucosamine biosynthetic process,0.495767883,RENBP
GO:0006054,BP,GO:0006054,N-acetylneuraminate metabolic process,0.495767883,RENBP
GO:0010820,BP,GO:0010820,positive regulation of T cell chemotaxis,0.495767883,TMEM102
GO:0032351,BP,GO:0032351,negative regulation of hormone metabolic process,0.495767883,BMP2
GO:0032494,BP,GO:0032494,response to peptidoglycan,0.495767883,IRF5
GO:0035435,BP,GO:0035435,phosphate ion transmembrane transport,0.495767883,SLC34A1
GO:0042482,BP,GO:0042482,positive regulation of odontogenesis,0.495767883,BMP2
GO:0045073,BP,GO:0045073,regulation of chemokine biosynthetic process,0.495767883,TICAM1
GO:0045351,BP,GO:0045351,type I interferon biosynthetic process,0.495767883,TICAM1
GO:0046689,BP,GO:0046689,response to mercury ion,0.495767883,SLC34A1
GO:0050910,BP,GO:0050910,detection of mechanical stimulus involved in sensory perception of sound,0.495767883,PDZD7
GO:0060315,BP,GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity,0.495767883,CALM3
GO:0061365,BP,GO:0061365,positive regulation of triglyceride lipase activity,0.495767883,GPIHBP1
GO:0070106,BP,GO:0070106,interleukin-27-mediated signaling pathway,0.495767883,IL27RA
GO:0070757,BP,GO:0070757,interleukin-35-mediated signaling pathway,0.495767883,IL27RA
GO:0071044,BP,GO:0071044,histone mRNA catabolic process,0.495767883,PAPD5
GO:0071107,BP,GO:0071107,response to parathyroid hormone,0.495767883,SLC34A1
GO:0072070,BP,GO:0072070,loop of Henle development,0.495767883,HES5
GO:0072173,BP,GO:0072173,metanephric tubule morphogenesis,0.495767883,HES5
GO:0090084,BP,GO:0090084,negative regulation of inclusion body assembly,0.495767883,DNAJB6
GO:0090128,BP,GO:0090128,regulation of synapse maturation,0.495767883,DAB2IP
GO:0090527,BP,GO:0090527,actin filament reorganization,0.495767883,CASS4
GO:0097104,BP,GO:0097104,postsynaptic membrane assembly,0.495767883,NRXN2
GO:1990001,BP,GO:1990001,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,0.495767883,BIRC5
GO:0050684,BP,GO:0050684,regulation of mRNA processing,0.499014184,"MBNL3,JMJD6,DAZAP1"
GO:0006397,BP,GO:0006397,mRNA processing,0.499014184,"H2AFB2,YBX1,MBNL3,PAPD5,SNRNP27,JMJD6,DAZAP1,PDCD11"
GO:0014015,BP,GO:0014015,positive regulation of gliogenesis,0.501285123,"SPINT1,BMP2"
GO:0042108,BP,GO:0042108,positive regulation of cytokine biosynthetic process,0.501285123,"TICAM1,TNFRSF13C"
GO:0042063,BP,GO:0042063,gliogenesis,0.501285123,"HES5,SPINT1,BMP2,FA2H,DAB2IP"
GO:0006399,BP,GO:0006399,tRNA metabolic process,0.501285123,"VARS,VARS2,PARS2,ADAT3"
GO:0002066,BP,GO:0002066,"columnar,cuboidal epithelial cell development",0.501285123,"PDZD7,TRIOBP"
GO:0072665,BP,GO:0072665,protein localization to vacuole,0.501285123,"SNF8,HGS"
GO:1905207,BP,GO:1905207,regulation of cardiocyte differentiation,0.501285123,"CTDP1,BMP2"
GO:0043484,BP,GO:0043484,regulation of RNA splicing,0.501285123,"MBNL3,JMJD6,DAZAP1"
GO:0003306,BP,GO:0003306,Wnt signaling pathway involved in heart development,0.501285123,BMP2
GO:0005984,BP,GO:0005984,disaccharide metabolic process,0.501285123,FBP2
GO:0006705,BP,GO:0006705,mineralocorticoid biosynthetic process,0.501285123,BMP2
GO:0008212,BP,GO:0008212,mineralocorticoid metabolic process,0.501285123,BMP2
GO:0010649,BP,GO:0010649,regulation of cell communication by electrical coupling,0.501285123,CALM3
GO:0010819,BP,GO:0010819,regulation of T cell chemotaxis,0.501285123,TMEM102
GO:0021903,BP,GO:0021903,rostrocaudal neural tube patterning,0.501285123,SSBP3
GO:0042033,BP,GO:0042033,chemokine biosynthetic process,0.501285123,TICAM1
GO:0045078,BP,GO:0045078,positive regulation of interferon-gamma biosynthetic process,0.501285123,TNFRSF13C
GO:0045324,BP,GO:0045324,late endosome to vacuole transport,0.501285123,SNF8
GO:0048266,BP,GO:0048266,behavioral response to pain,0.501285123,P2RX3
GO:0048302,BP,GO:0048302,regulation of isotype switching to IgG isotypes,0.501285123,IL27RA
GO:0048712,BP,GO:0048712,negative regulation of astrocyte differentiation,0.501285123,HES5
GO:0048715,BP,GO:0048715,negative regulation of oligodendrocyte differentiation,0.501285123,HES5
GO:0050755,BP,GO:0050755,chemokine metabolic process,0.501285123,TICAM1
GO:0051798,BP,GO:0051798,positive regulation of hair follicle development,0.501285123,HPSE
GO:0055062,BP,GO:0055062,phosphate ion homeostasis,0.501285123,SLC34A1
GO:0060019,BP,GO:0060019,radial glial cell differentiation,0.501285123,HES5
GO:0060670,BP,GO:0060670,branching involved in labyrinthine layer morphogenesis,0.501285123,SPINT1
GO:0061042,BP,GO:0061042,vascular wound healing,0.501285123,HPSE
GO:0071257,BP,GO:0071257,cellular response to electrical stimulus,0.501285123,PALM
GO:0072505,BP,GO:0072505,divalent inorganic anion homeostasis,0.501285123,SLC34A1
GO:0072506,BP,GO:0072506,trivalent inorganic anion homeostasis,0.501285123,SLC34A1
GO:0099563,BP,GO:0099563,modification of synaptic structure,0.501285123,SYNPO
GO:0060135,BP,GO:0060135,maternal process involved in female pregnancy,0.501285123,"KLF1,DAZAP1"
GO:0006493,BP,GO:0006493,protein O-linked glycosylation,0.501285123,"ST3GAL2,SDF2L1,POMGNT1"
GO:0006364,BP,GO:0006364,rRNA processing,0.501285123,"PAPD5,UTP14A,PDCD11,DDX49,DDX51"
GO:0006486,BP,GO:0006486,protein glycosylation,0.501285123,"ASGR2,KRTCAP2,ST3GAL2,SDF2L1,POMGNT1"
GO:0043413,BP,GO:0043413,macromolecule glycosylation,0.501285123,"ASGR2,KRTCAP2,ST3GAL2,SDF2L1,POMGNT1"
GO:0007626,BP,GO:0007626,locomotory behavior,0.501697011,"BSX,EFNB3,MYO15A,ARCN1"
GO:0006826,BP,GO:0006826,iron ion transport,0.506706153,"MCOLN1,ATP6V0B"
GO:0034121,BP,GO:0034121,regulation of toll-like receptor signaling pathway,0.506706153,"TICAM1,DAB2IP"
GO:0002683,BP,GO:0002683,negative regulation of immune system process,0.506706153,"MAFB,SPINK5,TICAM1,HES5,IFNL1,DAB2IP,IL27RA"
GO:0030888,BP,GO:0030888,regulation of B cell proliferation,0.506706153,"TICAM1,TNFRSF13C"
GO:0099565,BP,GO:0099565,"chemical synaptic transmission, postsynaptic",0.506706153,"P2RX5,P2RX3,SHANK2"
GO:0048568,BP,GO:0048568,embryonic organ development,0.506706153,"MAFB,VASH1,SPINT1,MYO15A,PDZD7,DNAJB6,TRIOBP"
GO:0009895,BP,GO:0009895,negative regulation of catabolic process,0.506706153,"RILP,YBX1,SECISBP2,DAB2IP,DAP"
GO:0005513,BP,GO:0005513,detection of calcium ion,0.506706153,CALM3
GO:0010566,BP,GO:0010566,regulation of ketone biosynthetic process,0.506706153,BMP2
GO:0014067,BP,GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,0.506706153,DAB2IP
GO:0021781,BP,GO:0021781,glial cell fate commitment,0.506706153,HES5
GO:0021819,BP,GO:0021819,layer formation in cerebral cortex,0.506706153,DAB2IP
GO:0021978,BP,GO:0021978,telencephalon regionalization,0.506706153,BMP2
GO:0030002,BP,GO:0030002,cellular anion homeostasis,0.506706153,SLC34A1
GO:0030320,BP,GO:0030320,cellular monovalent inorganic anion homeostasis,0.506706153,SLC34A1
GO:0031223,BP,GO:0031223,auditory behavior,0.506706153,NRXN2
GO:0032530,BP,GO:0032530,regulation of microvillus organization,0.506706153,CDHR2
GO:0034370,BP,GO:0034370,triglyceride-rich lipoprotein particle remodeling,0.506706153,GPIHBP1
GO:0035333,BP,GO:0035333,"Notch receptor processing, ligand-dependent",0.506706153,YBX1
GO:0042635,BP,GO:0042635,positive regulation of hair cycle,0.506706153,HPSE
GO:0045838,BP,GO:0045838,positive regulation of membrane potential,0.506706153,SLC34A1
GO:0046349,BP,GO:0046349,amino sugar biosynthetic process,0.506706153,RENBP
GO:0046479,BP,GO:0046479,glycosphingolipid catabolic process,0.506706153,NEU4
GO:0048291,BP,GO:0048291,isotype switching to IgG isotypes,0.506706153,IL27RA
GO:0071712,BP,GO:0071712,ER-associated misfolded protein catabolic process,0.506706153,SDF2L1
GO:1900004,BP,GO:1900004,negative regulation of serine-type endopeptidase activity,0.506706153,SPINK5
GO:1902572,BP,GO:1902572,negative regulation of serine-type peptidase activity,0.506706153,SPINK5
GO:1903726,BP,GO:1903726,negative regulation of phospholipid metabolic process,0.506706153,DAB2IP
GO:1904668,BP,GO:1904668,positive regulation of ubiquitin protein ligase activity,0.506706153,UBE2C
GO:0010001,BP,GO:0010001,glial cell differentiation,0.514880175,"HES5,SPINT1,BMP2,FA2H"
GO:0070085,BP,GO:0070085,glycosylation,0.523031321,"ASGR2,KRTCAP2,ST3GAL2,SDF2L1,POMGNT1"
GO:0009913,BP,GO:0009913,epidermal cell differentiation,0.526661733,"SPINK5,HES5,KRT32,PDZD7,FA2H,TRIOBP"
GO:0060078,BP,GO:0060078,regulation of postsynaptic membrane potential,0.526661733,"P2RX5,P2RX3,SHANK2"
GO:0006012,BP,GO:0006012,galactose metabolic process,0.526661733,GALK1
GO:0007175,BP,GO:0007175,negative regulation of epidermal growth factor-activated receptor activity,0.526661733,CBLC
GO:0009313,BP,GO:0009313,oligosaccharide catabolic process,0.526661733,NEU4
GO:0021984,BP,GO:0021984,adenohypophysis development,0.526661733,BMP2
GO:0035864,BP,GO:0035864,response to potassium ion,0.526661733,SLC34A1
GO:0042487,BP,GO:0042487,regulation of odontogenesis of dentin-containing tooth,0.526661733,BMP2
GO:0043217,BP,GO:0043217,myelin maintenance,0.526661733,FA2H
GO:0046348,BP,GO:0046348,amino sugar catabolic process,0.526661733,RENBP
GO:0048711,BP,GO:0048711,positive regulation of astrocyte differentiation,0.526661733,BMP2
GO:0051645,BP,GO:0051645,Golgi localization,0.526661733,ARCN1
GO:1900103,BP,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,0.526661733,DAB2IP
GO:1900424,BP,GO:1900424,regulation of defense response to bacterium,0.526661733,SPINK5
GO:1903894,BP,GO:1903894,regulation of IRE1-mediated unfolded protein response,0.526661733,DAB2IP
GO:0033077,BP,GO:0033077,T cell differentiation in thymus,0.530103134,"MAFB,JMJD6"
GO:0033619,BP,GO:0033619,membrane protein proteolysis,0.530103134,"YBX1,SNX9"
GO:0042116,BP,GO:0042116,macrophage activation,0.530103134,"TICAM1,JMJD6"
GO:1903313,BP,GO:1903313,positive regulation of mRNA metabolic process,0.530103134,"GTPBP1,DAZAP1"
GO:0032535,BP,GO:0032535,regulation of cellular component size,0.530103134,"RILP,SNF8,KEL,CIT,TRIOBP,CDHR2"
GO:0051146,BP,GO:0051146,striated muscle cell differentiation,0.532047771,"YBX1,BCL9,CTDP1,BMP2,KEL"
GO:0007034,BP,GO:0007034,vacuolar transport,0.532203626,"RILP,SNF8,HGS"
GO:0050909,BP,GO:0050909,sensory perception of taste,0.532203626,"CST1,P2RX3"
GO:0000281,BP,GO:0000281,mitotic cytokinesis,0.532203626,"SNX9,CIT"
GO:0042531,BP,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,0.532203626,"HES5,IFNL1"
GO:0001946,BP,GO:0001946,lymphangiogenesis,0.532203626,VASH1
GO:0002467,BP,GO:0002467,germinal center formation,0.532203626,TNFRSF13C
GO:0002827,BP,GO:0002827,positive regulation of T-helper 1 type immune response,0.532203626,IL27RA
GO:0006000,BP,GO:0006000,fructose metabolic process,0.532203626,FBP2
GO:0007252,BP,GO:0007252,I-kappaB phosphorylation,0.532203626,DAB2IP
GO:0007638,BP,GO:0007638,mechanosensory behavior,0.532203626,NRXN2
GO:0010801,BP,GO:0010801,negative regulation of peptidyl-threonine phosphorylation,0.532203626,CALM3
GO:0016973,BP,GO:0016973,poly(A)+ mRNA export from nucleus,0.532203626,NXF2
GO:0019377,BP,GO:0019377,glycolipid catabolic process,0.532203626,NEU4
GO:0032816,BP,GO:0032816,positive regulation of natural killer cell activation,0.532203626,TICAM1
GO:0035269,BP,GO:0035269,protein O-linked mannosylation,0.532203626,SDF2L1
GO:0046184,BP,GO:0046184,aldehyde biosynthetic process,0.532203626,BMP2
GO:0048172,BP,GO:0048172,regulation of short-term neuronal synaptic plasticity,0.532203626,SHISA9
GO:0051044,BP,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,0.532203626,SNX9
GO:0051280,BP,GO:0051280,negative regulation of release of sequestered calcium ion into cytosol,0.532203626,CALM3
GO:0097340,BP,GO:0097340,inhibition of cysteine-type endopeptidase activity,0.532203626,BIRC5
GO:0097341,BP,GO:0097341,zymogen inhibition,0.532203626,BIRC5
GO:1900003,BP,GO:1900003,regulation of serine-type endopeptidase activity,0.532203626,SPINK5
GO:1901317,BP,GO:1901317,regulation of flagellated sperm motility,0.532203626,TACR3
GO:1902571,BP,GO:1902571,regulation of serine-type peptidase activity,0.532203626,SPINK5
GO:2001224,BP,GO:2001224,positive regulation of neuron migration,0.532203626,DAB2IP
GO:0030574,BP,GO:0030574,collagen catabolic process,0.542124224,"ADAMTS14,COL5A3"
GO:0055008,BP,GO:0055008,cardiac muscle tissue morphogenesis,0.542124224,"XIRP2,BMP2"
GO:0002224,BP,GO:0002224,toll-like receptor signaling pathway,0.542124224,"TICAM1,IKBKG,DAB2IP"
GO:0071356,BP,GO:0071356,cellular response to tumor necrosis factor,0.542124224,"RELT,IKBKG,TNFRSF14,DAB2IP,TNFRSF13C"
GO:0036498,BP,GO:0036498,IRE1-mediated unfolded protein response,0.542124224,"TATDN2,DAB2IP"
GO:0048708,BP,GO:0048708,astrocyte differentiation,0.542124224,"HES5,BMP2"
GO:1900006,BP,GO:1900006,positive regulation of dendrite development,0.542124224,"SHANK2,DAB2IP"
GO:0007612,BP,GO:0007612,learning,0.542124224,"NRXN2,SYNPO,SHANK2"
GO:0006047,BP,GO:0006047,UDP-N-acetylglucosamine metabolic process,0.542124224,RENBP
GO:0007076,BP,GO:0007076,mitotic chromosome condensation,0.542124224,PHF13
GO:0007158,BP,GO:0007158,neuron cell-cell adhesion,0.542124224,NRXN2
GO:0007635,BP,GO:0007635,chemosensory behavior,0.542124224,P2RX3
GO:0032075,BP,GO:0032075,positive regulation of nuclease activity,0.542124224,DAB2IP
GO:0032495,BP,GO:0032495,response to muramyl dipeptide,0.542124224,IRF5
GO:0034755,BP,GO:0034755,iron ion transmembrane transport,0.542124224,MCOLN1
GO:0043931,BP,GO:0043931,ossification involved in bone maturation,0.542124224,BMP2
GO:0045056,BP,GO:0045056,transcytosis,0.542124224,GPIHBP1
GO:0045072,BP,GO:0045072,regulation of interferon-gamma biosynthetic process,0.542124224,TNFRSF13C
GO:0046514,BP,GO:0046514,ceramide catabolic process,0.542124224,NEU4
GO:0048820,BP,GO:0048820,hair follicle maturation,0.542124224,SPINK5
GO:0051284,BP,GO:0051284,positive regulation of sequestering of calcium ion,0.542124224,CALM3
GO:0072148,BP,GO:0072148,epithelial cell fate commitment,0.542124224,HES5
GO:0090083,BP,GO:0090083,regulation of inclusion body assembly,0.542124224,DNAJB6
GO:0140131,BP,GO:0140131,positive regulation of lymphocyte chemotaxis,0.542124224,TMEM102
GO:1900017,BP,GO:1900017,positive regulation of cytokine production involved in inflammatory response,0.542124224,TICAM1
GO:0019226,BP,GO:0019226,transmission of nerve impulse,0.546684391,"P2RX3,MYH14"
GO:0045732,BP,GO:0045732,positive regulation of protein catabolic process,0.548669513,"RILP,SNX9,SNF8,DAB2IP"
GO:0051249,BP,GO:0051249,regulation of lymphocyte activation,0.554444041,"SPINK5,TICAM1,IFNL1,EFNB3,TNFRSF14,IL27RA,TNFRSF13C"
GO:0006171,BP,GO:0006171,cAMP biosynthetic process,0.554444041,"PALM,CALM3"
GO:0002262,BP,GO:0002262,myeloid cell homeostasis,0.554444041,"MAFB,JMJD6,KLF1"
GO:0016236,BP,GO:0016236,macroautophagy,0.554444041,"MCOLN1,SNF8,IKBKG,ATP6V0B,HGS"
GO:0042274,BP,GO:0042274,ribosomal small subunit biogenesis,0.554444041,"UTP14A,PDCD11"
GO:0006044,BP,GO:0006044,N-acetylglucosamine metabolic process,0.554444041,RENBP
GO:0007220,BP,GO:0007220,Notch receptor processing,0.554444041,YBX1
GO:0010642,BP,GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway,0.554444041,HGS
GO:0021756,BP,GO:0021756,striatum development,0.554444041,SECISBP2
GO:0032354,BP,GO:0032354,response to follicle-stimulating hormone,0.554444041,PAPPA
GO:0033189,BP,GO:0033189,response to vitamin A,0.554444041,SLC34A1
GO:0034143,BP,GO:0034143,regulation of toll-like receptor 4 signaling pathway,0.554444041,DAB2IP
GO:0042095,BP,GO:0042095,interferon-gamma biosynthetic process,0.554444041,TNFRSF13C
GO:0043923,BP,GO:0043923,positive regulation by host of viral transcription,0.554444041,CTDP1
GO:0046339,BP,GO:0046339,diacylglycerol metabolic process,0.554444041,LIPE
GO:0048026,BP,GO:0048026,"positive regulation of mRNA splicing, via spliceosome",0.554444041,DAZAP1
GO:0051782,BP,GO:0051782,negative regulation of cell division,0.554444041,ORC6
GO:0097067,BP,GO:0097067,cellular response to thyroid hormone stimulus,0.554444041,GAS2L1
GO:1900746,BP,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,0.554444041,DAB2IP
GO:0001508,BP,GO:0001508,action potential,0.556978224,"P2RX3,MYH14,CACNA1S"
GO:0050777,BP,GO:0050777,negative regulation of immune response,0.556978224,"SPINK5,IFNL1,IL27RA"
GO:0008544,BP,GO:0008544,epidermis development,0.559745971,"SPINK5,HES5,KRT32,HPSE,PDZD7,FA2H,TRIOBP"
GO:0072078,BP,GO:0072078,nephron tubule morphogenesis,0.559745971,"HES5,BMP2"
GO:0071901,BP,GO:0071901,"negative regulation of protein serine,threonine kinase activity",0.559745971,"DAB2IP,FAM212B,CBLC"
GO:1903707,BP,GO:1903707,negative regulation of hemopoiesis,0.559745971,"MAFB,HES5,IFNL1"
GO:0014706,BP,GO:0014706,striated muscle tissue development,0.559745971,"XIRP2,BCL9,CTDP1,BMP2,KEL,MYH14"
GO:0061337,BP,GO:0061337,cardiac conduction,0.559745971,"FXYD6,CALM3,CACNA1S"
GO:0043462,BP,GO:0043462,regulation of ATPase activity,0.559745971,"DNAJB6,HSCB"
GO:0016072,BP,GO:0016072,rRNA metabolic process,0.559745971,"PAPD5,UTP14A,PDCD11,DDX49,DDX51"
GO:0035148,BP,GO:0035148,tube formation,0.559745971,"HES5,SPINT1,DAB2IP"
GO:0000185,BP,GO:0000185,activation of MAPKKK activity,0.559745971,DAB2IP
GO:0001573,BP,GO:0001573,ganglioside metabolic process,0.559745971,NEU4
GO:0002320,BP,GO:0002320,lymphoid progenitor cell differentiation,0.559745971,HES5
GO:0006704,BP,GO:0006704,glucocorticoid biosynthetic process,0.559745971,BMP2
GO:0007096,BP,GO:0007096,regulation of exit from mitosis,0.559745971,UBE2C
GO:0016137,BP,GO:0016137,glycoside metabolic process,0.559745971,SLC34A1
GO:0031000,BP,GO:0031000,response to caffeine,0.559745971,CACNA1S
GO:0032026,BP,GO:0032026,response to magnesium ion,0.559745971,SLC34A1
GO:0032516,BP,GO:0032516,positive regulation of phosphoprotein phosphatase activity,0.559745971,CALM3
GO:0036270,BP,GO:0036270,response to diuretic,0.559745971,CACNA1S
GO:0036303,BP,GO:0036303,lymph vessel morphogenesis,0.559745971,VASH1
GO:0043011,BP,GO:0043011,myeloid dendritic cell differentiation,0.559745971,BATF3
GO:0048268,BP,GO:0048268,clathrin coat assembly,0.559745971,CALY
GO:0051016,BP,GO:0051016,barbed-end actin filament capping,0.559745971,TRIOBP
GO:0070977,BP,GO:0070977,bone maturation,0.559745971,BMP2
GO:0097320,BP,GO:0097320,plasma membrane tubulation,0.559745971,SNX9
GO:1902547,BP,GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,0.559745971,DAB2IP
GO:0072088,BP,GO:0072088,nephron epithelium morphogenesis,0.563229589,"HES5,BMP2"
GO:1903312,BP,GO:1903312,negative regulation of mRNA metabolic process,0.563229589,"YBX1,SECISBP2"
GO:1903779,BP,GO:1903779,regulation of cardiac conduction,0.563229589,"FXYD6,CALM3"
GO:1904062,BP,GO:1904062,regulation of cation transmembrane transport,0.568336376,"SHISA9,FXYD6,KEL,SHANK2,CALM3"
GO:0006081,BP,GO:0006081,cellular aldehyde metabolic process,0.568993718,"BMP2,ALDH3A1"
GO:0000187,BP,GO:0000187,activation of MAPK activity,0.568993718,"IKBKG,BMP2,DAB2IP"
GO:0009187,BP,GO:0009187,cyclic nucleotide metabolic process,0.568993718,"PALM,GUCY2D,CALM3"
GO:0014074,BP,GO:0014074,response to purine-containing compound,0.568993718,"P2RX5,P2RX3,CACNA1S"
GO:0001759,BP,GO:0001759,organ induction,0.568993718,BMP2
GO:0006337,BP,GO:0006337,nucleosome disassembly,0.568993718,GRWD1
GO:0010523,BP,GO:0010523,negative regulation of calcium ion transport into cytosol,0.568993718,CALM3
GO:0034138,BP,GO:0034138,toll-like receptor 3 signaling pathway,0.568993718,TICAM1
GO:0042053,BP,GO:0042053,regulation of dopamine metabolic process,0.568993718,TACR3
GO:0042069,BP,GO:0042069,regulation of catecholamine metabolic process,0.568993718,TACR3
GO:0043162,BP,GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,0.568993718,SNF8
GO:0061050,BP,GO:0061050,regulation of cell growth involved in cardiac muscle cell development,0.568993718,CTDP1
GO:0072079,BP,GO:0072079,nephron tubule formation,0.568993718,HES5
GO:0072111,BP,GO:0072111,cell proliferation involved in kidney development,0.568993718,BMP2
GO:0034612,BP,GO:0034612,response to tumor necrosis factor,0.568993718,"RELT,IKBKG,TNFRSF14,DAB2IP,TNFRSF13C"
GO:0002824,BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.568993718,"IL27RA,TNFRSF13C"
GO:0006501,BP,GO:0006501,C-terminal protein lipidation,0.568993718,"GPIHBP1,SPRN"
GO:0042509,BP,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,0.568993718,"HES5,IFNL1"
GO:0061333,BP,GO:0061333,renal tubule morphogenesis,0.568993718,"HES5,BMP2"
GO:0072028,BP,GO:0072028,nephron morphogenesis,0.568993718,"HES5,BMP2"
GO:0030217,BP,GO:0030217,T cell differentiation,0.570708341,"MAFB,SPINK5,IFNL1,JMJD6"
GO:0071695,BP,GO:0071695,anatomical structure maturation,0.577171091,"SPINK5,BMP2,ARCN1"
GO:0007009,BP,GO:0007009,plasma membrane organization,0.577171091,"SNX9,FA2H"
GO:0043407,BP,GO:0043407,negative regulation of MAP kinase activity,0.577171091,"DAB2IP,CBLC"
GO:0045785,BP,GO:0045785,positive regulation of cell adhesion,0.578802255,"APBB1IP,TMEM102,EFNB3,TNFRSF14,TRIOBP,TNFRSF13C"
GO:0008344,BP,GO:0008344,adult locomotory behavior,0.578802255,"EFNB3,ARCN1"
GO:0010506,BP,GO:0010506,regulation of autophagy,0.578802255,"TICAM1,IKBKG,DAP,ATP6V0B,TMEM150B"
GO:0016226,BP,GO:0016226,iron-sulfur cluster assembly,0.578802255,HSCB
GO:0031163,BP,GO:0031163,metallo-sulfur cluster assembly,0.578802255,HSCB
GO:0032211,BP,GO:0032211,negative regulation of telomere maintenance via telomerase,0.578802255,PAPD5
GO:0032727,BP,GO:0032727,positive regulation of interferon-alpha production,0.578802255,IRF5
GO:0033617,BP,GO:0033617,mitochondrial cytochrome c oxidase assembly,0.578802255,PET100
GO:0050849,BP,GO:0050849,negative regulation of calcium-mediated signaling,0.578802255,CALM3
GO:0060039,BP,GO:0060039,pericardium development,0.578802255,BMP2
GO:0060716,BP,GO:0060716,labyrinthine layer blood vessel development,0.578802255,VASH1
GO:0072234,BP,GO:0072234,metanephric nephron tubule development,0.578802255,HES5
GO:1904666,BP,GO:1904666,regulation of ubiquitin protein ligase activity,0.578802255,UBE2C
GO:2000178,BP,GO:2000178,negative regulation of neural precursor cell proliferation,0.578802255,SPINT1
GO:2000737,BP,GO:2000737,negative regulation of stem cell differentiation,0.578802255,HES5
GO:0043062,BP,GO:0043062,extracellular structure organization,0.582435074,"SPINK5,GPIHBP1,ADAMTS14,SPINT1,DNAJB6,COL5A3"
GO:0031330,BP,GO:0031330,negative regulation of cellular catabolic process,0.583778648,"YBX1,SECISBP2,DAB2IP,DAP"
GO:0007260,BP,GO:0007260,tyrosine phosphorylation of STAT protein,0.583778648,"HES5,IFNL1"
GO:0046427,BP,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,0.583778648,"HES5,IFNL1"
GO:0060537,BP,GO:0060537,muscle tissue development,0.583778648,"XIRP2,BCL9,CTDP1,BMP2,KEL,MYH14"
GO:0007517,BP,GO:0007517,muscle organ development,0.584319354,"XIRP2,BCL9,CTDP1,BMP2,KEL,MYH14"
GO:0002821,BP,GO:0002821,positive regulation of adaptive immune response,0.584319354,"IL27RA,TNFRSF13C"
GO:0045921,BP,GO:0045921,positive regulation of exocytosis,0.584319354,"SNF8,HGS"
GO:0060415,BP,GO:0060415,muscle tissue morphogenesis,0.584319354,"XIRP2,BMP2"
GO:0061640,BP,GO:0061640,cytoskeleton-dependent cytokinesis,0.584319354,"SNX9,CIT"
GO:0003181,BP,GO:0003181,atrioventricular valve morphogenesis,0.584319354,BMP2
GO:0006622,BP,GO:0006622,protein targeting to lysosome,0.584319354,HGS
GO:0006817,BP,GO:0006817,phosphate ion transport,0.584319354,SLC34A1
GO:0014821,BP,GO:0014821,phasic smooth muscle contraction,0.584319354,P2RX3
GO:0019400,BP,GO:0019400,alditol metabolic process,0.584319354,GALK1
GO:0021801,BP,GO:0021801,cerebral cortex radial glia guided migration,0.584319354,DAB2IP
GO:0022030,BP,GO:0022030,telencephalon glial cell migration,0.584319354,DAB2IP
GO:0031498,BP,GO:0031498,chromatin disassembly,0.584319354,GRWD1
GO:0032656,BP,GO:0032656,regulation of interleukin-13 production,0.584319354,IFNL1
GO:0032674,BP,GO:0032674,regulation of interleukin-5 production,0.584319354,IFNL1
GO:0032986,BP,GO:0032986,protein-DNA complex disassembly,0.584319354,GRWD1
GO:0039702,BP,GO:0039702,viral budding via host ESCRT complex,0.584319354,SNF8
GO:0043496,BP,GO:0043496,regulation of protein homodimerization activity,0.584319354,TICAM1
GO:0070584,BP,GO:0070584,mitochondrion morphogenesis,0.584319354,MYH14
GO:0097503,BP,GO:0097503,sialylation,0.584319354,ST3GAL2
GO:0032465,BP,GO:0032465,regulation of cytokinesis,0.586174439,"CIT,CALM3"
GO:0045445,BP,GO:0045445,myoblast differentiation,0.586174439,"MBNL3,NMRK2"
GO:0045833,BP,GO:0045833,negative regulation of lipid metabolic process,0.586174439,"BMP2,DAB2IP"
GO:1904894,BP,GO:1904894,positive regulation of receptor signaling pathway via STAT,0.586174439,"HES5,IFNL1"
GO:0032412,BP,GO:0032412,regulation of ion transmembrane transporter activity,0.587249205,"SHISA9,FXYD6,SHANK2,CALM3"
GO:0021915,BP,GO:0021915,neural tube development,0.587842945,"HES5,SPINT1,SSBP3"
GO:0000466,BP,GO:0000466,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",0.587842945,PDCD11
GO:0002825,BP,GO:0002825,regulation of T-helper 1 type immune response,0.587842945,IL27RA
GO:0006972,BP,GO:0006972,hyperosmotic response,0.587842945,TACR3
GO:0007035,BP,GO:0007035,vacuolar acidification,0.587842945,ATP6V0B
GO:0009068,BP,GO:0009068,aspartate family amino acid catabolic process,0.587842945,ASPG
GO:0009651,BP,GO:0009651,response to salt stress,0.587842945,TACR3
GO:0010842,BP,GO:0010842,retina layer formation,0.587842945,FJX1
GO:0010881,BP,GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,0.587842945,CALM3
GO:0010984,BP,GO:0010984,regulation of lipoprotein particle clearance,0.587842945,GPIHBP1
GO:0032634,BP,GO:0032634,interleukin-5 production,0.587842945,IFNL1
GO:0035268,BP,GO:0035268,protein mannosylation,0.587842945,SDF2L1
GO:0045109,BP,GO:0045109,intermediate filament organization,0.587842945,DNAJB6
GO:0048799,BP,GO:0048799,animal organ maturation,0.587842945,BMP2
GO:0051004,BP,GO:0051004,regulation of lipoprotein lipase activity,0.587842945,GPIHBP1
GO:0060055,BP,GO:0060055,angiogenesis involved in wound healing,0.587842945,HPSE
GO:0070841,BP,GO:0070841,inclusion body assembly,0.587842945,DNAJB6
GO:0071467,BP,GO:0071467,cellular response to pH,0.587842945,MCOLN1
GO:0097150,BP,GO:0097150,neuronal stem cell population maintenance,0.587842945,HES5
GO:1901623,BP,GO:1901623,regulation of lymphocyte chemotaxis,0.587842945,TMEM102
GO:0021537,BP,GO:0021537,telencephalon development,0.587842945,"HES5,SECISBP2,BMP2,DAB2IP"
GO:0050730,BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,0.587842945,"HES5,IFNL1,TMEM102,CBLC"
GO:0051260,BP,GO:0051260,protein homooligomerization,0.587842945,"SLC34A1,MCOLN1,P2RX3,KCNC3,SHKBP1"
GO:0051781,BP,GO:0051781,positive regulation of cell division,0.587924368,"YBX1,CIT"
GO:0030203,BP,GO:0030203,glycosaminoglycan metabolic process,0.587924368,"ST3GAL2,ITIH4,HPSE"
GO:0050864,BP,GO:0050864,regulation of B cell activation,0.587924368,"TICAM1,IL27RA,TNFRSF13C"
GO:0050863,BP,GO:0050863,regulation of T cell activation,0.589112614,"SPINK5,IFNL1,EFNB3,TNFRSF14,TNFRSF13C"
GO:0048872,BP,GO:0048872,homeostasis of number of cells,0.589112614,"MAFB,JMJD6,KLF1,TNFRSF13C"
GO:2001257,BP,GO:2001257,regulation of cation channel activity,0.589112614,"SHISA9,SHANK2,CALM3"
GO:0007215,BP,GO:0007215,glutamate receptor signaling pathway,0.589112614,"SHISA9,SHANK2"
GO:0042475,BP,GO:0042475,odontogenesis of dentin-containing tooth,0.589112614,"SLC34A1,BMP2"
GO:0022898,BP,GO:0022898,regulation of transmembrane transporter activity,0.589112614,"SHISA9,FXYD6,SHANK2,CALM3"
GO:0043270,BP,GO:0043270,positive regulation of ion transport,0.589112614,"SLC34A1,P2RX5,P2RX3,CALM3"
GO:0006029,BP,GO:0006029,proteoglycan metabolic process,0.589112614,"BMP2,HPSE"
GO:0018410,BP,GO:0018410,C-terminal protein amino acid modification,0.589112614,"GPIHBP1,SPRN"
GO:0009226,BP,GO:0009226,nucleotide-sugar biosynthetic process,0.589112614,RENBP
GO:0010288,BP,GO:0010288,response to lead ion,0.589112614,SLC34A1
GO:0010818,BP,GO:0010818,T cell chemotaxis,0.589112614,TMEM102
GO:0010894,BP,GO:0010894,negative regulation of steroid biosynthetic process,0.589112614,BMP2
GO:0016338,BP,GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,0.589112614,BMP2
GO:0018126,BP,GO:0018126,protein hydroxylation,0.589112614,JMJD6
GO:0021544,BP,GO:0021544,subpallium development,0.589112614,SECISBP2
GO:0021680,BP,GO:0021680,cerebellar Purkinje cell layer development,0.589112614,ARCN1
GO:0032506,BP,GO:0032506,cytokinetic process,0.589112614,SNX9
GO:0032616,BP,GO:0032616,interleukin-13 production,0.589112614,IFNL1
GO:0051043,BP,GO:0051043,regulation of membrane protein ectodomain proteolysis,0.589112614,SNX9
GO:0072170,BP,GO:0072170,metanephric tubule development,0.589112614,HES5
GO:0072243,BP,GO:0072243,metanephric nephron epithelium development,0.589112614,HES5
GO:0086064,BP,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,0.589112614,CALM3
GO:1901522,BP,GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,0.589112614,BMP2
GO:1902895,BP,GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,0.589112614,BMP2
GO:0000377,BP,GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",0.592396093,"YBX1,MBNL3,SNRNP27,JMJD6,DAZAP1"
GO:0000398,BP,GO:0000398,"mRNA splicing, via spliceosome",0.592396093,"YBX1,MBNL3,SNRNP27,JMJD6,DAZAP1"
GO:0002285,BP,GO:0002285,lymphocyte activation involved in immune response,0.592396093,"IFNL1,APBB1IP,IL27RA"
GO:0010717,BP,GO:0010717,regulation of epithelial to mesenchymal transition,0.592396093,"BMP2,DAB2IP"
GO:0032092,BP,GO:0032092,positive regulation of protein binding,0.592396093,"TICAM1,BMP2"
GO:0048644,BP,GO:0048644,muscle organ morphogenesis,0.592396093,"XIRP2,BMP2"
GO:1904063,BP,GO:1904063,negative regulation of cation transmembrane transport,0.592396093,"KEL,CALM3"
GO:0008016,BP,GO:0008016,regulation of heart contraction,0.592396093,"TACR3,FXYD6,CALM3,CACNA1S"
GO:0001942,BP,GO:0001942,hair follicle development,0.592396093,"SPINK5,HPSE"
GO:0000375,BP,GO:0000375,"RNA splicing, via transesterification reactions",0.592396093,"YBX1,MBNL3,SNRNP27,JMJD6,DAZAP1"
GO:0001945,BP,GO:0001945,lymph vessel development,0.592396093,VASH1
GO:0003171,BP,GO:0003171,atrioventricular valve development,0.592396093,BMP2
GO:0008334,BP,GO:0008334,histone mRNA metabolic process,0.592396093,PAPD5
GO:0010460,BP,GO:0010460,positive regulation of heart rate,0.592396093,TACR3
GO:0010640,BP,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,0.592396093,HGS
GO:0010996,BP,GO:0010996,response to auditory stimulus,0.592396093,NRXN2
GO:0021871,BP,GO:0021871,forebrain regionalization,0.592396093,BMP2
GO:0031293,BP,GO:0031293,membrane protein intracellular domain proteolysis,0.592396093,YBX1
GO:0031646,BP,GO:0031646,positive regulation of nervous system process,0.592396093,P2RX3
GO:0032461,BP,GO:0032461,positive regulation of protein oligomerization,0.592396093,SNX9
GO:0032528,BP,GO:0032528,microvillus organization,0.592396093,CDHR2
GO:0042430,BP,GO:0042430,indole-containing compound metabolic process,0.592396093,SLC34A1
GO:0045686,BP,GO:0045686,negative regulation of glial cell differentiation,0.592396093,HES5
GO:0046755,BP,GO:0046755,viral budding,0.592396093,SNF8
GO:0060259,BP,GO:0060259,regulation of feeding behavior,0.592396093,TACR3
GO:1903959,BP,GO:1903959,regulation of anion transmembrane transport,0.592396093,SLC34A1
GO:0048709,BP,GO:0048709,oligodendrocyte differentiation,0.598184829,"HES5,FA2H"
GO:0007519,BP,GO:0007519,skeletal muscle tissue development,0.598184829,"BCL9,KEL,MYH14"
GO:0022404,BP,GO:0022404,molting cycle process,0.598184829,"SPINK5,HPSE"
GO:0022405,BP,GO:0022405,hair cycle process,0.598184829,"SPINK5,HPSE"
GO:0098773,BP,GO:0098773,skin epidermis development,0.598184829,"SPINK5,HPSE"
GO:0006700,BP,GO:0006700,C21-steroid hormone biosynthetic process,0.598184829,BMP2
GO:0008211,BP,GO:0008211,glucocorticoid metabolic process,0.598184829,BMP2
GO:0008535,BP,GO:0008535,respiratory chain complex IV assembly,0.598184829,PET100
GO:0030149,BP,GO:0030149,sphingolipid catabolic process,0.598184829,NEU4
GO:0045939,BP,GO:0045939,negative regulation of steroid metabolic process,0.598184829,BMP2
GO:0046885,BP,GO:0046885,regulation of hormone biosynthetic process,0.598184829,BMP2
GO:0050974,BP,GO:0050974,detection of mechanical stimulus involved in sensory perception,0.598184829,PDZD7
GO:0055083,BP,GO:0055083,monovalent inorganic anion homeostasis,0.598184829,SLC34A1
GO:0055094,BP,GO:0055094,response to lipoprotein particle,0.598184829,TICAM1
GO:1901071,BP,GO:1901071,glucosamine-containing compound metabolic process,0.598184829,RENBP
GO:2000406,BP,GO:2000406,positive regulation of T cell migration,0.598184829,TMEM102
GO:2000463,BP,GO:2000463,positive regulation of excitatory postsynaptic potential,0.598184829,SHANK2
GO:0051147,BP,GO:0051147,regulation of muscle cell differentiation,0.598184829,"YBX1,CTDP1,BMP2"
GO:2000116,BP,GO:2000116,regulation of cysteine-type endopeptidase activity,0.598184829,"CST1,DNAJB6,DAP,BIRC5"
GO:0032088,BP,GO:0032088,negative regulation of NF-kappaB transcription factor activity,0.598184829,"DAB2IP,DAP"
GO:0043154,BP,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.598184829,"DNAJB6,BIRC5"
GO:0055024,BP,GO:0055024,regulation of cardiac muscle tissue development,0.598184829,"CTDP1,BMP2"
GO:0031331,BP,GO:0031331,positive regulation of cellular catabolic process,0.598184829,"TICAM1,GTPBP1,SNX9,IKBKG,DAB2IP"
GO:0042254,BP,GO:0042254,ribosome biogenesis,0.598184829,"PAPD5,UTP14A,PDCD11,DDX49,DDX51"
GO:0060993,BP,GO:0060993,kidney morphogenesis,0.598184829,"HES5,BMP2"
GO:0072080,BP,GO:0072080,nephron tubule development,0.598184829,"HES5,BMP2"
GO:1902106,BP,GO:1902106,negative regulation of leukocyte differentiation,0.598184829,"MAFB,IFNL1"
GO:0034470,BP,GO:0034470,ncRNA processing,0.598184829,"PAPD5,UTP14A,PDCD11,DDX49,ADAT3,DDX51"
GO:0006515,BP,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,0.598184829,SDF2L1
GO:0018195,BP,GO:0018195,peptidyl-arginine modification,0.598184829,KRTCAP2
GO:0022011,BP,GO:0022011,myelination in peripheral nervous system,0.598184829,FA2H
GO:0022400,BP,GO:0022400,regulation of rhodopsin mediated signaling pathway,0.598184829,GUCY2D
GO:0030194,BP,GO:0030194,positive regulation of blood coagulation,0.598184829,HPSE
GO:0032292,BP,GO:0032292,peripheral nervous system axon ensheathment,0.598184829,FA2H
GO:0032647,BP,GO:0032647,regulation of interferon-alpha production,0.598184829,IRF5
GO:0032814,BP,GO:0032814,regulation of natural killer cell activation,0.598184829,TICAM1
GO:0042481,BP,GO:0042481,regulation of odontogenesis,0.598184829,BMP2
GO:0043567,BP,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,0.598184829,BMP2
GO:0048169,BP,GO:0048169,regulation of long-term neuronal synaptic plasticity,0.598184829,SYNPO
GO:0050685,BP,GO:0050685,positive regulation of mRNA processing,0.598184829,DAZAP1
GO:0055022,BP,GO:0055022,negative regulation of cardiac muscle tissue growth,0.598184829,CTDP1
GO:0060314,BP,GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,0.598184829,CALM3
GO:0060706,BP,GO:0060706,cell differentiation involved in embryonic placenta development,0.598184829,DNAJB6
GO:0061117,BP,GO:0061117,negative regulation of heart growth,0.598184829,CTDP1
GO:0061615,BP,GO:0061615,glycolytic process through fructose-6-phosphate,0.598184829,GALK1
GO:0061620,BP,GO:0061620,glycolytic process through glucose-6-phosphate,0.598184829,GALK1
GO:0072273,BP,GO:0072273,metanephric nephron morphogenesis,0.598184829,HES5
GO:1900048,BP,GO:1900048,positive regulation of hemostasis,0.598184829,HPSE
GO:1900745,BP,GO:1900745,positive regulation of p38MAPK cascade,0.598184829,BMP2
GO:0031647,BP,GO:0031647,regulation of protein stability,0.598184829,"ASGR2,NCLN,GPIHBP1,BMP2"
GO:0042100,BP,GO:0042100,B cell proliferation,0.598184829,"TICAM1,TNFRSF13C"
GO:0010256,BP,GO:0010256,endomembrane system organization,0.598184829,"RILP,SNX9,SNF8,FA2H,CIT,HGS"
GO:0010596,BP,GO:0010596,negative regulation of endothelial cell migration,0.598184829,"VASH1,DAB2IP"
GO:0021782,BP,GO:0021782,glial cell development,0.598184829,"HES5,FA2H"
GO:0035282,BP,GO:0035282,segmentation,0.598184829,"MAFB,HES5"
GO:0036503,BP,GO:0036503,ERAD pathway,0.598184829,"SDF2L1,DNAJB12"
GO:0061326,BP,GO:0061326,renal tubule development,0.598184829,"HES5,BMP2"
GO:0000910,BP,GO:0000910,cytokinesis,0.598184829,"SNX9,CIT,CALM3"
GO:0006022,BP,GO:0006022,aminoglycan metabolic process,0.598184829,"ST3GAL2,ITIH4,HPSE"
GO:0032409,BP,GO:0032409,regulation of transporter activity,0.598184829,"SHISA9,FXYD6,SHANK2,CALM3"
GO:0030198,BP,GO:0030198,extracellular matrix organization,0.598184829,"SPINK5,ADAMTS14,SPINT1,DNAJB6,COL5A3"
GO:0009101,BP,GO:0009101,glycoprotein biosynthetic process,0.598184829,"ASGR2,KRTCAP2,ST3GAL2,SDF2L1,POMGNT1"
GO:0001773,BP,GO:0001773,myeloid dendritic cell activation,0.598184829,BATF3
GO:0007628,BP,GO:0007628,adult walking behavior,0.598184829,EFNB3
GO:0010575,BP,GO:0010575,positive regulation of vascular endothelial growth factor production,0.598184829,HPSE
GO:0010882,BP,GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,0.598184829,CALM3
GO:0031954,BP,GO:0031954,positive regulation of protein autophosphorylation,0.598184829,CALM3
GO:0032607,BP,GO:0032607,interferon-alpha production,0.598184829,IRF5
GO:0034661,BP,GO:0034661,ncRNA catabolic process,0.598184829,PAPD5
GO:0043921,BP,GO:0043921,modulation by host of viral transcription,0.598184829,CTDP1
GO:0045671,BP,GO:0045671,negative regulation of osteoclast differentiation,0.598184829,MAFB
GO:0046835,BP,GO:0046835,carbohydrate phosphorylation,0.598184829,GALK1
GO:0050820,BP,GO:0050820,positive regulation of coagulation,0.598184829,HPSE
GO:0052472,BP,GO:0052472,modulation by host of symbiont transcription,0.598184829,CTDP1
GO:0061099,BP,GO:0061099,negative regulation of protein tyrosine kinase activity,0.598184829,CBLC
GO:0071402,BP,GO:0071402,cellular response to lipoprotein particle stimulus,0.598184829,TICAM1
GO:0072207,BP,GO:0072207,metanephric epithelium development,0.598184829,HES5
GO:0090383,BP,GO:0090383,phagosome acidification,0.598184829,ATP6V0B
GO:1900101,BP,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,0.598184829,DAB2IP
GO:1904357,BP,GO:1904357,negative regulation of telomere maintenance via telomere lengthening,0.598184829,PAPD5
GO:0060538,BP,GO:0060538,skeletal muscle organ development,0.598184829,"BCL9,KEL,MYH14"
GO:0016925,BP,GO:0016925,protein sumoylation,0.598692168,"BIRC5,TOP1"
GO:0018958,BP,GO:0018958,phenol-containing compound metabolic process,0.598692168,"TACR3,AOC2"
GO:0042035,BP,GO:0042035,regulation of cytokine biosynthetic process,0.598692168,"TICAM1,TNFRSF13C"
GO:0008380,BP,GO:0008380,RNA splicing,0.600083742,"YBX1,MBNL3,SNRNP27,JMJD6,DAZAP1,DCAF4"
GO:0071466,BP,GO:0071466,cellular response to xenobiotic stimulus,0.600083742,"AOC2,ALDH3A1,CACNA1S"
GO:0071772,BP,GO:0071772,response to BMP,0.600083742,"HES5,SPINT1,BMP2"
GO:0071773,BP,GO:0071773,cellular response to BMP stimulus,0.600083742,"HES5,SPINT1,BMP2"
GO:0043405,BP,GO:0043405,regulation of MAP kinase activity,0.600439531,"IKBKG,BMP2,DAB2IP,CBLC,HGS"
GO:0002286,BP,GO:0002286,T cell activation involved in immune response,0.601683954,"IFNL1,APBB1IP"
GO:0002237,BP,GO:0002237,response to molecule of bacterial origin,0.601683954,"RELT,TICAM1,IRF5,TNFRSF14,DAB2IP"
GO:0010644,BP,GO:0010644,cell communication by electrical coupling,0.601683954,CALM3
GO:0021602,BP,GO:0021602,cranial nerve morphogenesis,0.601683954,MAFB
GO:0021799,BP,GO:0021799,cerebral cortex radially oriented cell migration,0.601683954,DAB2IP
GO:0034368,BP,GO:0034368,protein-lipid complex remodeling,0.601683954,GPIHBP1
GO:0034369,BP,GO:0034369,plasma lipoprotein particle remodeling,0.601683954,GPIHBP1
GO:0048265,BP,GO:0048265,response to pain,0.601683954,P2RX3
GO:0052312,BP,GO:0052312,modulation of transcription in other organism involved in symbiotic interaction,0.601683954,CTDP1
GO:0060292,BP,GO:0060292,long-term synaptic depression,0.601683954,SHANK2
GO:0061311,BP,GO:0061311,cell surface receptor signaling pathway involved in heart development,0.601683954,BMP2
GO:0071709,BP,GO:0071709,membrane assembly,0.601683954,NRXN2
GO:0090162,BP,GO:0090162,establishment of epithelial cell polarity,0.601683954,HES5
GO:0090659,BP,GO:0090659,walking behavior,0.601683954,EFNB3
GO:1901380,BP,GO:1901380,negative regulation of potassium ion transmembrane transport,0.601683954,KEL
GO:0002027,BP,GO:0002027,regulation of heart rate,0.601683954,"TACR3,CALM3"
GO:0006900,BP,GO:0006900,vesicle budding from membrane,0.601683954,"RILP,TRAPPC1"
GO:0048010,BP,GO:0048010,vascular endothelial growth factor receptor signaling pathway,0.601683954,"DAB2IP,HGS"
GO:0042391,BP,GO:0042391,regulation of membrane potential,0.607934747,"SLC34A1,P2RX5,P2RX3,MYH14,SHANK2,CACNA1S"
GO:0006469,BP,GO:0006469,negative regulation of protein kinase activity,0.607934747,"LRRC3C,DAB2IP,FAM212B,CBLC"
GO:0001782,BP,GO:0001782,B cell homeostasis,0.607934747,TNFRSF13C
GO:0003203,BP,GO:0003203,endocardial cushion morphogenesis,0.607934747,BMP2
GO:0007176,BP,GO:0007176,regulation of epidermal growth factor-activated receptor activity,0.607934747,CBLC
GO:0007194,BP,GO:0007194,negative regulation of adenylate cyclase activity,0.607934747,PALM
GO:0010614,BP,GO:0010614,negative regulation of cardiac muscle hypertrophy,0.607934747,CTDP1
GO:0010800,BP,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,0.607934747,CALM3
GO:0014044,BP,GO:0014044,Schwann cell development,0.607934747,FA2H
GO:0018146,BP,GO:0018146,keratan sulfate biosynthetic process,0.607934747,ST3GAL2
GO:0034367,BP,GO:0034367,protein-containing complex remodeling,0.607934747,GPIHBP1
GO:0034698,BP,GO:0034698,response to gonadotropin,0.607934747,PAPPA
GO:0046466,BP,GO:0046466,membrane lipid catabolic process,0.607934747,NEU4
GO:0051085,BP,GO:0051085,chaperone cofactor-dependent protein refolding,0.607934747,DNAJB12
GO:0051968,BP,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",0.607934747,SHANK2
GO:2000272,BP,GO:2000272,negative regulation of signaling receptor activity,0.607934747,CBLC
GO:0034766,BP,GO:0034766,negative regulation of ion transmembrane transport,0.608044966,"KEL,CALM3"
GO:0006986,BP,GO:0006986,response to unfolded protein,0.608044966,"TATDN2,DAB2IP,DNAJC4"
GO:0001822,BP,GO:0001822,kidney development,0.609553374,"SLC34A1,HES5,BMP2,JMJD6"
GO:0006936,BP,GO:0006936,muscle contraction,0.611325239,"TACR3,P2RX3,MYH14,CALM3,CACNA1S"
GO:0007041,BP,GO:0007041,lysosomal transport,0.612982095,"RILP,HGS"
GO:0030282,BP,GO:0030282,bone mineralization,0.612982095,"ASGR2,BMP2"
GO:0002221,BP,GO:0002221,pattern recognition receptor signaling pathway,0.612982095,"TICAM1,IKBKG,DAB2IP"
GO:0061013,BP,GO:0061013,regulation of mRNA catabolic process,0.612982095,"YBX1,GTPBP1,SECISBP2"
GO:0009065,BP,GO:0009065,glutamine family amino acid catabolic process,0.612982095,ASPG
GO:0010719,BP,GO:0010719,negative regulation of epithelial to mesenchymal transition,0.612982095,DAB2IP
GO:0010880,BP,GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,0.612982095,CALM3
GO:0016056,BP,GO:0016056,rhodopsin mediated signaling pathway,0.612982095,GUCY2D
GO:0016577,BP,GO:0016577,histone demethylation,0.612982095,JMJD6
GO:0031128,BP,GO:0031128,developmental induction,0.612982095,BMP2
GO:0032069,BP,GO:0032069,regulation of nuclease activity,0.612982095,DAB2IP
GO:0045191,BP,GO:0045191,regulation of isotype switching,0.612982095,IL27RA
GO:0048821,BP,GO:0048821,erythrocyte development,0.612982095,JMJD6
GO:0051491,BP,GO:0051491,positive regulation of filopodium assembly,0.612982095,PALM
GO:0061036,BP,GO:0061036,positive regulation of cartilage development,0.612982095,BMP2
GO:0065005,BP,GO:0065005,protein-lipid complex assembly,0.612982095,SNX9
GO:0042176,BP,GO:0042176,regulation of protein catabolic process,0.613564491,"RILP,SNX9,SNF8,DAB2IP,HGS"
GO:0090100,BP,GO:0090100,"positive regulation of transmembrane receptor protein serine,threonine kinase signaling pathway",0.620377941,"HES5,BMP2"
GO:0099173,BP,GO:0099173,postsynapse organization,0.620377941,"NRXN2,SHANK2"
GO:0140014,BP,GO:0140014,mitotic nuclear division,0.621255213,"UBE2C,CTDP1,PHF13,BIRC5"
GO:0001893,BP,GO:0001893,maternal placenta development,0.621255213,DAZAP1
GO:0003298,BP,GO:0003298,physiological muscle hypertrophy,0.621255213,CTDP1
GO:0003301,BP,GO:0003301,physiological cardiac muscle hypertrophy,0.621255213,CTDP1
GO:0014741,BP,GO:0014741,negative regulation of muscle hypertrophy,0.621255213,CTDP1
GO:0030201,BP,GO:0030201,heparan sulfate proteoglycan metabolic process,0.621255213,HPSE
GO:0031280,BP,GO:0031280,negative regulation of cyclase activity,0.621255213,PALM
GO:0033120,BP,GO:0033120,positive regulation of RNA splicing,0.621255213,DAZAP1
GO:0034142,BP,GO:0034142,toll-like receptor 4 signaling pathway,0.621255213,DAB2IP
GO:0061049,BP,GO:0061049,cell growth involved in cardiac muscle cell development,0.621255213,CTDP1
GO:2000403,BP,GO:2000403,positive regulation of lymphocyte migration,0.621255213,TMEM102
GO:0051261,BP,GO:0051261,protein depolymerization,0.621255213,"KIF19,TRIOBP"
GO:0003012,BP,GO:0003012,muscle system process,0.623980293,"CTDP1,TACR3,P2RX3,MYH14,CALM3,CACNA1S"
GO:0007565,BP,GO:0007565,female pregnancy,0.625461292,"PAPPA,KLF1,DAZAP1"
GO:0006482,BP,GO:0006482,protein demethylation,0.625461292,JMJD6
GO:0008038,BP,GO:0008038,neuron recognition,0.625461292,EFNB3
GO:0008214,BP,GO:0008214,protein dealkylation,0.625461292,JMJD6
GO:0009954,BP,GO:0009954,"proximal,distal pattern formation",0.625461292,HES5
GO:0010574,BP,GO:0010574,regulation of vascular endothelial growth factor production,0.625461292,HPSE
GO:0014072,BP,GO:0014072,response to isoquinoline alkaloid,0.625461292,TACR3
GO:0032735,BP,GO:0032735,positive regulation of interleukin-12 production,0.625461292,IRF5
GO:0042755,BP,GO:0042755,eating behavior,0.625461292,BSX
GO:0043276,BP,GO:0043276,anoikis,0.625461292,IKBKG
GO:0043278,BP,GO:0043278,response to morphine,0.625461292,TACR3
GO:0043403,BP,GO:0043403,skeletal muscle tissue regeneration,0.625461292,BCL9
GO:0046039,BP,GO:0046039,GTP metabolic process,0.625461292,GTPBP1
GO:0060317,BP,GO:0060317,cardiac epithelial to mesenchymal transition,0.625461292,BMP2
GO:1902893,BP,GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,0.625461292,BMP2
GO:0002698,BP,GO:0002698,negative regulation of immune effector process,0.625461292,"SPINK5,IFNL1"
GO:0010508,BP,GO:0010508,positive regulation of autophagy,0.625461292,"TICAM1,IKBKG"
GO:0042089,BP,GO:0042089,cytokine biosynthetic process,0.625461292,"TICAM1,TNFRSF13C"
GO:0046058,BP,GO:0046058,cAMP metabolic process,0.625461292,"PALM,CALM3"
GO:0010959,BP,GO:0010959,regulation of metal ion transport,0.625606545,"P2RX5,P2RX3,FXYD6,KEL,CALM3"
GO:0034976,BP,GO:0034976,response to endoplasmic reticulum stress,0.625606545,"SDF2L1,TATDN2,DNAJB12,DAB2IP"
GO:1901136,BP,GO:1901136,carbohydrate derivative catabolic process,0.627027497,"NEU4,HPSE,RENBP"
GO:0060047,BP,GO:0060047,heart contraction,0.627027497,"TACR3,FXYD6,CALM3,CACNA1S"
GO:0006939,BP,GO:0006939,smooth muscle contraction,0.627027497,"TACR3,P2RX3"
GO:0031398,BP,GO:0031398,positive regulation of protein ubiquitination,0.627027497,"UBE2C,TICAM1"
GO:0042107,BP,GO:0042107,cytokine metabolic process,0.627027497,"TICAM1,TNFRSF13C"
GO:0042692,BP,GO:0042692,muscle cell differentiation,0.627027497,"YBX1,BCL9,CTDP1,BMP2,KEL"
GO:0002701,BP,GO:0002701,negative regulation of production of molecular mediator of immune response,0.627027497,SPINK5
GO:0003338,BP,GO:0003338,metanephros morphogenesis,0.627027497,HES5
GO:0007274,BP,GO:0007274,neuromuscular synaptic transmission,0.627027497,P2RX3
GO:0015988,BP,GO:0015988,"energy coupled proton transmembrane transport, against electrochemical gradient",0.627027497,ATP6V0B
GO:0019433,BP,GO:0019433,triglyceride catabolic process,0.627027497,LIPE
GO:0030513,BP,GO:0030513,positive regulation of BMP signaling pathway,0.627027497,HES5
GO:0032350,BP,GO:0032350,regulation of hormone metabolic process,0.627027497,BMP2
GO:0044091,BP,GO:0044091,membrane biogenesis,0.627027497,NRXN2
GO:0048147,BP,GO:0048147,negative regulation of fibroblast proliferation,0.627027497,DAB2IP
GO:0051350,BP,GO:0051350,negative regulation of lyase activity,0.627027497,PALM
GO:0055090,BP,GO:0055090,acylglycerol homeostasis,0.627027497,GPIHBP1
GO:0070328,BP,GO:0070328,triglyceride homeostasis,0.627027497,GPIHBP1
GO:1901021,BP,GO:1901021,positive regulation of calcium ion transmembrane transporter activity,0.627027497,CALM3
GO:2000404,BP,GO:2000404,regulation of T cell migration,0.627027497,TMEM102
GO:0009410,BP,GO:0009410,response to xenobiotic stimulus,0.627027497,"TACR3,AOC2,ALDH3A1,CACNA1S"
GO:0010324,BP,GO:0010324,membrane invagination,0.627027497,"SNX9,HGS"
GO:0003015,BP,GO:0003015,heart process,0.62968956,"TACR3,FXYD6,CALM3,CACNA1S"
GO:0007631,BP,GO:0007631,feeding behavior,0.62968956,"BSX,TACR3"
GO:0009165,BP,GO:0009165,nucleotide biosynthetic process,0.62968956,"PALM,GALK1,GUCY2D,CALM3,NMRK2"
GO:0072001,BP,GO:0072001,renal system development,0.62968956,"SLC34A1,HES5,BMP2,JMJD6"
GO:0000460,BP,GO:0000460,maturation of 5.8S rRNA,0.62968956,PDCD11
GO:0002385,BP,GO:0002385,mucosal immune response,0.62968956,IFNLR1
GO:0003156,BP,GO:0003156,regulation of animal organ formation,0.62968956,BMP2
GO:0006623,BP,GO:0006623,protein targeting to vacuole,0.62968956,HGS
GO:0010573,BP,GO:0010573,vascular endothelial growth factor production,0.62968956,HPSE
GO:0014808,BP,GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,0.62968956,CALM3
GO:0030261,BP,GO:0030261,chromosome condensation,0.62968956,PHF13
GO:0038084,BP,GO:0038084,vascular endothelial growth factor signaling pathway,0.62968956,DAB2IP
GO:0042339,BP,GO:0042339,keratan sulfate metabolic process,0.62968956,ST3GAL2
GO:0045987,BP,GO:0045987,positive regulation of smooth muscle contraction,0.62968956,TACR3
GO:0046621,BP,GO:0046621,negative regulation of organ growth,0.62968956,CTDP1
GO:0051443,BP,GO:0051443,positive regulation of ubiquitin-protein transferase activity,0.62968956,UBE2C
GO:0051930,BP,GO:0051930,regulation of sensory perception of pain,0.62968956,P2RX3
GO:0051931,BP,GO:0051931,regulation of sensory perception,0.62968956,P2RX3
GO:0097502,BP,GO:0097502,mannosylation,0.62968956,SDF2L1
GO:1900015,BP,GO:1900015,regulation of cytokine production involved in inflammatory response,0.62968956,TICAM1
GO:1900026,BP,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,0.62968956,TRIOBP
GO:0072009,BP,GO:0072009,nephron epithelium development,0.629727646,"HES5,BMP2"
GO:0000041,BP,GO:0000041,transition metal ion transport,0.636712592,"MCOLN1,ATP6V0B"
GO:1901293,BP,GO:1901293,nucleoside phosphate biosynthetic process,0.636712592,"PALM,GALK1,GUCY2D,CALM3,NMRK2"
GO:0033673,BP,GO:0033673,negative regulation of kinase activity,0.636712592,"LRRC3C,DAB2IP,FAM212B,CBLC"
GO:0017004,BP,GO:0017004,cytochrome complex assembly,0.636712592,PET100
GO:0030501,BP,GO:0030501,positive regulation of bone mineralization,0.636712592,BMP2
GO:0031641,BP,GO:0031641,regulation of myelination,0.636712592,HES5
GO:0032456,BP,GO:0032456,endocytic recycling,0.636712592,SNF8
GO:0044331,BP,GO:0044331,cell-cell adhesion mediated by cadherin,0.636712592,CDHR2
GO:0048713,BP,GO:0048713,regulation of oligodendrocyte differentiation,0.636712592,HES5
GO:0048741,BP,GO:0048741,skeletal muscle fiber development,0.636712592,KEL
GO:0051084,BP,GO:0051084,'de novo' posttranslational protein folding,0.636712592,DNAJB12
GO:1903514,BP,GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,0.636712592,CALM3
GO:2000826,BP,GO:2000826,regulation of heart morphogenesis,0.636712592,BMP2
GO:0010633,BP,GO:0010633,negative regulation of epithelial cell migration,0.637110599,"VASH1,DAB2IP"
GO:0014902,BP,GO:0014902,myotube differentiation,0.638303355,"BCL9,KEL"
GO:0051209,BP,GO:0051209,release of sequestered calcium ion into cytosol,0.638303355,"MCOLN1,CALM3"
GO:0051283,BP,GO:0051283,negative regulation of sequestering of calcium ion,0.638303355,"MCOLN1,CALM3"
GO:0001941,BP,GO:0001941,postsynaptic membrane organization,0.638303355,NRXN2
GO:0002251,BP,GO:0002251,organ or tissue specific immune response,0.638303355,IFNLR1
GO:0003179,BP,GO:0003179,heart valve morphogenesis,0.638303355,BMP2
GO:0007257,BP,GO:0007257,activation of JUN kinase activity,0.638303355,DAB2IP
GO:0007603,BP,GO:0007603,"phototransduction, visible light",0.638303355,GUCY2D
GO:0030212,BP,GO:0030212,hyaluronan metabolic process,0.638303355,ITIH4
GO:0032205,BP,GO:0032205,negative regulation of telomere maintenance,0.638303355,PAPD5
GO:0035418,BP,GO:0035418,protein localization to synapse,0.638303355,NRXN2
GO:0043267,BP,GO:0043267,negative regulation of potassium ion transport,0.638303355,KEL
GO:0045684,BP,GO:0045684,positive regulation of epidermis development,0.638303355,HPSE
GO:0048854,BP,GO:0048854,brain morphogenesis,0.638303355,SHANK2
GO:0051693,BP,GO:0051693,actin filament capping,0.638303355,TRIOBP
GO:0060323,BP,GO:0060323,head morphogenesis,0.638303355,SSBP3
GO:0060416,BP,GO:0060416,response to growth hormone,0.638303355,SLC34A1
GO:0070266,BP,GO:0070266,necroptotic process,0.638303355,TICAM1
GO:0097352,BP,GO:0097352,autophagosome maturation,0.638303355,MCOLN1
GO:2000279,BP,GO:2000279,negative regulation of DNA biosynthetic process,0.638303355,PAPD5
GO:2001222,BP,GO:2001222,regulation of neuron migration,0.638303355,DAB2IP
GO:0042177,BP,GO:0042177,negative regulation of protein catabolic process,0.638303355,"RILP,DAB2IP"
GO:0051282,BP,GO:0051282,regulation of sequestering of calcium ion,0.638303355,"MCOLN1,CALM3"
GO:0070268,BP,GO:0070268,cornification,0.638303355,"SPINK5,KRT32"
GO:0048562,BP,GO:0048562,embryonic organ morphogenesis,0.641269339,"MAFB,MYO15A,PDZD7,TRIOBP"
GO:1903510,BP,GO:1903510,mucopolysaccharide metabolic process,0.641269339,"ST3GAL2,ITIH4"
GO:0000462,BP,GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",0.641269339,PDCD11
GO:0002534,BP,GO:0002534,cytokine production involved in inflammatory response,0.641269339,TICAM1
GO:0006308,BP,GO:0006308,DNA catabolic process,0.641269339,TATDN2
GO:0008207,BP,GO:0008207,C21-steroid hormone metabolic process,0.641269339,BMP2
GO:0009225,BP,GO:0009225,nucleotide-sugar metabolic process,0.641269339,RENBP
GO:0014037,BP,GO:0014037,Schwann cell differentiation,0.641269339,FA2H
GO:0019068,BP,GO:0019068,virion assembly,0.641269339,SNF8
GO:0032467,BP,GO:0032467,positive regulation of cytokinesis,0.641269339,CIT
GO:0045581,BP,GO:0045581,negative regulation of T cell differentiation,0.641269339,IFNL1
GO:0045742,BP,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,0.641269339,SHKBP1
GO:0045777,BP,GO:0045777,positive regulation of blood pressure,0.641269339,TACR3
GO:0045823,BP,GO:0045823,positive regulation of heart contraction,0.641269339,TACR3
GO:0061462,BP,GO:0061462,protein localization to lysosome,0.641269339,HGS
GO:0070423,BP,GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,0.641269339,IKBKG
GO:1905898,BP,GO:1905898,positive regulation of response to endoplasmic reticulum stress,0.641269339,DAB2IP
GO:1903522,BP,GO:1903522,regulation of blood circulation,0.641269339,"TACR3,FXYD6,CALM3,CACNA1S"
GO:0002700,BP,GO:0002700,regulation of production of molecular mediator of immune response,0.642342546,"SPINK5,IL27RA"
GO:0009152,BP,GO:0009152,purine ribonucleotide biosynthetic process,0.644684106,"PALM,GALK1,GUCY2D,CALM3"
GO:0071103,BP,GO:0071103,DNA conformation change,0.645249548,"H2AFB2,GRWD1,PHF13,TOP1"
GO:0019751,BP,GO:0019751,polyol metabolic process,0.645249548,"SLC34A1,GALK1"
GO:0051208,BP,GO:0051208,sequestering of calcium ion,0.645249548,"MCOLN1,CALM3"
GO:0014904,BP,GO:0014904,myotube cell development,0.645249548,KEL
GO:0035307,BP,GO:0035307,positive regulation of protein dephosphorylation,0.645249548,CALM3
GO:0035872,BP,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",0.645249548,IKBKG
GO:0042417,BP,GO:0042417,dopamine metabolic process,0.645249548,TACR3
GO:0048255,BP,GO:0048255,mRNA stabilization,0.645249548,YBX1
GO:0050691,BP,GO:0050691,regulation of defense response to virus by host,0.645249548,IFNLR1
GO:0051281,BP,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,0.645249548,CALM3
GO:0061614,BP,GO:0061614,pri-miRNA transcription by RNA polymerase II,0.645249548,BMP2
GO:0070296,BP,GO:0070296,sarcoplasmic reticulum calcium ion transport,0.645249548,CALM3
GO:0072350,BP,GO:0072350,tricarboxylic acid metabolic process,0.645249548,SLC34A1
GO:0098815,BP,GO:0098815,modulation of excitatory postsynaptic potential,0.645249548,SHANK2
GO:1901998,BP,GO:1901998,toxin transport,0.645249548,DNAJC17
GO:0006164,BP,GO:0006164,purine nucleotide biosynthetic process,0.652818902,"PALM,GALK1,GUCY2D,CALM3"
GO:0007204,BP,GO:0007204,positive regulation of cytosolic calcium ion concentration,0.652818902,"P2RX5,MCOLN1,P2RX3,CALM3"
GO:0022407,BP,GO:0022407,regulation of cell-cell adhesion,0.652818902,"IFNL1,EFNB3,BMP2,TNFRSF14,TNFRSF13C"
GO:0003197,BP,GO:0003197,endocardial cushion development,0.652818902,BMP2
GO:0021532,BP,GO:0021532,neural tube patterning,0.652818902,SSBP3
GO:0030835,BP,GO:0030835,negative regulation of actin filament depolymerization,0.652818902,TRIOBP
GO:0042088,BP,GO:0042088,T-helper 1 type immune response,0.652818902,IL27RA
GO:0048009,BP,GO:0048009,insulin-like growth factor receptor signaling pathway,0.652818902,BMP2
GO:0061014,BP,GO:0061014,positive regulation of mRNA catabolic process,0.652818902,GTPBP1
GO:1901020,BP,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,0.652818902,CALM3
GO:1901186,BP,GO:1901186,positive regulation of ERBB signaling pathway,0.652818902,SHKBP1
GO:0043393,BP,GO:0043393,regulation of protein binding,0.653198839,"TICAM1,BMP2,DAB2IP"
GO:0046718,BP,GO:0046718,viral entry into host cell,0.653198839,"EFNB3,TNFRSF14"
GO:0050871,BP,GO:0050871,positive regulation of B cell activation,0.653198839,"TICAM1,TNFRSF13C"
GO:0007584,BP,GO:0007584,response to nutrient,0.653198839,"SLC34A1,P2RX5,P2RX3"
GO:0002822,BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.653198839,"IL27RA,TNFRSF13C"
GO:0006805,BP,GO:0006805,xenobiotic metabolic process,0.653198839,"AOC2,ALDH3A1"
GO:0055088,BP,GO:0055088,lipid homeostasis,0.653198839,"ASGR2,GPIHBP1"
GO:0006323,BP,GO:0006323,DNA packaging,0.653198839,"H2AFB2,GRWD1,PHF13"
GO:0001709,BP,GO:0001709,cell fate determination,0.653198839,HES5
GO:0003009,BP,GO:0003009,skeletal muscle contraction,0.653198839,MYH14
GO:0003170,BP,GO:0003170,heart valve development,0.653198839,BMP2
GO:0006040,BP,GO:0006040,amino sugar metabolic process,0.653198839,RENBP
GO:0007019,BP,GO:0007019,microtubule depolymerization,0.653198839,KIF19
GO:0014014,BP,GO:0014014,negative regulation of gliogenesis,0.653198839,HES5
GO:0018023,BP,GO:0018023,peptidyl-lysine trimethylation,0.653198839,EEF2KMT
GO:0042181,BP,GO:0042181,ketone biosynthetic process,0.653198839,BMP2
GO:0045761,BP,GO:0045761,regulation of adenylate cyclase activity,0.653198839,PALM
GO:0046461,BP,GO:0046461,neutral lipid catabolic process,0.653198839,LIPE
GO:0046464,BP,GO:0046464,acylglycerol catabolic process,0.653198839,LIPE
GO:0070169,BP,GO:0070169,positive regulation of biomineral tissue development,0.653198839,BMP2
GO:0070317,BP,GO:0070317,negative regulation of G0 to G1 transition,0.653198839,DAB2IP
GO:0071364,BP,GO:0071364,cellular response to epidermal growth factor stimulus,0.653198839,DAB2IP
GO:0097028,BP,GO:0097028,dendritic cell differentiation,0.653198839,BATF3
GO:0034763,BP,GO:0034763,negative regulation of transmembrane transport,0.654784571,"KEL,CALM3"
GO:0051592,BP,GO:0051592,response to calcium ion,0.654784571,"MCOLN1,CALM3"
GO:0055007,BP,GO:0055007,cardiac muscle cell differentiation,0.654784571,"CTDP1,BMP2"
GO:0007160,BP,GO:0007160,cell-matrix adhesion,0.654784571,"HPSE,MSLNL,COL5A3"
GO:0009612,BP,GO:0009612,response to mechanical stimulus,0.654784571,"P2RX3,NRXN2,PDZD7"
GO:0001838,BP,GO:0001838,embryonic epithelial tube formation,0.656809647,"HES5,SPINT1"
GO:1903037,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,0.656809647,"IFNL1,EFNB3,TNFRSF14,TNFRSF13C"
GO:0001580,BP,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,0.656809647,CST1
GO:0006182,BP,GO:0006182,cGMP biosynthetic process,0.656809647,GUCY2D
GO:0009268,BP,GO:0009268,response to pH,0.656809647,MCOLN1
GO:0010799,BP,GO:0010799,regulation of peptidyl-threonine phosphorylation,0.656809647,CALM3
GO:0010955,BP,GO:0010955,negative regulation of protein processing,0.656809647,BIRC5
GO:0050434,BP,GO:0050434,positive regulation of viral transcription,0.656809647,CTDP1
GO:0060999,BP,GO:0060999,positive regulation of dendritic spine development,0.656809647,SHANK2
GO:0072210,BP,GO:0072210,metanephric nephron development,0.656809647,HES5
GO:0097300,BP,GO:0097300,programmed necrotic cell death,0.656809647,TICAM1
GO:1903318,BP,GO:1903318,negative regulation of protein maturation,0.656809647,BIRC5
GO:0090066,BP,GO:0090066,regulation of anatomical structure size,0.656853504,"RILP,SNF8,KEL,CIT,TRIOBP,CDHR2"
GO:0042476,BP,GO:0042476,odontogenesis,0.656853504,"SLC34A1,BMP2"
GO:0060359,BP,GO:0060359,response to ammonium ion,0.656853504,"SLC34A1,TACR3"
GO:0062014,BP,GO:0062014,negative regulation of small molecule metabolic process,0.656853504,"PALM,BMP2"
GO:0009260,BP,GO:0009260,ribonucleotide biosynthetic process,0.656853504,"PALM,GALK1,GUCY2D,CALM3"
GO:0032963,BP,GO:0032963,collagen metabolic process,0.656853504,"ADAMTS14,COL5A3"
GO:1903322,BP,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,0.656853504,"UBE2C,TICAM1"
GO:0050870,BP,GO:0050870,positive regulation of T cell activation,0.656853504,"EFNB3,TNFRSF14,TNFRSF13C"
GO:0002204,BP,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,0.656853504,IL27RA
GO:0002208,BP,GO:0002208,somatic diversification of immunoglobulins involved in immune response,0.656853504,IL27RA
GO:0006509,BP,GO:0006509,membrane protein ectodomain proteolysis,0.656853504,SNX9
GO:0021795,BP,GO:0021795,cerebral cortex cell migration,0.656853504,DAB2IP
GO:0031952,BP,GO:0031952,regulation of protein autophosphorylation,0.656853504,CALM3
GO:0032459,BP,GO:0032459,regulation of protein oligomerization,0.656853504,SNX9
GO:0043124,BP,GO:0043124,"negative regulation of I-kappaB kinase,NF-kappaB signaling",0.656853504,DAB2IP
GO:0043489,BP,GO:0043489,RNA stabilization,0.656853504,YBX1
GO:0045190,BP,GO:0045190,isotype switching,0.656853504,IL27RA
GO:0045429,BP,GO:0045429,positive regulation of nitric oxide biosynthetic process,0.656853504,TICAM1
GO:0051489,BP,GO:0051489,regulation of filopodium assembly,0.656853504,PALM
GO:0051602,BP,GO:0051602,response to electrical stimulus,0.656853504,PALM
GO:0090382,BP,GO:0090382,phagosome maturation,0.656853504,ATP6V0B
GO:1903793,BP,GO:1903793,positive regulation of anion transport,0.656853504,SLC34A1
GO:1904407,BP,GO:1904407,positive regulation of nitric oxide metabolic process,0.656853504,TICAM1
GO:0032355,BP,GO:0032355,response to estradiol,0.660957783,"SLC34A1,TACR3"
GO:0072522,BP,GO:0072522,purine-containing compound biosynthetic process,0.660957783,"PALM,GALK1,GUCY2D,CALM3"
GO:1901615,BP,GO:1901615,organic hydroxy compound metabolic process,0.660957783,"SLC34A1,LIPE,GALK1,TACR3,BMP2,AOC2"
GO:0016050,BP,GO:0016050,vesicle organization,0.660957783,"RILP,SNX9,SNF8,TRAPPC1,HGS"
GO:0046390,BP,GO:0046390,ribose phosphate biosynthetic process,0.660957783,"PALM,GALK1,GUCY2D,CALM3"
GO:0002832,BP,GO:0002832,negative regulation of response to biotic stimulus,0.660957783,SPINK5
GO:0006270,BP,GO:0006270,DNA replication initiation,0.660957783,ORC6
GO:0021762,BP,GO:0021762,substantia nigra development,0.660957783,CALM3
GO:0021983,BP,GO:0021983,pituitary gland development,0.660957783,BMP2
GO:0043277,BP,GO:0043277,apoptotic cell clearance,0.660957783,JMJD6
GO:0043631,BP,GO:0043631,RNA polyadenylation,0.660957783,PAPD5
GO:0045104,BP,GO:0045104,intermediate filament cytoskeleton organization,0.660957783,DNAJB6
GO:0050982,BP,GO:0050982,detection of mechanical stimulus,0.660957783,PDZD7
GO:1903170,BP,GO:1903170,negative regulation of calcium ion transmembrane transport,0.660957783,CALM3
GO:0006664,BP,GO:0006664,glycolipid metabolic process,0.660957783,"ST3GAL2,NEU4"
GO:1903509,BP,GO:1903509,liposaccharide metabolic process,0.660957783,"ST3GAL2,NEU4"
GO:0043281,BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.662127563,"DNAJB6,DAP,BIRC5"
GO:0051348,BP,GO:0051348,negative regulation of transferase activity,0.663050096,"LRRC3C,DAB2IP,FAM212B,CBLC"
GO:0002831,BP,GO:0002831,regulation of response to biotic stimulus,0.666083045,"IFNLR1,SPINK5"
GO:0044706,BP,GO:0044706,multi-multicellular organism process,0.667973285,"PAPPA,KLF1,DAZAP1"
GO:0034198,BP,GO:0034198,cellular response to amino acid starvation,0.667973285,DAP
GO:0045103,BP,GO:0045103,intermediate filament-based process,0.667973285,DNAJB6
GO:0070316,BP,GO:0070316,regulation of G0 to G1 transition,0.667973285,DAB2IP
GO:0070849,BP,GO:0070849,response to epidermal growth factor,0.667973285,DAB2IP
GO:1904837,BP,GO:1904837,beta-catenin-TCF complex assembly,0.667973285,BCL9
GO:0045580,BP,GO:0045580,regulation of T cell differentiation,0.668405396,"SPINK5,IFNL1"
GO:0097553,BP,GO:0097553,calcium ion transmembrane import into cytosol,0.668405396,"MCOLN1,CALM3"
GO:0009581,BP,GO:0009581,detection of external stimulus,0.670833456,"PDZD7,GUCY2D"
GO:0000381,BP,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",0.670833456,MBNL3
GO:0008347,BP,GO:0008347,glial cell migration,0.670833456,DAB2IP
GO:0032011,BP,GO:0032011,ARF protein signal transduction,0.670833456,IQSEC3
GO:0032012,BP,GO:0032012,regulation of ARF protein signal transduction,0.670833456,IQSEC3
GO:0043551,BP,GO:0043551,regulation of phosphatidylinositol 3-kinase activity,0.670833456,DAB2IP
GO:0045646,BP,GO:0045646,regulation of erythrocyte differentiation,0.670833456,MAFB
GO:0048538,BP,GO:0048538,thymus development,0.670833456,MAFB
GO:0050912,BP,GO:0050912,detection of chemical stimulus involved in sensory perception of taste,0.670833456,CST1
GO:0050913,BP,GO:0050913,sensory perception of bitter taste,0.670833456,CST1
GO:0070534,BP,GO:0070534,protein K63-linked ubiquitination,0.670833456,UBE2T
GO:0071827,BP,GO:0071827,plasma lipoprotein particle organization,0.670833456,GPIHBP1
GO:2000772,BP,GO:2000772,regulation of cellular senescence,0.670833456,VASH1
GO:0032984,BP,GO:0032984,protein-containing complex disassembly,0.670833456,"KIF19,GRWD1,MCOLN1,TRIOBP"
GO:0019359,BP,GO:0019359,nicotinamide nucleotide biosynthetic process,0.670833456,"GALK1,NMRK2"
GO:0019363,BP,GO:0019363,pyridine nucleotide biosynthetic process,0.670833456,"GALK1,NMRK2"
GO:0030968,BP,GO:0030968,endoplasmic reticulum unfolded protein response,0.670833456,"TATDN2,DAB2IP"
GO:0072175,BP,GO:0072175,epithelial tube formation,0.670833456,"HES5,SPINT1"
GO:0006643,BP,GO:0006643,membrane lipid metabolic process,0.670833456,"ST3GAL2,NEU4,FA2H"
GO:0048738,BP,GO:0048738,cardiac muscle tissue development,0.670833456,"XIRP2,CTDP1,BMP2"
GO:0051251,BP,GO:0051251,positive regulation of lymphocyte activation,0.671127973,"TICAM1,EFNB3,TNFRSF14,TNFRSF13C"
GO:0001655,BP,GO:0001655,urogenital system development,0.671127973,"SLC34A1,HES5,BMP2,JMJD6"
GO:0002819,BP,GO:0002819,regulation of adaptive immune response,0.671127973,"IL27RA,TNFRSF13C"
GO:0046683,BP,GO:0046683,response to organophosphorus,0.671127973,"P2RX5,P2RX3"
GO:0002067,BP,GO:0002067,glandular epithelial cell differentiation,0.671127973,BMP2
GO:0002712,BP,GO:0002712,regulation of B cell mediated immunity,0.671127973,IL27RA
GO:0002762,BP,GO:0002762,negative regulation of myeloid leukocyte differentiation,0.671127973,MAFB
GO:0002889,BP,GO:0002889,regulation of immunoglobulin mediated immune response,0.671127973,IL27RA
GO:0016447,BP,GO:0016447,somatic recombination of immunoglobulin gene segments,0.671127973,IL27RA
GO:0019731,BP,GO:0019731,antibacterial humoral response,0.671127973,SPINK5
GO:0043330,BP,GO:0043330,response to exogenous dsRNA,0.671127973,TICAM1
GO:0045023,BP,GO:0045023,G0 to G1 transition,0.671127973,DAB2IP
GO:0045620,BP,GO:0045620,negative regulation of lymphocyte differentiation,0.671127973,IFNL1
GO:0045744,BP,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,0.671127973,PALM
GO:0060443,BP,GO:0060443,mammary gland morphogenesis,0.671127973,BSX
GO:0072132,BP,GO:0072132,mesenchyme morphogenesis,0.671127973,BMP2
GO:0043122,BP,GO:0043122,"regulation of I-kappaB kinase,NF-kappaB signaling",0.67148863,"TICAM1,IKBKG,DAB2IP"
GO:0006816,BP,GO:0006816,calcium ion transport,0.671535318,"P2RX5,MCOLN1,P2RX3,CALM3,CACNA1S"
GO:0043588,BP,GO:0043588,skin development,0.671535318,"SPINK5,KRT32,HPSE,FA2H,COL5A3"
GO:0009582,BP,GO:0009582,detection of abiotic stimulus,0.671886433,"PDZD7,GUCY2D"
GO:0050671,BP,GO:0050671,positive regulation of lymphocyte proliferation,0.671886433,"TICAM1,TNFRSF13C"
GO:0072329,BP,GO:0072329,monocarboxylic acid catabolic process,0.671886433,"LIPE,ASPG"
GO:1903039,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,0.672470168,"EFNB3,TNFRSF14,TNFRSF13C"
GO:0031589,BP,GO:0031589,cell-substrate adhesion,0.672470168,"HPSE,TRIOBP,MSLNL,COL5A3"
GO:0031214,BP,GO:0031214,biomineral tissue development,0.672470168,"ASGR2,BMP2"
GO:0032946,BP,GO:0032946,positive regulation of mononuclear cell proliferation,0.672470168,"TICAM1,TNFRSF13C"
GO:0072525,BP,GO:0072525,pyridine-containing compound biosynthetic process,0.672470168,"GALK1,NMRK2"
GO:0009409,BP,GO:0009409,response to cold,0.672470168,P2RX3
GO:0016339,BP,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,0.672470168,PCDHB16
GO:0021695,BP,GO:0021695,cerebellar cortex development,0.672470168,ARCN1
GO:0030809,BP,GO:0030809,negative regulation of nucleotide biosynthetic process,0.672470168,PALM
GO:0034260,BP,GO:0034260,negative regulation of GTPase activity,0.672470168,DAB2IP
GO:0050732,BP,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,0.672470168,CBLC
GO:1900372,BP,GO:1900372,negative regulation of purine nucleotide biosynthetic process,0.672470168,PALM
GO:1901028,BP,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,0.672470168,TMEM102
GO:0006414,BP,GO:0006414,translational elongation,0.675010075,"GTPBP1,SECISBP2"
GO:0002381,BP,GO:0002381,immunoglobulin production involved in immunoglobulin mediated immune response,0.675010075,IL27RA
GO:0006953,BP,GO:0006953,acute-phase response,0.675010075,ITIH4
GO:0007528,BP,GO:0007528,neuromuscular junction development,0.675010075,SHANK2
GO:0008542,BP,GO:0008542,visual learning,0.675010075,SYNPO
GO:0010463,BP,GO:0010463,mesenchymal cell proliferation,0.675010075,BMP2
GO:0010718,BP,GO:0010718,positive regulation of epithelial to mesenchymal transition,0.675010075,BMP2
GO:0010862,BP,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,0.675010075,BMP2
GO:0017001,BP,GO:0017001,antibiotic catabolic process,0.675010075,RENBP
GO:0021545,BP,GO:0021545,cranial nerve development,0.675010075,MAFB
GO:0030071,BP,GO:0030071,"regulation of mitotic metaphase,anaphase transition",0.675010075,UBE2C
GO:0045747,BP,GO:0045747,positive regulation of Notch signaling pathway,0.675010075,HES5
GO:0046580,BP,GO:0046580,negative regulation of Ras protein signal transduction,0.675010075,DAB2IP
GO:0051452,BP,GO:0051452,intracellular pH reduction,0.675010075,ATP6V0B
GO:0060042,BP,GO:0060042,retina morphogenesis in camera-type eye,0.675010075,FJX1
GO:0009308,BP,GO:0009308,amine metabolic process,0.675010075,"TACR3,AOC2"
GO:0044409,BP,GO:0044409,entry into host,0.675010075,"EFNB3,TNFRSF14"
GO:0006874,BP,GO:0006874,cellular calcium ion homeostasis,0.677986736,"P2RX5,MCOLN1,P2RX3,KEL,CALM3"
GO:0001837,BP,GO:0001837,epithelial to mesenchymal transition,0.678359392,"BMP2,DAB2IP"
GO:0034767,BP,GO:0034767,positive regulation of ion transmembrane transport,0.678359392,"SLC34A1,CALM3"
GO:0050773,BP,GO:0050773,regulation of dendrite development,0.678359392,"SHANK2,DAB2IP"
GO:0051480,BP,GO:0051480,regulation of cytosolic calcium ion concentration,0.678359392,"P2RX5,MCOLN1,P2RX3,CALM3"
GO:0010171,BP,GO:0010171,body morphogenesis,0.678359392,SSBP3
GO:0030834,BP,GO:0030834,regulation of actin filament depolymerization,0.678359392,TRIOBP
GO:0045851,BP,GO:0045851,pH reduction,0.678359392,ATP6V0B
GO:0051055,BP,GO:0051055,negative regulation of lipid biosynthetic process,0.678359392,BMP2
GO:0086010,BP,GO:0086010,membrane depolarization during action potential,0.678359392,CACNA1S
GO:1900024,BP,GO:1900024,regulation of substrate adhesion-dependent cell spreading,0.678359392,TRIOBP
GO:1902099,BP,GO:1902099,"regulation of metaphase,anaphase transition of cell cycle",0.678359392,UBE2C
GO:2000401,BP,GO:2000401,regulation of lymphocyte migration,0.678359392,TMEM102
GO:2000649,BP,GO:2000649,regulation of sodium ion transmembrane transporter activity,0.678359392,FXYD6
GO:0051924,BP,GO:0051924,regulation of calcium ion transport,0.678486331,"P2RX5,P2RX3,CALM3"
GO:0072006,BP,GO:0072006,nephron development,0.67903038,"HES5,BMP2"
GO:0007389,BP,GO:0007389,pattern specification process,0.682864046,"MAFB,HES5,BMP2,RTTN,SSBP3"
GO:0032496,BP,GO:0032496,response to lipopolysaccharide,0.682864046,"RELT,TICAM1,TNFRSF14,DAB2IP"
GO:0060041,BP,GO:0060041,retina development in camera-type eye,0.682864046,"FJX1,JMJD6"
GO:0032655,BP,GO:0032655,regulation of interleukin-12 production,0.682864046,IRF5
GO:0036297,BP,GO:0036297,interstrand cross-link repair,0.682864046,UBE2T
GO:0043113,BP,GO:0043113,receptor clustering,0.682864046,NRXN2
GO:0045933,BP,GO:0045933,positive regulation of muscle contraction,0.682864046,TACR3
GO:0050879,BP,GO:0050879,multicellular organismal movement,0.682864046,MYH14
GO:0050881,BP,GO:0050881,musculoskeletal movement,0.682864046,MYH14
GO:0055081,BP,GO:0055081,anion homeostasis,0.682864046,SLC34A1
GO:0009267,BP,GO:0009267,cellular response to starvation,0.684980085,"DAP,GAS2L1"
GO:0016999,BP,GO:0016999,antibiotic metabolic process,0.684980085,"SLC34A1,RENBP"
GO:0030098,BP,GO:0030098,lymphocyte differentiation,0.68770607,"MAFB,SPINK5,IFNL1,JMJD6"
GO:0070665,BP,GO:0070665,positive regulation of leukocyte proliferation,0.68770607,"TICAM1,TNFRSF13C"
GO:0072073,BP,GO:0072073,kidney epithelium development,0.68770607,"HES5,BMP2"
GO:0007091,BP,GO:0007091,"metaphase,anaphase transition of mitotic cell cycle",0.68770607,UBE2C
GO:0042220,BP,GO:0042220,response to cocaine,0.68770607,TACR3
GO:0060997,BP,GO:0060997,dendritic spine morphogenesis,0.68770607,SHANK2
GO:0070206,BP,GO:0070206,protein trimerization,0.68770607,TRIM4
GO:0072678,BP,GO:0072678,T cell migration,0.68770607,TMEM102
GO:2001258,BP,GO:2001258,negative regulation of cation channel activity,0.68770607,CALM3
GO:0008277,BP,GO:0008277,regulation of G protein-coupled receptor signaling pathway,0.691288397,"PALM,GUCY2D"
GO:0051092,BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,0.691288397,"TICAM1,IKBKG"
GO:0003002,BP,GO:0003002,regionalization,0.69185014,"MAFB,HES5,BMP2,SSBP3"
GO:0055074,BP,GO:0055074,calcium ion homeostasis,0.69185014,"P2RX5,MCOLN1,P2RX3,KEL,CALM3"
GO:0009435,BP,GO:0009435,NAD biosynthetic process,0.69185014,NMRK2
GO:0019320,BP,GO:0019320,hexose catabolic process,0.69185014,GALK1
GO:0030042,BP,GO:0030042,actin filament depolymerization,0.69185014,TRIOBP
GO:0032615,BP,GO:0032615,interleukin-12 production,0.69185014,IRF5
GO:0044784,BP,GO:0044784,"metaphase,anaphase transition of cell cycle",0.69185014,UBE2C
GO:0045840,BP,GO:0045840,positive regulation of mitotic nuclear division,0.69185014,UBE2C
GO:0048008,BP,GO:0048008,platelet-derived growth factor receptor signaling pathway,0.69185014,HGS
GO:0070265,BP,GO:0070265,necrotic cell death,0.69185014,TICAM1
GO:0007159,BP,GO:0007159,leukocyte cell-cell adhesion,0.694275758,"IFNL1,EFNB3,TNFRSF14,TNFRSF13C"
GO:0050804,BP,GO:0050804,modulation of chemical synaptic transmission,0.694275758,"SHISA9,P2RX3,SYNPO,SHANK2"
GO:0099177,BP,GO:0099177,regulation of trans-synaptic signaling,0.694275758,"SHISA9,P2RX3,SYNPO,SHANK2"
GO:0016202,BP,GO:0016202,regulation of striated muscle tissue development,0.694275758,"CTDP1,BMP2"
GO:0000819,BP,GO:0000819,sister chromatid segregation,0.694275758,"UBE2C,PHF13,BIRC5"
GO:0006458,BP,GO:0006458,'de novo' protein folding,0.694275758,DNAJB12
GO:0007632,BP,GO:0007632,visual behavior,0.694275758,SYNPO
GO:0021879,BP,GO:0021879,forebrain neuron differentiation,0.694275758,HES5
GO:0032210,BP,GO:0032210,regulation of telomere maintenance via telomerase,0.694275758,PAPD5
GO:0043550,BP,GO:0043550,regulation of lipid kinase activity,0.694275758,DAB2IP
GO:0046068,BP,GO:0046068,cGMP metabolic process,0.694275758,GUCY2D
GO:0051438,BP,GO:0051438,regulation of ubiquitin-protein transferase activity,0.694275758,UBE2C
GO:0090342,BP,GO:0090342,regulation of cell aging,0.694275758,VASH1
GO:1901068,BP,GO:1901068,guanosine-containing compound metabolic process,0.694275758,GTPBP1
GO:1903428,BP,GO:1903428,positive regulation of reactive oxygen species biosynthetic process,0.694275758,TICAM1
GO:0001933,BP,GO:0001933,negative regulation of protein phosphorylation,0.694491415,"LRRC3C,DAB2IP,FAM212B,CBLC,CALM3"
GO:0043271,BP,GO:0043271,negative regulation of ion transport,0.694491415,"KEL,CALM3"
GO:0051017,BP,GO:0051017,actin filament bundle assembly,0.694491415,"SYNPO,TRIOBP"
GO:0007611,BP,GO:0007611,learning or memory,0.696042777,"NRXN2,SYNPO,SHANK2"
GO:0007269,BP,GO:0007269,neurotransmitter secretion,0.696042777,"SYN2,NRXN2"
GO:0030902,BP,GO:0030902,hindbrain development,0.696042777,"MAFB,ARCN1"
GO:0046467,BP,GO:0046467,membrane lipid biosynthetic process,0.696042777,"ST3GAL2,FA2H"
GO:0099643,BP,GO:0099643,signal release from synapse,0.696042777,"SYN2,NRXN2"
GO:1901861,BP,GO:1901861,regulation of muscle tissue development,0.696042777,"CTDP1,BMP2"
GO:0010965,BP,GO:0010965,regulation of mitotic sister chromatid separation,0.696042777,UBE2C
GO:0022029,BP,GO:0022029,telencephalon cell migration,0.696042777,DAB2IP
GO:0031663,BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,0.696042777,TICAM1
GO:0034394,BP,GO:0034394,protein localization to cell surface,0.696042777,GPIHBP1
GO:0035924,BP,GO:0035924,cellular response to vascular endothelial growth factor stimulus,0.696042777,DAB2IP
GO:0051058,BP,GO:0051058,negative regulation of small GTPase mediated signal transduction,0.696042777,DAB2IP
GO:0090303,BP,GO:0090303,positive regulation of wound healing,0.696042777,HPSE
GO:0090257,BP,GO:0090257,regulation of muscle system process,0.697329021,"CTDP1,TACR3,CALM3"
GO:0098742,BP,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,0.697329021,"BMP2,PCDHB16,CDHR2"
GO:0006334,BP,GO:0006334,nucleosome assembly,0.697329021,"H2AFB2,GRWD1"
GO:0016482,BP,GO:0016482,cytosolic transport,0.697329021,"RILP,SNF8"
GO:0007596,BP,GO:0007596,blood coagulation,0.700211108,"PHF21A,P2RX5,P2RX3,HPSE"
GO:0035725,BP,GO:0035725,sodium ion transmembrane transport,0.700211108,"SLC34A1,FXYD6"
GO:0048634,BP,GO:0048634,regulation of muscle organ development,0.700211108,"CTDP1,BMP2"
GO:0032722,BP,GO:0032722,positive regulation of chemokine production,0.700211108,TICAM1
GO:0032922,BP,GO:0032922,circadian regulation of gene expression,0.700211108,TOP1
GO:0086065,BP,GO:0086065,cell communication involved in cardiac conduction,0.700211108,CALM3
GO:0097345,BP,GO:0097345,mitochondrial outer membrane permeabilization,0.700211108,TMEM102
GO:0019932,BP,GO:0019932,second-messenger-mediated signaling,0.701362328,"P2RX5,MCOLN1,P2RX3,CALM3"
GO:0016331,BP,GO:0016331,morphogenesis of embryonic epithelium,0.70359057,"HES5,SPINT1"
GO:0061572,BP,GO:0061572,actin filament bundle organization,0.70359057,"SYNPO,TRIOBP"
GO:0002562,BP,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,0.704120551,IL27RA
GO:0002637,BP,GO:0002637,regulation of immunoglobulin production,0.704120551,IL27RA
GO:0008333,BP,GO:0008333,endosome to lysosome transport,0.704120551,RILP
GO:0016444,BP,GO:0016444,somatic cell DNA recombination,0.704120551,IL27RA
GO:0016445,BP,GO:0016445,somatic diversification of immunoglobulins,0.704120551,IL27RA
GO:0031122,BP,GO:0031122,cytoplasmic microtubule organization,0.704120551,KIF19
GO:0031279,BP,GO:0031279,regulation of cyclase activity,0.704120551,PALM
GO:0051306,BP,GO:0051306,mitotic sister chromatid separation,0.704120551,UBE2C
GO:0034620,BP,GO:0034620,cellular response to unfolded protein,0.704120551,"TATDN2,DAB2IP"
GO:1901657,BP,GO:1901657,glycosyl compound metabolic process,0.704120551,"SLC34A1,GTPBP1"
GO:0035051,BP,GO:0035051,cardiocyte differentiation,0.706058924,"CTDP1,BMP2"
GO:0007599,BP,GO:0007599,hemostasis,0.706058924,"PHF21A,P2RX5,P2RX3,HPSE"
GO:0000380,BP,GO:0000380,"alternative mRNA splicing, via spliceosome",0.706058924,MBNL3
GO:0002532,BP,GO:0002532,production of molecular mediator involved in inflammatory response,0.706058924,TICAM1
GO:0009066,BP,GO:0009066,aspartate family amino acid metabolic process,0.706058924,ASPG
GO:0021885,BP,GO:0021885,forebrain cell migration,0.706058924,DAB2IP
GO:0030837,BP,GO:0030837,negative regulation of actin filament polymerization,0.706058924,TRIOBP
GO:0032233,BP,GO:0032233,positive regulation of actin filament bundle assembly,0.706058924,SYNPO
GO:0034381,BP,GO:0034381,plasma lipoprotein particle clearance,0.706058924,GPIHBP1
GO:0046503,BP,GO:0046503,glycerolipid catabolic process,0.706058924,LIPE
GO:0051339,BP,GO:0051339,regulation of lyase activity,0.706058924,PALM
GO:0072577,BP,GO:0072577,endothelial cell apoptotic process,0.706058924,DAB2IP
GO:1900543,BP,GO:1900543,negative regulation of purine nucleotide metabolic process,0.706058924,PALM
GO:0050817,BP,GO:0050817,coagulation,0.706296261,"PHF21A,P2RX5,P2RX3,HPSE"
GO:0032874,BP,GO:0032874,positive regulation of stress-activated MAPK cascade,0.707118989,"BMP2,DAB2IP"
GO:0051262,BP,GO:0051262,protein tetramerization,0.707118989,"MCOLN1,KCNC3"
GO:0000070,BP,GO:0000070,mitotic sister chromatid segregation,0.707270119,"UBE2C,PHF13"
GO:0070304,BP,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,0.707270119,"BMP2,DAB2IP"
GO:0090288,BP,GO:0090288,negative regulation of cellular response to growth factor stimulus,0.707270119,"DAB2IP,HGS"
GO:0007050,BP,GO:0007050,cell cycle arrest,0.707270119,"VASH1,DAB2IP,GAS2L1"
GO:0007602,BP,GO:0007602,phototransduction,0.707270119,GUCY2D
GO:0009584,BP,GO:0009584,detection of visible light,0.707270119,GUCY2D
GO:0045428,BP,GO:0045428,regulation of nitric oxide biosynthetic process,0.707270119,TICAM1
GO:0045604,BP,GO:0045604,regulation of epidermal cell differentiation,0.707270119,HES5
GO:0045980,BP,GO:0045980,negative regulation of nucleotide metabolic process,0.707270119,PALM
GO:0046847,BP,GO:0046847,filopodium assembly,0.707270119,PALM
GO:0051865,BP,GO:0051865,protein autoubiquitination,0.707270119,UBE2T
GO:1905818,BP,GO:1905818,regulation of chromosome separation,0.707270119,UBE2C
GO:2001259,BP,GO:2001259,positive regulation of cation channel activity,0.707270119,CALM3
GO:1900371,BP,GO:1900371,regulation of purine nucleotide biosynthetic process,0.710987916,"PALM,CALM3"
GO:0002696,BP,GO:0002696,positive regulation of leukocyte activation,0.711460118,"TICAM1,EFNB3,TNFRSF14,TNFRSF13C"
GO:0006402,BP,GO:0006402,mRNA catabolic process,0.711460118,"YBX1,GTPBP1,PAPD5,SECISBP2"
GO:0001658,BP,GO:0001658,branching involved in ureteric bud morphogenesis,0.712342162,BMP2
GO:0061844,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,0.712342162,SPINK5
GO:0070059,BP,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.712342162,DAB2IP
GO:0071806,BP,GO:0071806,protein transmembrane transport,0.712342162,GPIHBP1
GO:1902305,BP,GO:1902305,regulation of sodium ion transmembrane transport,0.712342162,FXYD6
GO:0030808,BP,GO:0030808,regulation of nucleotide biosynthetic process,0.712370431,"PALM,CALM3"
GO:0045089,BP,GO:0045089,positive regulation of innate immune response,0.714283652,"TICAM1,IKBKG,DAB2IP,POLR3D"
GO:0019827,BP,GO:0019827,stem cell population maintenance,0.714283652,"HES5,BCL9"
GO:0110053,BP,GO:0110053,regulation of actin filament organization,0.714283652,"SYNPO,CIT,TRIOBP"
GO:0002753,BP,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,0.714283652,IKBKG
GO:0003407,BP,GO:0003407,neural retina development,0.714283652,FJX1
GO:0006910,BP,GO:0006910,"phagocytosis, recognition",0.714283652,JMJD6
GO:0045600,BP,GO:0045600,positive regulation of fat cell differentiation,0.714283652,BMP2
GO:0045669,BP,GO:0045669,positive regulation of osteoblast differentiation,0.714283652,BMP2
GO:0048247,BP,GO:0048247,lymphocyte chemotaxis,0.714283652,TMEM102
GO:0048747,BP,GO:0048747,muscle fiber development,0.714283652,KEL
GO:0071242,BP,GO:0071242,cellular response to ammonium ion,0.714283652,SLC34A1
GO:0071277,BP,GO:0071277,cellular response to calcium ion,0.714283652,MCOLN1
GO:1904356,BP,GO:1904356,regulation of telomere maintenance via telomere lengthening,0.714283652,PAPD5
GO:0071902,BP,GO:0071902,"positive regulation of protein serine,threonine kinase activity",0.714546137,"IKBKG,BMP2,DAB2IP,CALM3"
GO:0045619,BP,GO:0045619,regulation of lymphocyte differentiation,0.714546137,"SPINK5,IFNL1"
GO:0071248,BP,GO:0071248,cellular response to metal ion,0.714546137,"SLC34A1,MCOLN1"
GO:0099531,BP,GO:0099531,presynaptic process involved in chemical synaptic transmission,0.714546137,"SYN2,NRXN2"
GO:0072503,BP,GO:0072503,cellular divalent inorganic cation homeostasis,0.716104395,"P2RX5,MCOLN1,P2RX3,KEL,CALM3"
GO:0007249,BP,GO:0007249,"I-kappaB kinase,NF-kappaB signaling",0.716104395,"TICAM1,IKBKG,DAB2IP"
GO:1902105,BP,GO:1902105,regulation of leukocyte differentiation,0.716104395,"MAFB,SPINK5,IFNL1"
GO:0098727,BP,GO:0098727,maintenance of cell number,0.716104395,"HES5,BCL9"
GO:0070838,BP,GO:0070838,divalent metal ion transport,0.716104395,"P2RX5,MCOLN1,P2RX3,CALM3,CACNA1S"
GO:0050678,BP,GO:0050678,regulation of epithelial cell proliferation,0.716104395,"HES5,VASH1,BMP2,DAB2IP"
GO:0002292,BP,GO:0002292,T cell differentiation involved in immune response,0.716104395,IFNL1
GO:0010803,BP,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,0.716104395,IKBKG
GO:0060393,BP,GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,0.716104395,BMP2
GO:1902110,BP,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,0.716104395,TMEM102
GO:0006457,BP,GO:0006457,protein folding,0.716887792,"DNAJB12,DNAJB6,DNAJC4"
GO:0022409,BP,GO:0022409,positive regulation of cell-cell adhesion,0.716887792,"EFNB3,TNFRSF14,TNFRSF13C"
GO:0007059,BP,GO:0007059,chromosome segregation,0.717588979,"UBE2C,PHF13,BIRC5,TOP1"
GO:0007156,BP,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,0.717588979,"PCDHB16,CDHR2"
GO:0050680,BP,GO:0050680,negative regulation of epithelial cell proliferation,0.717588979,"VASH1,DAB2IP"
GO:0016311,BP,GO:0016311,dephosphorylation,0.718327793,"FBP2,HDHD2,CTDP1,BMP2,CALM3"
GO:0006027,BP,GO:0006027,glycosaminoglycan catabolic process,0.718327793,HPSE
GO:0016239,BP,GO:0016239,positive regulation of macroautophagy,0.718327793,IKBKG
GO:0046365,BP,GO:0046365,monosaccharide catabolic process,0.718327793,GALK1
GO:0050771,BP,GO:0050771,negative regulation of axonogenesis,0.718327793,EFNB3
GO:0060193,BP,GO:0060193,positive regulation of lipase activity,0.718327793,GPIHBP1
GO:1901880,BP,GO:1901880,negative regulation of protein depolymerization,0.718327793,TRIOBP
GO:0006497,BP,GO:0006497,protein lipidation,0.718327793,"GPIHBP1,SPRN"
GO:0022408,BP,GO:0022408,negative regulation of cell-cell adhesion,0.718327793,"IFNL1,BMP2"
GO:0072511,BP,GO:0072511,divalent inorganic cation transport,0.720066065,"P2RX5,MCOLN1,P2RX3,CALM3,CACNA1S"
GO:0002260,BP,GO:0002260,lymphocyte homeostasis,0.723304887,TNFRSF13C
GO:0042246,BP,GO:0042246,tissue regeneration,0.723304887,BCL9
GO:0048857,BP,GO:0048857,neural nucleus development,0.723304887,CALM3
GO:0051785,BP,GO:0051785,positive regulation of nuclear division,0.723304887,UBE2C
GO:1902686,BP,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,0.723304887,TMEM102
GO:0050867,BP,GO:0050867,positive regulation of cell activation,0.72475937,"TICAM1,EFNB3,TNFRSF14,TNFRSF13C"
GO:0031667,BP,GO:0031667,response to nutrient levels,0.72475937,"SLC34A1,P2RX5,P2RX3,DAP,GAS2L1"
GO:0001936,BP,GO:0001936,regulation of endothelial cell proliferation,0.72475937,"VASH1,BMP2"
GO:0030509,BP,GO:0030509,BMP signaling pathway,0.72475937,"HES5,BMP2"
GO:0055002,BP,GO:0055002,striated muscle cell development,0.72475937,"CTDP1,KEL"
GO:0016266,BP,GO:0016266,O-glycan processing,0.72475937,ST3GAL2
GO:0021872,BP,GO:0021872,forebrain generation of neurons,0.72475937,HES5
GO:0046686,BP,GO:0046686,response to cadmium ion,0.72475937,SLC34A1
GO:0046782,BP,GO:0046782,regulation of viral transcription,0.72475937,CTDP1
GO:0048207,BP,GO:0048207,"vesicle targeting, rough ER to cis-Golgi",0.72475937,TRAPPC1
GO:0048208,BP,GO:0048208,COPII vesicle coating,0.72475937,TRAPPC1
GO:0060389,BP,GO:0060389,pathway-restricted SMAD protein phosphorylation,0.72475937,BMP2
GO:0060675,BP,GO:0060675,ureteric bud morphogenesis,0.72475937,BMP2
GO:1903036,BP,GO:1903036,positive regulation of response to wounding,0.72475937,HPSE
GO:0022604,BP,GO:0022604,regulation of cell morphogenesis,0.725482349,"PALM,EFNB3,KEL,MYH14,TRIOBP"
GO:0008360,BP,GO:0008360,regulation of cell shape,0.725482349,"PALM,MYH14"
GO:0030900,BP,GO:0030900,forebrain development,0.725482349,"HES5,SECISBP2,BMP2,DAB2IP"
GO:0045765,BP,GO:0045765,regulation of angiogenesis,0.725482349,"SPINK5,VASH1,DAB2IP,HGS"
GO:0006520,BP,GO:0006520,cellular amino acid metabolic process,0.725482349,"VARS,VARS2,PARS2,ASPG"
GO:0006940,BP,GO:0006940,regulation of smooth muscle contraction,0.725482349,TACR3
GO:0007585,BP,GO:0007585,respiratory gaseous exchange by respiratory system,0.725482349,MAFB
GO:0033047,BP,GO:0033047,regulation of mitotic sister chromatid segregation,0.725482349,UBE2C
GO:0035794,BP,GO:0035794,positive regulation of mitochondrial membrane permeability,0.725482349,TMEM102
GO:0051926,BP,GO:0051926,negative regulation of calcium ion transport,0.725482349,CALM3
GO:0061035,BP,GO:0061035,regulation of cartilage development,0.725482349,BMP2
GO:0072171,BP,GO:0072171,mesonephric tubule morphogenesis,0.725482349,BMP2
GO:1904427,BP,GO:1904427,positive regulation of calcium ion transmembrane transport,0.725482349,CALM3
GO:0006665,BP,GO:0006665,sphingolipid metabolic process,0.725482349,"NEU4,FA2H"
GO:0016241,BP,GO:0016241,regulation of macroautophagy,0.725482349,"IKBKG,ATP6V0B"
GO:0031497,BP,GO:0031497,chromatin assembly,0.725482349,"H2AFB2,GRWD1"
GO:0042158,BP,GO:0042158,lipoprotein biosynthetic process,0.725482349,"GPIHBP1,SPRN"
GO:0006937,BP,GO:0006937,regulation of muscle contraction,0.727082708,"TACR3,CALM3"
GO:0050807,BP,GO:0050807,regulation of synapse organization,0.727082708,"CBLN2,DAB2IP"
GO:0051403,BP,GO:0051403,stress-activated MAPK cascade,0.727082708,"IKBKG,BMP2,DAB2IP"
GO:0002312,BP,GO:0002312,B cell activation involved in immune response,0.727082708,IL27RA
GO:0006513,BP,GO:0006513,protein monoubiquitination,0.727082708,UBE2T
GO:0010611,BP,GO:0010611,regulation of cardiac muscle hypertrophy,0.727082708,CTDP1
GO:0045670,BP,GO:0045670,regulation of osteoclast differentiation,0.727082708,MAFB
GO:0046324,BP,GO:0046324,regulation of glucose import,0.727082708,ASPSCR1
GO:0050795,BP,GO:0050795,regulation of behavior,0.727082708,TACR3
GO:0060395,BP,GO:0060395,SMAD protein signal transduction,0.727082708,BMP2
GO:0042326,BP,GO:0042326,negative regulation of phosphorylation,0.727082708,"LRRC3C,DAB2IP,FAM212B,CBLC,CALM3"
GO:0043406,BP,GO:0043406,positive regulation of MAP kinase activity,0.727082708,"IKBKG,BMP2,DAB2IP"
GO:0016054,BP,GO:0016054,organic acid catabolic process,0.727082708,"LIPE,ASPG,RENBP"
GO:0046395,BP,GO:0046395,carboxylic acid catabolic process,0.727082708,"LIPE,ASPG,RENBP"
GO:0043123,BP,GO:0043123,"positive regulation of I-kappaB kinase,NF-kappaB signaling",0.727082708,"TICAM1,IKBKG"
GO:0050770,BP,GO:0050770,regulation of axonogenesis,0.727082708,"EFNB3,KEL"
GO:0022613,BP,GO:0022613,ribonucleoprotein complex biogenesis,0.727082708,"PAPD5,UTP14A,PDCD11,DDX49,DDX51"
GO:0072507,BP,GO:0072507,divalent inorganic cation homeostasis,0.727082708,"P2RX5,MCOLN1,P2RX3,KEL,CALM3"
GO:0002200,BP,GO:0002200,somatic diversification of immune receptors,0.727082708,IL27RA
GO:0003281,BP,GO:0003281,ventricular septum development,0.727082708,XIRP2
GO:0030500,BP,GO:0030500,regulation of bone mineralization,0.727082708,BMP2
GO:0032760,BP,GO:0032760,positive regulation of tumor necrosis factor production,0.727082708,TICAM1
GO:0048663,BP,GO:0048663,neuron fate commitment,0.727082708,HES5
GO:0051965,BP,GO:0051965,positive regulation of synapse assembly,0.727082708,CBLN2
GO:0070373,BP,GO:0070373,negative regulation of ERK1 and ERK2 cascade,0.727082708,DAB2IP
GO:0090307,BP,GO:0090307,mitotic spindle assembly,0.727082708,BIRC5
GO:1902108,BP,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,0.727082708,TMEM102
GO:1905710,BP,GO:1905710,positive regulation of membrane permeability,0.727082708,TMEM102
GO:0006901,BP,GO:0006901,vesicle coating,0.730037669,TRAPPC1
GO:0007004,BP,GO:0007004,telomere maintenance via telomerase,0.730037669,PAPD5
GO:0009247,BP,GO:0009247,glycolipid biosynthetic process,0.730037669,ST3GAL2
GO:0014743,BP,GO:0014743,regulation of muscle hypertrophy,0.730037669,CTDP1
GO:0030810,BP,GO:0030810,positive regulation of nucleotide biosynthetic process,0.730037669,CALM3
GO:0033555,BP,GO:0033555,multicellular organismal response to stress,0.730037669,P2RX3
GO:0050688,BP,GO:0050688,regulation of defense response to virus,0.730037669,IFNLR1
GO:0060998,BP,GO:0060998,regulation of dendritic spine development,0.730037669,SHANK2
GO:0061515,BP,GO:0061515,myeloid cell development,0.730037669,JMJD6
GO:1900373,BP,GO:1900373,positive regulation of purine nucleotide biosynthetic process,0.730037669,CALM3
GO:0043433,BP,GO:0043433,negative regulation of DNA-binding transcription factor activity,0.730061645,"DAB2IP,DAP"
GO:0090287,BP,GO:0090287,regulation of cellular response to growth factor stimulus,0.730061645,"HES5,DAB2IP,HGS"
GO:0019362,BP,GO:0019362,pyridine nucleotide metabolic process,0.730061645,"GALK1,NMRK2"
GO:0030308,BP,GO:0030308,negative regulation of cell growth,0.730061645,"CTDP1,CDHR2"
GO:0046496,BP,GO:0046496,nicotinamide nucleotide metabolic process,0.730061645,"GALK1,NMRK2"
GO:0051099,BP,GO:0051099,positive regulation of binding,0.730061645,"TICAM1,BMP2"
GO:0071347,BP,GO:0071347,cellular response to interleukin-1,0.730061645,"IKBKG,DAB2IP"
GO:0042113,BP,GO:0042113,B cell activation,0.730061645,"TICAM1,IL27RA,TNFRSF13C"
GO:0006026,BP,GO:0006026,aminoglycan catabolic process,0.730061645,HPSE
GO:0006809,BP,GO:0006809,nitric oxide biosynthetic process,0.730061645,TICAM1
GO:0006970,BP,GO:0006970,response to osmotic stress,0.730061645,TACR3
GO:0032272,BP,GO:0032272,negative regulation of protein polymerization,0.730061645,TRIOBP
GO:0035914,BP,GO:0035914,skeletal muscle cell differentiation,0.730061645,BCL9
GO:0043242,BP,GO:0043242,negative regulation of protein-containing complex disassembly,0.730061645,TRIOBP
GO:0051966,BP,GO:0051966,"regulation of synaptic transmission, glutamatergic",0.730061645,SHANK2
GO:0055021,BP,GO:0055021,regulation of cardiac muscle tissue growth,0.730061645,CTDP1
GO:0010921,BP,GO:0010921,regulation of phosphatase activity,0.731728833,"BMP2,CALM3"
GO:0010769,BP,GO:0010769,regulation of cell morphogenesis involved in differentiation,0.731728833,"EFNB3,KEL,TRIOBP"
GO:0002521,BP,GO:0002521,leukocyte differentiation,0.731728833,"MAFB,SPINK5,IFNL1,JMJD6,BATF3"
GO:0018108,BP,GO:0018108,peptidyl-tyrosine phosphorylation,0.731728833,"HES5,IFNL1,TMEM102,CBLC"
GO:0001937,BP,GO:0001937,negative regulation of endothelial cell proliferation,0.731728833,VASH1
GO:0009301,BP,GO:0009301,snRNA transcription,0.731728833,SNAPC2
GO:0042795,BP,GO:0042795,snRNA transcription by RNA polymerase II,0.731728833,SNAPC2
GO:0043507,BP,GO:0043507,positive regulation of JUN kinase activity,0.731728833,DAB2IP
GO:0070988,BP,GO:0070988,demethylation,0.731728833,JMJD6
GO:0097061,BP,GO:0097061,dendritic spine organization,0.731728833,SHANK2
GO:1903524,BP,GO:1903524,positive regulation of blood circulation,0.731728833,TACR3
GO:1903557,BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,0.731728833,TICAM1
GO:0090090,BP,GO:0090090,negative regulation of canonical Wnt signaling pathway,0.731728833,"BMP2,DAB2IP"
GO:0006941,BP,GO:0006941,striated muscle contraction,0.733124529,"MYH14,CALM3"
GO:0043409,BP,GO:0043409,negative regulation of MAPK cascade,0.733124529,"DAB2IP,CBLC"
GO:0050890,BP,GO:0050890,cognition,0.733124529,"NRXN2,SYNPO,SHANK2"
GO:0090068,BP,GO:0090068,positive regulation of cell cycle process,0.733124529,"UBE2C,CIT,DAB2IP"
GO:0008306,BP,GO:0008306,associative learning,0.733124529,SYNPO
GO:0009583,BP,GO:0009583,detection of light stimulus,0.733124529,GUCY2D
GO:0019674,BP,GO:0019674,NAD metabolic process,0.733124529,NMRK2
GO:0031644,BP,GO:0031644,regulation of nervous system process,0.733124529,P2RX3
GO:0051851,BP,GO:0051851,modulation by host of symbiont process,0.733124529,CTDP1
GO:0090114,BP,GO:0090114,COPII-coated vesicle budding,0.733124529,TRAPPC1
GO:0090398,BP,GO:0090398,cellular senescence,0.733124529,VASH1
GO:1903363,BP,GO:1903363,negative regulation of cellular protein catabolic process,0.733124529,DAB2IP
GO:0018212,BP,GO:0018212,peptidyl-tyrosine modification,0.73338826,"HES5,IFNL1,TMEM102,CBLC"
GO:0002478,BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,0.73338826,"RILP,IKBKG"
GO:0009408,BP,GO:0009408,response to heat,0.73338826,"P2RX3,DNAJB6"
GO:0071222,BP,GO:0071222,cellular response to lipopolysaccharide,0.73338826,"TICAM1,DAB2IP"
GO:0072524,BP,GO:0072524,pyridine-containing compound metabolic process,0.736265888,"GALK1,NMRK2"
GO:0042632,BP,GO:0042632,cholesterol homeostasis,0.736265888,GPIHBP1
GO:0048199,BP,GO:0048199,"vesicle targeting, to, from or within Golgi",0.736265888,TRAPPC1
GO:0055092,BP,GO:0055092,sterol homeostasis,0.736265888,GPIHBP1
GO:0006401,BP,GO:0006401,RNA catabolic process,0.736265888,"YBX1,GTPBP1,PAPD5,SECISBP2"
GO:0001935,BP,GO:0001935,endothelial cell proliferation,0.737061525,"VASH1,BMP2"
GO:0034728,BP,GO:0034728,nucleosome organization,0.737061525,"H2AFB2,GRWD1"
GO:0050803,BP,GO:0050803,regulation of synapse structure or activity,0.737061525,"CBLN2,DAB2IP"
GO:0000018,BP,GO:0000018,regulation of DNA recombination,0.737061525,IL27RA
GO:0006687,BP,GO:0006687,glycosphingolipid metabolic process,0.737061525,NEU4
GO:0009064,BP,GO:0009064,glutamine family amino acid metabolic process,0.737061525,ASPG
GO:0035019,BP,GO:0035019,somatic stem cell population maintenance,0.737061525,BCL9
GO:0046209,BP,GO:0046209,nitric oxide metabolic process,0.737061525,TICAM1
GO:0050805,BP,GO:0050805,negative regulation of synaptic transmission,0.737061525,SHANK2
GO:0060291,BP,GO:0060291,long-term synaptic potentiation,0.737061525,SHANK2
GO:0070509,BP,GO:0070509,calcium ion import,0.737061525,CACNA1S
GO:0106027,BP,GO:0106027,neuron projection organization,0.737061525,SHANK2
GO:1901992,BP,GO:1901992,positive regulation of mitotic cell cycle phase transition,0.737061525,UBE2C
GO:0008217,BP,GO:0008217,regulation of blood pressure,0.737061525,"TACR3,RENBP"
GO:0042594,BP,GO:0042594,response to starvation,0.737061525,"DAP,GAS2L1"
GO:0055001,BP,GO:0055001,muscle cell development,0.737061525,"CTDP1,KEL"
GO:0051962,BP,GO:0051962,positive regulation of nervous system development,0.738632601,"SPINT1,BMP2,CBLN2,SHANK2,DAB2IP"
GO:0007015,BP,GO:0007015,actin filament organization,0.738632601,"SYNPO,CIT,TRIOBP,CASS4"
GO:0002758,BP,GO:0002758,innate immune response-activating signal transduction,0.738632601,"TICAM1,IKBKG,DAB2IP"
GO:0010507,BP,GO:0010507,negative regulation of autophagy,0.738632601,DAP
GO:0032642,BP,GO:0032642,regulation of chemokine production,0.738632601,TICAM1
GO:0032755,BP,GO:0032755,positive regulation of interleukin-6 production,0.738632601,TICAM1
GO:0046128,BP,GO:0046128,purine ribonucleoside metabolic process,0.738632601,GTPBP1
GO:0072347,BP,GO:0072347,response to anesthetic,0.738632601,TACR3
GO:1903725,BP,GO:1903725,regulation of phospholipid metabolic process,0.738632601,DAB2IP
GO:0009991,BP,GO:0009991,response to extracellular stimulus,0.740285548,"SLC34A1,P2RX5,P2RX3,DAP,GAS2L1"
GO:0016052,BP,GO:0016052,carbohydrate catabolic process,0.740285548,"GALK1,NEU4"
GO:0050731,BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,0.740285548,"HES5,IFNL1"
GO:0018205,BP,GO:0018205,peptidyl-lysine modification,0.740724074,"EEF2KMT,JMJD6,BIRC5,TOP1"
GO:0002479,BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",0.740902029,IKBKG
GO:0006278,BP,GO:0006278,RNA-dependent DNA biosynthetic process,0.740902029,PAPD5
GO:0030101,BP,GO:0030101,natural killer cell activation,0.740902029,TICAM1
GO:0051702,BP,GO:0051702,interaction with symbiont,0.740902029,CTDP1
GO:0060420,BP,GO:0060420,regulation of heart growth,0.740902029,CTDP1
GO:0043900,BP,GO:0043900,regulation of multi-organism process,0.740902029,"IFNLR1,SPINK5,CTDP1,SNF8"
GO:0071241,BP,GO:0071241,cellular response to inorganic substance,0.740943477,"SLC34A1,MCOLN1"
GO:0008064,BP,GO:0008064,regulation of actin polymerization or depolymerization,0.743514994,"CIT,TRIOBP"
GO:0019884,BP,GO:0019884,antigen processing and presentation of exogenous antigen,0.743514994,"RILP,IKBKG"
GO:0021536,BP,GO:0021536,diencephalon development,0.743514994,BMP2
GO:0033045,BP,GO:0033045,regulation of sister chromatid segregation,0.743514994,UBE2C
GO:0042310,BP,GO:0042310,vasoconstriction,0.743514994,KEL
GO:0055013,BP,GO:0055013,cardiac muscle cell development,0.743514994,CTDP1
GO:0070167,BP,GO:0070167,regulation of biomineral tissue development,0.743514994,BMP2
GO:2001057,BP,GO:2001057,reactive nitrogen species metabolic process,0.743514994,TICAM1
GO:0030099,BP,GO:0030099,myeloid cell differentiation,0.744236721,"MAFB,JMJD6,KLF1,BATF3"
GO:0030832,BP,GO:0030832,regulation of actin filament length,0.744236721,"CIT,TRIOBP"
GO:0071219,BP,GO:0071219,cellular response to molecule of bacterial origin,0.744236721,"TICAM1,DAB2IP"
GO:0006094,BP,GO:0006094,gluconeogenesis,0.744236721,FBP2
GO:0006400,BP,GO:0006400,tRNA modification,0.744236721,ADAT3
GO:0007422,BP,GO:0007422,peripheral nervous system development,0.744236721,FA2H
GO:0021675,BP,GO:0021675,nerve development,0.744236721,MAFB
GO:0032413,BP,GO:0032413,negative regulation of ion transmembrane transporter activity,0.744236721,CALM3
GO:0042278,BP,GO:0042278,purine nucleoside metabolic process,0.744236721,GTPBP1
GO:0043537,BP,GO:0043537,negative regulation of blood vessel endothelial cell migration,0.744236721,VASH1
GO:0051279,BP,GO:0051279,regulation of release of sequestered calcium ion into cytosol,0.744236721,CALM3
GO:0061097,BP,GO:0061097,regulation of protein tyrosine kinase activity,0.744236721,CBLC
GO:2000177,BP,GO:2000177,regulation of neural precursor cell proliferation,0.744236721,SPINT1
GO:1901342,BP,GO:1901342,regulation of vasculature development,0.744837306,"SPINK5,VASH1,DAB2IP,HGS"
GO:0031396,BP,GO:0031396,regulation of protein ubiquitination,0.746231313,"UBE2C,TICAM1"
GO:0051216,BP,GO:0051216,cartilage development,0.746231313,"HES5,BMP2"
GO:0010827,BP,GO:0010827,regulation of glucose transmembrane transport,0.746231313,ASPSCR1
GO:0030193,BP,GO:0030193,regulation of blood coagulation,0.746231313,HPSE
GO:0042590,BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,0.746231313,IKBKG
GO:0055117,BP,GO:0055117,regulation of cardiac muscle contraction,0.746231313,CALM3
GO:1900034,BP,GO:1900034,regulation of cellular response to heat,0.746231313,DNAJB6
GO:1900046,BP,GO:1900046,regulation of hemostasis,0.746231313,HPSE
GO:1905897,BP,GO:1905897,regulation of response to endoplasmic reticulum stress,0.746231313,DAB2IP
GO:0061138,BP,GO:0061138,morphogenesis of a branching epithelium,0.747470754,"SPINT1,BMP2"
GO:0002244,BP,GO:0002244,hematopoietic progenitor cell differentiation,0.747693111,"HES5,SSBP3"
GO:0017157,BP,GO:0017157,regulation of exocytosis,0.747693111,"SNF8,HGS"
GO:0010833,BP,GO:0010833,telomere maintenance via telomere lengthening,0.747693111,PAPD5
GO:0030317,BP,GO:0030317,flagellated sperm motility,0.747693111,TACR3
GO:0032204,BP,GO:0032204,regulation of telomere maintenance,0.747693111,PAPD5
GO:0033238,BP,GO:0033238,regulation of cellular amine metabolic process,0.747693111,TACR3
GO:0046323,BP,GO:0046323,glucose import,0.747693111,ASPSCR1
GO:0046902,BP,GO:0046902,regulation of mitochondrial membrane permeability,0.747693111,TMEM102
GO:0051289,BP,GO:0051289,protein homotetramerization,0.747693111,MCOLN1
GO:1901879,BP,GO:1901879,regulation of protein depolymerization,0.747693111,TRIOBP
GO:0006733,BP,GO:0006733,oxidoreduction coenzyme metabolic process,0.749356841,"GALK1,NMRK2"
GO:0008037,BP,GO:0008037,cell recognition,0.749356841,"EFNB3,JMJD6"
GO:0034764,BP,GO:0034764,positive regulation of transmembrane transport,0.749356841,"SLC34A1,CALM3"
GO:0048002,BP,GO:0048002,antigen processing and presentation of peptide antigen,0.749356841,"RILP,IKBKG"
GO:0019319,BP,GO:0019319,hexose biosynthetic process,0.749967371,FBP2
GO:0031145,BP,GO:0031145,anaphase-promoting complex-dependent catabolic process,0.749967371,UBE2C
GO:0048194,BP,GO:0048194,Golgi vesicle budding,0.749967371,TRAPPC1
GO:0051304,BP,GO:0051304,chromosome separation,0.749967371,UBE2C
GO:0061077,BP,GO:0061077,chaperone-mediated protein folding,0.749967371,DNAJB12
GO:0006260,BP,GO:0006260,DNA replication,0.75141716,"GRWD1,ORC6,TOP1"
GO:0031098,BP,GO:0031098,stress-activated protein kinase signaling cascade,0.75141716,"IKBKG,BMP2,DAB2IP"
GO:0043010,BP,GO:0043010,camera-type eye development,0.753496393,"HES5,FJX1,JMJD6"
GO:0008652,BP,GO:0008652,cellular amino acid biosynthetic process,0.753496393,ASPG
GO:0032602,BP,GO:0032602,chemokine production,0.753496393,TICAM1
GO:1901379,BP,GO:1901379,regulation of potassium ion transmembrane transport,0.753496393,KEL
GO:0002697,BP,GO:0002697,regulation of immune effector process,0.753713524,"IFNLR1,SPINK5,IFNL1,IL27RA"
GO:0006333,BP,GO:0006333,chromatin assembly or disassembly,0.755565846,"H2AFB2,GRWD1"
GO:0050810,BP,GO:0050810,regulation of steroid biosynthetic process,0.757389322,BMP2
GO:0055006,BP,GO:0055006,cardiac cell development,0.757389322,CTDP1
GO:0097722,BP,GO:0097722,sperm motility,0.757389322,TACR3
GO:0002573,BP,GO:0002573,myeloid leukocyte differentiation,0.757729786,"MAFB,BATF3"
GO:0070555,BP,GO:0070555,response to interleukin-1,0.758963783,"IKBKG,DAB2IP"
GO:0050673,BP,GO:0050673,epithelial cell proliferation,0.758963783,"HES5,VASH1,BMP2,DAB2IP"
GO:0002218,BP,GO:0002218,activation of innate immune response,0.758963783,"TICAM1,IKBKG,DAB2IP"
GO:0010721,BP,GO:0010721,negative regulation of cell development,0.758963783,"HES5,CTDP1,EFNB3"
GO:0006890,BP,GO:0006890,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",0.758963783,ARCN1
GO:0008625,BP,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,0.758963783,DAB2IP
GO:0034637,BP,GO:0034637,cellular carbohydrate biosynthetic process,0.758963783,FBP2
GO:0042446,BP,GO:0042446,hormone biosynthetic process,0.758963783,BMP2
GO:0044070,BP,GO:0044070,regulation of anion transport,0.758963783,SLC34A1
GO:0000280,BP,GO:0000280,nuclear division,0.762244874,"UBE2C,CTDP1,PHF13,BIRC5"
GO:0001776,BP,GO:0001776,leukocyte homeostasis,0.762244874,TNFRSF13C
GO:0050818,BP,GO:0050818,regulation of coagulation,0.762244874,HPSE
GO:0060191,BP,GO:0060191,regulation of lipase activity,0.762244874,GPIHBP1
GO:0097756,BP,GO:0097756,negative regulation of blood vessel diameter,0.762244874,KEL
GO:1903426,BP,GO:1903426,regulation of reactive oxygen species biosynthetic process,0.762244874,TICAM1
GO:1900542,BP,GO:1900542,regulation of purine nucleotide metabolic process,0.762270104,"PALM,CALM3"
GO:0002028,BP,GO:0002028,regulation of sodium ion transport,0.765446634,FXYD6
GO:0016575,BP,GO:0016575,histone deacetylation,0.765446634,PHF21A
GO:0032410,BP,GO:0032410,negative regulation of transporter activity,0.765446634,CALM3
GO:0043506,BP,GO:0043506,regulation of JUN kinase activity,0.765446634,DAB2IP
GO:0045778,BP,GO:0045778,positive regulation of ossification,0.765446634,BMP2
GO:0050792,BP,GO:0050792,regulation of viral process,0.767249386,"CTDP1,SNF8"
GO:0034446,BP,GO:0034446,substrate adhesion-dependent cell spreading,0.767612641,TRIOBP
GO:0046364,BP,GO:0046364,monosaccharide biosynthetic process,0.767612641,FBP2
GO:0048661,BP,GO:0048661,positive regulation of smooth muscle cell proliferation,0.767612641,HES5
GO:0051090,BP,GO:0051090,regulation of DNA-binding transcription factor activity,0.767612641,"TICAM1,IKBKG,DAB2IP,DAP"
GO:0098813,BP,GO:0098813,nuclear chromosome segregation,0.767612641,"UBE2C,PHF13,BIRC5"
GO:0001505,BP,GO:0001505,regulation of neurotransmitter levels,0.767612641,"TICAM1,SYN2,NRXN2"
GO:0070588,BP,GO:0070588,calcium ion transmembrane transport,0.767612641,"MCOLN1,CALM3,CACNA1S"
GO:0001763,BP,GO:0001763,morphogenesis of a branching structure,0.767612641,"SPINT1,BMP2"
GO:0017038,BP,GO:0017038,protein import,0.767612641,"GPIHBP1,SPRN"
GO:0042157,BP,GO:0042157,lipoprotein metabolic process,0.767612641,"GPIHBP1,SPRN"
GO:0001843,BP,GO:0001843,neural tube closure,0.767612641,SPINT1
GO:0002690,BP,GO:0002690,positive regulation of leukocyte chemotaxis,0.767612641,TMEM102
GO:0006672,BP,GO:0006672,ceramide metabolic process,0.767612641,NEU4
GO:0006903,BP,GO:0006903,vesicle targeting,0.767612641,TRAPPC1
GO:0045981,BP,GO:0045981,positive regulation of nucleotide metabolic process,0.767612641,CALM3
GO:0048013,BP,GO:0048013,ephrin receptor signaling pathway,0.767612641,EFNB3
GO:0048145,BP,GO:0048145,regulation of fibroblast proliferation,0.767612641,DAB2IP
GO:0090559,BP,GO:0090559,regulation of membrane permeability,0.767612641,TMEM102
GO:1900544,BP,GO:1900544,positive regulation of purine nucleotide metabolic process,0.767612641,CALM3
GO:1901989,BP,GO:1901989,positive regulation of cell cycle phase transition,0.767612641,UBE2C
GO:0035303,BP,GO:0035303,regulation of dephosphorylation,0.768884015,"BMP2,CALM3"
GO:0071214,BP,GO:0071214,cellular response to abiotic stimulus,0.768884015,"PALM,MCOLN1,GUCY2D"
GO:0104004,BP,GO:0104004,cellular response to environmental stimulus,0.768884015,"PALM,MCOLN1,GUCY2D"
GO:0032414,BP,GO:0032414,positive regulation of ion transmembrane transporter activity,0.768884015,CALM3
GO:0045638,BP,GO:0045638,negative regulation of myeloid cell differentiation,0.768884015,MAFB
GO:0048144,BP,GO:0048144,fibroblast proliferation,0.768884015,DAB2IP
GO:0051963,BP,GO:0051963,regulation of synapse assembly,0.768884015,CBLN2
GO:0060606,BP,GO:0060606,tube closure,0.768884015,SPINT1
GO:0071158,BP,GO:0071158,positive regulation of cell cycle arrest,0.768884015,DAB2IP
GO:0007254,BP,GO:0007254,JNK cascade,0.768884015,"IKBKG,DAB2IP"
GO:0007018,BP,GO:0007018,microtubule-based movement,0.76907477,"KIF19,MYO15A,MYH14"
GO:0002064,BP,GO:0002064,epithelial cell development,0.76907477,"PDZD7,TRIOBP"
GO:0006140,BP,GO:0006140,regulation of nucleotide metabolic process,0.76907477,"PALM,CALM3"
GO:0050670,BP,GO:0050670,regulation of lymphocyte proliferation,0.76907477,"TICAM1,TNFRSF13C"
GO:0001656,BP,GO:0001656,metanephros development,0.76907477,HES5
GO:0007193,BP,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,0.76907477,PALM
GO:0010771,BP,GO:0010771,negative regulation of cell morphogenesis involved in differentiation,0.76907477,EFNB3
GO:0030510,BP,GO:0030510,regulation of BMP signaling pathway,0.76907477,HES5
GO:0060333,BP,GO:0060333,interferon-gamma-mediated signaling pathway,0.76907477,IRF5
GO:0060337,BP,GO:0060337,type I interferon signaling pathway,0.76907477,IRF5
GO:0071357,BP,GO:0071357,cellular response to type I interferon,0.76907477,IRF5
GO:1901019,BP,GO:1901019,regulation of calcium ion transmembrane transporter activity,0.76907477,CALM3
GO:0032944,BP,GO:0032944,regulation of mononuclear cell proliferation,0.770018922,"TICAM1,TNFRSF13C"
GO:0048762,BP,GO:0048762,mesenchymal cell differentiation,0.770018922,"BMP2,DAB2IP"
GO:0008154,BP,GO:0008154,actin polymerization or depolymerization,0.77058599,"CIT,TRIOBP"
GO:0045665,BP,GO:0045665,negative regulation of neuron differentiation,0.77058599,"HES5,EFNB3"
GO:0001523,BP,GO:0001523,retinoid metabolic process,0.77058599,GPIHBP1
GO:0032231,BP,GO:0032231,regulation of actin filament bundle assembly,0.77058599,SYNPO
GO:0033273,BP,GO:0033273,response to vitamin,0.77058599,SLC34A1
GO:0060996,BP,GO:0060996,dendritic spine development,0.77058599,SHANK2
GO:0097006,BP,GO:0097006,regulation of plasma lipoprotein particle levels,0.77058599,GPIHBP1
GO:0044282,BP,GO:0044282,small molecule catabolic process,0.77094378,"LIPE,GALK1,ASPG,RENBP"
GO:0071216,BP,GO:0071216,cellular response to biotic stimulus,0.772407635,"TICAM1,DAB2IP"
GO:0019058,BP,GO:0019058,viral life cycle,0.772407635,"EFNB3,SNF8,TNFRSF14"
GO:0060562,BP,GO:0060562,epithelial tube morphogenesis,0.772407635,"HES5,SPINT1,BMP2"
GO:0006919,BP,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,0.772407635,DAP
GO:0030316,BP,GO:0030316,osteoclast differentiation,0.772407635,MAFB
GO:0051453,BP,GO:0051453,regulation of intracellular pH,0.772407635,ATP6V0B
GO:0120034,BP,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,0.772407635,PALM
GO:0045088,BP,GO:0045088,regulation of innate immune response,0.772407635,"TICAM1,IKBKG,DAB2IP,POLR3D"
GO:0006888,BP,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,0.772433125,"TRAPPC1,ARCN1"
GO:0007601,BP,GO:0007601,visual perception,0.772433125,"GUCY2D,AOC2"
GO:0009952,BP,GO:0009952,"anterior,posterior pattern specification",0.772433125,"BMP2,SSBP3"
GO:0060070,BP,GO:0060070,canonical Wnt signaling pathway,0.772461596,"BCL9,BMP2,DAB2IP"
GO:0006942,BP,GO:0006942,regulation of striated muscle contraction,0.774278245,CALM3
GO:0050830,BP,GO:0050830,defense response to Gram-positive bacterium,0.774278245,IL27RA
GO:2000379,BP,GO:2000379,positive regulation of reactive oxygen species metabolic process,0.774278245,TICAM1
GO:0048608,BP,GO:0048608,reproductive structure development,0.775400899,"VASH1,SPINT1,DNAJB6,DAZAP1"
GO:0048732,BP,GO:0048732,gland development,0.775400899,"MAFB,BSX,BMP2,FA2H"
GO:0050769,BP,GO:0050769,positive regulation of neurogenesis,0.775400899,"SPINT1,BMP2,SHANK2,DAB2IP"
GO:0030178,BP,GO:0030178,negative regulation of Wnt signaling pathway,0.775955783,"BMP2,DAB2IP"
GO:0016042,BP,GO:0016042,lipid catabolic process,0.776841011,"LIPE,NEU4,ASPG"
GO:0031669,BP,GO:0031669,cellular response to nutrient levels,0.776841011,"DAP,GAS2L1"
GO:0044242,BP,GO:0044242,cellular lipid catabolic process,0.776841011,"LIPE,NEU4"
GO:0061458,BP,GO:0061458,reproductive system development,0.776841011,"VASH1,SPINT1,DNAJB6,DAZAP1"
GO:0000956,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,0.776841011,"PAPD5,SECISBP2"
GO:0043624,BP,GO:0043624,cellular protein complex disassembly,0.776841011,"KIF19,TRIOBP"
GO:0050953,BP,GO:0050953,sensory perception of light stimulus,0.776841011,"GUCY2D,AOC2"
GO:0002474,BP,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,0.776841011,IKBKG
GO:0014020,BP,GO:0014020,primary neural tube formation,0.776841011,SPINT1
GO:0021549,BP,GO:0021549,cerebellum development,0.776841011,ARCN1
GO:0030901,BP,GO:0030901,midbrain development,0.776841011,CALM3
GO:0034340,BP,GO:0034340,response to type I interferon,0.776841011,IRF5
GO:0055017,BP,GO:0055017,cardiac muscle tissue growth,0.776841011,CTDP1
GO:0072676,BP,GO:0072676,lymphocyte migration,0.776841011,TMEM102
GO:0010594,BP,GO:0010594,regulation of endothelial cell migration,0.779323326,"VASH1,DAB2IP"
GO:0071805,BP,GO:0071805,potassium ion transmembrane transport,0.779323326,"KEL,KCNC3"
GO:0019233,BP,GO:0019233,sensory perception of pain,0.779323326,P2RX3
GO:0030641,BP,GO:0030641,regulation of cellular pH,0.779323326,ATP6V0B
GO:0035249,BP,GO:0035249,"synaptic transmission, glutamatergic",0.779323326,SHANK2
GO:0043502,BP,GO:0043502,regulation of muscle adaptation,0.779323326,CTDP1
GO:0006066,BP,GO:0006066,alcohol metabolic process,0.779834749,"SLC34A1,LIPE,GALK1"
GO:0051701,BP,GO:0051701,interaction with host,0.780113208,"EFNB3,TNFRSF14"
GO:0008593,BP,GO:0008593,regulation of Notch signaling pathway,0.781743353,HES5
GO:0042102,BP,GO:0042102,positive regulation of T cell proliferation,0.781743353,TNFRSF13C
GO:0070663,BP,GO:0070663,regulation of leukocyte proliferation,0.781743353,"TICAM1,TNFRSF13C"
GO:1903320,BP,GO:1903320,regulation of protein modification by small protein conjugation or removal,0.781743353,"UBE2C,TICAM1"
GO:0001657,BP,GO:0001657,ureteric bud development,0.784236906,BMP2
GO:0002062,BP,GO:0002062,chondrocyte differentiation,0.784236906,BMP2
GO:0016101,BP,GO:0016101,diterpenoid metabolic process,0.784236906,GPIHBP1
GO:0048640,BP,GO:0048640,negative regulation of developmental growth,0.784236906,CTDP1
GO:0006839,BP,GO:0006839,mitochondrial transport,0.784236906,"TMEM102,SLC25A34,MTX1"
GO:0032147,BP,GO:0032147,activation of protein kinase activity,0.784236906,"IKBKG,BMP2,DAB2IP"
GO:0043254,BP,GO:0043254,regulation of protein-containing complex assembly,0.784236906,"NCLN,SNX9,DAB2IP,TRIOBP"
GO:0003300,BP,GO:0003300,cardiac muscle hypertrophy,0.784236906,CTDP1
GO:0006476,BP,GO:0006476,protein deacetylation,0.784236906,PHF21A
GO:0006641,BP,GO:0006641,triglyceride metabolic process,0.784236906,LIPE
GO:0019886,BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,0.784236906,RILP
GO:0032411,BP,GO:0032411,positive regulation of transporter activity,0.784236906,CALM3
GO:0033108,BP,GO:0033108,mitochondrial respiratory chain complex assembly,0.784236906,PET100
GO:0042136,BP,GO:0042136,neurotransmitter biosynthetic process,0.784236906,TICAM1
GO:0043473,BP,GO:0043473,pigmentation,0.784236906,ARCN1
GO:0072163,BP,GO:0072163,mesonephric epithelium development,0.784236906,BMP2
GO:0072164,BP,GO:0072164,mesonephric tubule development,0.784236906,BMP2
GO:0016358,BP,GO:0016358,dendrite development,0.785681163,"SHANK2,DAB2IP"
GO:0032872,BP,GO:0032872,regulation of stress-activated MAPK cascade,0.785681163,"BMP2,DAB2IP"
GO:0006096,BP,GO:0006096,glycolytic process,0.785681163,GALK1
GO:0016073,BP,GO:0016073,snRNA metabolic process,0.785681163,SNAPC2
GO:0043331,BP,GO:0043331,response to dsRNA,0.785681163,TICAM1
GO:0099024,BP,GO:0099024,plasma membrane invagination,0.785681163,SNX9
GO:1904019,BP,GO:1904019,epithelial cell apoptotic process,0.785681163,DAB2IP
GO:0032956,BP,GO:0032956,regulation of actin cytoskeleton organization,0.785681163,"SYNPO,CIT,TRIOBP"
GO:0070302,BP,GO:0070302,regulation of stress-activated protein kinase signaling cascade,0.786968528,"BMP2,DAB2IP"
GO:0003279,BP,GO:0003279,cardiac septum development,0.787341384,XIRP2
GO:0006757,BP,GO:0006757,ATP generation from ADP,0.787341384,GALK1
GO:0014897,BP,GO:0014897,striated muscle hypertrophy,0.787341384,CTDP1
GO:0050868,BP,GO:0050868,negative regulation of T cell activation,0.787341384,IFNL1
GO:0051983,BP,GO:0051983,regulation of chromosome segregation,0.787341384,UBE2C
GO:0070498,BP,GO:0070498,interleukin-1-mediated signaling pathway,0.787341384,IKBKG
GO:0010038,BP,GO:0010038,response to metal ion,0.787341384,"SLC34A1,MCOLN1,CALM3"
GO:0001938,BP,GO:0001938,positive regulation of endothelial cell proliferation,0.787341384,BMP2
GO:0002495,BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,0.787341384,RILP
GO:0014066,BP,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,0.787341384,DAB2IP
GO:0030148,BP,GO:0030148,sphingolipid biosynthetic process,0.787341384,FA2H
GO:0031532,BP,GO:0031532,actin cytoskeleton reorganization,0.787341384,CASS4
GO:0043266,BP,GO:0043266,regulation of potassium ion transport,0.787341384,KEL
GO:0051899,BP,GO:0051899,membrane depolarization,0.787341384,CACNA1S
GO:0060419,BP,GO:0060419,heart growth,0.787341384,CTDP1
GO:0098781,BP,GO:0098781,ncRNA transcription,0.787341384,SNAPC2
GO:2000278,BP,GO:2000278,regulation of DNA biosynthetic process,0.787341384,PAPD5
GO:1902903,BP,GO:1902903,regulation of supramolecular fiber organization,0.787707194,"SYNPO,CIT,TRIOBP"
GO:0010975,BP,GO:0010975,regulation of neuron projection development,0.787707194,"EFNB3,KEL,SHANK2,DAB2IP"
GO:1903706,BP,GO:1903706,regulation of hemopoiesis,0.787707194,"MAFB,SPINK5,HES5,IFNL1"
GO:0001676,BP,GO:0001676,long-chain fatty acid metabolic process,0.787707194,LIPE
GO:0001823,BP,GO:0001823,mesonephros development,0.787707194,BMP2
GO:0001841,BP,GO:0001841,neural tube formation,0.787707194,SPINT1
GO:0002504,BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.787707194,RILP
GO:0006885,BP,GO:0006885,regulation of pH,0.787707194,ATP6V0B
GO:0014896,BP,GO:0014896,muscle hypertrophy,0.787707194,CTDP1
GO:0016051,BP,GO:0016051,carbohydrate biosynthetic process,0.787707194,"ST3GAL2,FBP2"
GO:0019882,BP,GO:0019882,antigen processing and presentation,0.787707194,"RILP,IKBKG"
GO:0043903,BP,GO:0043903,regulation of interspecies interactions between organisms,0.789705629,"CTDP1,SNF8"
GO:0009119,BP,GO:0009119,ribonucleoside metabolic process,0.789705629,GTPBP1
GO:0022037,BP,GO:0022037,metencephalon development,0.789705629,ARCN1
GO:0042866,BP,GO:0042866,pyruvate biosynthetic process,0.789705629,GALK1
GO:0048524,BP,GO:0048524,positive regulation of viral process,0.789705629,CTDP1
GO:0010498,BP,GO:0010498,proteasomal protein catabolic process,0.790499306,"UBE2C,SDF2L1,DNAJB12,DAB2IP"
GO:0002440,BP,GO:0002440,production of molecular mediator of immune response,0.790499306,"SPINK5,IL27RA"
GO:0006814,BP,GO:0006814,sodium ion transport,0.790499306,"SLC34A1,FXYD6"
GO:0031109,BP,GO:0031109,microtubule polymerization or depolymerization,0.79122939,KIF19
GO:1901606,BP,GO:1901606,alpha-amino acid catabolic process,0.79122939,ASPG
GO:1901800,BP,GO:1901800,positive regulation of proteasomal protein catabolic process,0.79122939,DAB2IP
GO:1903409,BP,GO:1903409,reactive oxygen species biosynthetic process,0.79122939,TICAM1
GO:0090092,BP,GO:0090092,"regulation of transmembrane receptor protein serine,threonine kinase signaling pathway",0.793541861,"HES5,BMP2"
GO:0043244,BP,GO:0043244,regulation of protein-containing complex disassembly,0.793541861,TRIOBP
GO:0046031,BP,GO:0046031,ADP metabolic process,0.793541861,GALK1
GO:0046620,BP,GO:0046620,regulation of organ growth,0.793541861,CTDP1
GO:1903008,BP,GO:1903008,organelle disassembly,0.793541861,KIF19
GO:0048285,BP,GO:0048285,organelle fission,0.794612426,"UBE2C,CTDP1,PHF13,BIRC5"
GO:0031424,BP,GO:0031424,keratinization,0.794948968,"SPINK5,KRT32"
GO:0045666,BP,GO:0045666,positive regulation of neuron differentiation,0.795270674,"BMP2,SHANK2,DAB2IP"
GO:0098661,BP,GO:0098661,inorganic anion transmembrane transport,0.796222127,SLC34A1
GO:0001654,BP,GO:0001654,eye development,0.796867227,"HES5,FJX1,JMJD6"
GO:0006024,BP,GO:0006024,glycosaminoglycan biosynthetic process,0.798849609,ST3GAL2
GO:0010811,BP,GO:0010811,positive regulation of cell-substrate adhesion,0.798849609,TRIOBP
GO:0051817,BP,GO:0051817,modulation of process of other organism involved in symbiotic interaction,0.798849609,CTDP1
GO:0006368,BP,GO:0006368,transcription elongation from RNA polymerase II promoter,0.800579648,CTDP1
GO:0019218,BP,GO:0019218,regulation of steroid metabolic process,0.800579648,BMP2
GO:0019730,BP,GO:0019730,antimicrobial humoral response,0.800579648,SPINK5
GO:0035601,BP,GO:0035601,protein deacylation,0.800579648,PHF21A
GO:0048593,BP,GO:0048593,camera-type eye morphogenesis,0.800579648,FJX1
GO:1904659,BP,GO:1904659,glucose transmembrane transport,0.800579648,ASPSCR1
GO:0019318,BP,GO:0019318,hexose metabolic process,0.801291164,"FBP2,GALK1"
GO:0006721,BP,GO:0006721,terpenoid metabolic process,0.802547885,GPIHBP1
GO:0021987,BP,GO:0021987,cerebral cortex development,0.802547885,DAB2IP
GO:0043666,BP,GO:0043666,regulation of phosphoprotein phosphatase activity,0.802547885,CALM3
GO:0098732,BP,GO:0098732,macromolecule deacylation,0.802547885,PHF21A
GO:0051098,BP,GO:0051098,regulation of binding,0.802547885,"TICAM1,BMP2,DAB2IP"
GO:0045862,BP,GO:0045862,positive regulation of proteolysis,0.804490696,"SNX9,DAB2IP,DAP"
GO:0031349,BP,GO:0031349,positive regulation of defense response,0.804610079,"TICAM1,IKBKG,DAB2IP,POLR3D"
GO:0009062,BP,GO:0009062,fatty acid catabolic process,0.805152603,LIPE
GO:0002688,BP,GO:0002688,regulation of leukocyte chemotaxis,0.806729776,TMEM102
GO:0006406,BP,GO:0006406,mRNA export from nucleus,0.806729776,NXF2
GO:0007569,BP,GO:0007569,cell aging,0.806729776,VASH1
GO:0032675,BP,GO:0032675,regulation of interleukin-6 production,0.806729776,TICAM1
GO:0043500,BP,GO:0043500,muscle adaptation,0.806729776,CTDP1
GO:0071427,BP,GO:0071427,mRNA-containing ribonucleoprotein complex export from nucleus,0.806729776,NXF2
GO:0031346,BP,GO:0031346,positive regulation of cell projection organization,0.807709801,"PALM,SHANK2,DAB2IP"
GO:1901532,BP,GO:1901532,regulation of hematopoietic progenitor cell differentiation,0.80952498,HES5
GO:1903038,BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,0.80952498,IFNL1
GO:0006023,BP,GO:0006023,aminoglycan biosynthetic process,0.811922642,ST3GAL2
GO:0007052,BP,GO:0007052,mitotic spindle organization,0.811922642,BIRC5
GO:0071156,BP,GO:0071156,regulation of cell cycle arrest,0.811922642,DAB2IP
GO:0009266,BP,GO:0009266,response to temperature stimulus,0.811922642,"P2RX3,DNAJB6"
GO:0031668,BP,GO:0031668,cellular response to extracellular stimulus,0.811922642,"DAP,GAS2L1"
GO:0002761,BP,GO:0002761,regulation of myeloid leukocyte differentiation,0.813279627,MAFB
GO:0008645,BP,GO:0008645,hexose transmembrane transport,0.813279627,ASPSCR1
GO:0030004,BP,GO:0030004,cellular monovalent inorganic cation homeostasis,0.813279627,ATP6V0B
GO:0032680,BP,GO:0032680,regulation of tumor necrosis factor production,0.813279627,TICAM1
GO:0045667,BP,GO:0045667,regulation of osteoblast differentiation,0.813279627,BMP2
GO:0034754,BP,GO:0034754,cellular hormone metabolic process,0.816779416,BMP2
GO:0061448,BP,GO:0061448,connective tissue development,0.817211499,"HES5,BMP2"
GO:0006639,BP,GO:0006639,acylglycerol metabolic process,0.819387372,LIPE
GO:0015749,BP,GO:0015749,monosaccharide transmembrane transport,0.819387372,ASPSCR1
GO:0006813,BP,GO:0006813,potassium ion transport,0.820926088,"KEL,KCNC3"
GO:0009108,BP,GO:0009108,coenzyme biosynthetic process,0.820926088,"GALK1,NMRK2"
GO:0006165,BP,GO:0006165,nucleoside diphosphate phosphorylation,0.821099904,GALK1
GO:0006638,BP,GO:0006638,neutral lipid metabolic process,0.821099904,LIPE
GO:0032640,BP,GO:0032640,tumor necrosis factor production,0.821099904,TICAM1
GO:0003007,BP,GO:0003007,heart morphogenesis,0.82159321,"XIRP2,BMP2"
GO:0007368,BP,GO:0007368,"determination of left,right symmetry",0.82159321,RTTN
GO:0009063,BP,GO:0009063,cellular amino acid catabolic process,0.82159321,ASPG
GO:0018022,BP,GO:0018022,peptidyl-lysine methylation,0.82159321,EEF2KMT
GO:0051668,BP,GO:0051668,localization within membrane,0.82159321,NRXN2
GO:1903555,BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,0.82159321,TICAM1
GO:0045926,BP,GO:0045926,negative regulation of growth,0.82159321,"CTDP1,CDHR2"
GO:0046578,BP,GO:0046578,regulation of Ras protein signal transduction,0.82159321,"IQSEC3,DAB2IP"
GO:0031503,BP,GO:0031503,protein-containing complex localization,0.822696293,"NXF2,BIRC5"
GO:0051091,BP,GO:0051091,positive regulation of DNA-binding transcription factor activity,0.822696293,"TICAM1,IKBKG"
GO:0018107,BP,GO:0018107,peptidyl-threonine phosphorylation,0.822696293,CALM3
GO:0022612,BP,GO:0022612,gland morphogenesis,0.822696293,BSX
GO:0034219,BP,GO:0034219,carbohydrate transmembrane transport,0.822696293,ASPSCR1
GO:1903052,BP,GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,0.822696293,DAB2IP
GO:0043312,BP,GO:0043312,neutrophil degranulation,0.823460782,"HPSE,SIGLEC14,TRAPPC1,CEACAM6"
GO:0006836,BP,GO:0006836,neurotransmitter transport,0.823460782,"SYN2,NRXN2"
GO:0030335,BP,GO:0030335,positive regulation of cell migration,0.82427629,"TMEM102,BMP2,DAB2IP,CEACAM6"
GO:0000184,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",0.82427629,SECISBP2
GO:0032635,BP,GO:0032635,interleukin-6 production,0.82427629,TICAM1
GO:0002283,BP,GO:0002283,neutrophil activation involved in immune response,0.825391418,"HPSE,SIGLEC14,TRAPPC1,CEACAM6"
GO:0003231,BP,GO:0003231,cardiac ventricle development,0.825391418,XIRP2
GO:0009135,BP,GO:0009135,purine nucleoside diphosphate metabolic process,0.825391418,GALK1
GO:0009179,BP,GO:0009179,purine ribonucleoside diphosphate metabolic process,0.825391418,GALK1
GO:0045598,BP,GO:0045598,regulation of fat cell differentiation,0.825391418,BMP2
GO:0071482,BP,GO:0071482,cellular response to light stimulus,0.825391418,GUCY2D
GO:0043542,BP,GO:0043542,endothelial cell migration,0.826548157,"VASH1,DAB2IP"
GO:0051650,BP,GO:0051650,establishment of vesicle localization,0.826548157,"IKBKG,TRAPPC1"
GO:0001503,BP,GO:0001503,ossification,0.826658962,"ASGR2,SLC34A1,BMP2"
GO:0051225,BP,GO:0051225,spindle assembly,0.826658962,BIRC5
GO:0034504,BP,GO:0034504,protein localization to nucleus,0.826658962,"SPRN,DNAJB6"
GO:1901652,BP,GO:1901652,response to peptide,0.826658962,"SLC34A1,IRF5,KLF1,ATP6V0B"
GO:0002223,BP,GO:0002223,stimulatory C-type lectin receptor signaling pathway,0.826658962,IKBKG
GO:0002687,BP,GO:0002687,positive regulation of leukocyte migration,0.826658962,TMEM102
GO:0006342,BP,GO:0006342,chromatin silencing,0.826658962,H2AFB2
GO:0009185,BP,GO:0009185,ribonucleoside diphosphate metabolic process,0.826658962,GALK1
GO:0030010,BP,GO:0030010,establishment of cell polarity,0.826658962,HES5
GO:0046939,BP,GO:0046939,nucleotide phosphorylation,0.826658962,GALK1
GO:0071706,BP,GO:0071706,tumor necrosis factor superfamily cytokine production,0.826658962,TICAM1
GO:2001251,BP,GO:2001251,negative regulation of chromosome organization,0.826658962,PAPD5
GO:0065004,BP,GO:0065004,protein-DNA complex assembly,0.827235347,"H2AFB2,GRWD1"
GO:0002706,BP,GO:0002706,regulation of lymphocyte mediated immunity,0.827235347,IL27RA
GO:0008033,BP,GO:0008033,tRNA processing,0.827235347,ADAT3
GO:0008286,BP,GO:0008286,insulin receptor signaling pathway,0.827235347,ATP6V0B
GO:0046330,BP,GO:0046330,positive regulation of JNK cascade,0.827235347,DAB2IP
GO:0050729,BP,GO:0050729,positive regulation of inflammatory response,0.827235347,TICAM1
GO:1904064,BP,GO:1904064,positive regulation of cation transmembrane transport,0.827235347,CALM3
GO:0002920,BP,GO:0002920,regulation of humoral immune response,0.829026744,SPINK5
GO:0008637,BP,GO:0008637,apoptotic mitochondrial changes,0.829026744,TMEM102
GO:0009116,BP,GO:0009116,nucleoside metabolic process,0.829026744,GTPBP1
GO:0035270,BP,GO:0035270,endocrine system development,0.829026744,BMP2
GO:0032970,BP,GO:0032970,regulation of actin filament-based process,0.829164118,"SYNPO,CIT,TRIOBP"
GO:0045787,BP,GO:0045787,positive regulation of cell cycle,0.829164118,"UBE2C,CIT,DAB2IP"
GO:0007162,BP,GO:0007162,negative regulation of cell adhesion,0.829593252,"IFNL1,BMP2"
GO:0044782,BP,GO:0044782,cilium organization,0.829593252,"RILP,KIF19,RTTN"
GO:0002220,BP,GO:0002220,innate immune response activating cell surface receptor signaling pathway,0.829593252,IKBKG
GO:0044106,BP,GO:0044106,cellular amine metabolic process,0.829593252,TACR3
GO:0042119,BP,GO:0042119,neutrophil activation,0.829593252,"HPSE,SIGLEC14,TRAPPC1,CEACAM6"
GO:0050878,BP,GO:0050878,regulation of body fluid levels,0.830939519,"PHF21A,P2RX5,P2RX3,HPSE"
GO:0007224,BP,GO:0007224,smoothened signaling pathway,0.831026597,HES5
GO:0009855,BP,GO:0009855,determination of bilateral symmetry,0.831026597,RTTN
GO:0035304,BP,GO:0035304,regulation of protein dephosphorylation,0.831026597,CALM3
GO:0002446,BP,GO:0002446,neutrophil mediated immunity,0.831026597,"HPSE,SIGLEC14,TRAPPC1,CEACAM6"
GO:0060485,BP,GO:0060485,mesenchyme development,0.831217174,"BMP2,DAB2IP"
GO:0002576,BP,GO:0002576,platelet degranulation,0.832493306,ITIH4
GO:0006720,BP,GO:0006720,isoprenoid metabolic process,0.832493306,GPIHBP1
GO:0009799,BP,GO:0009799,specification of symmetry,0.832493306,RTTN
GO:0045165,BP,GO:0045165,cell fate commitment,0.833885575,"HES5,BMP2"
GO:0050768,BP,GO:0050768,negative regulation of neurogenesis,0.833885575,"HES5,EFNB3"
GO:0043280,BP,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.834544259,DAP
GO:0010976,BP,GO:0010976,positive regulation of neuron projection development,0.834986159,"SHANK2,DAB2IP"
GO:0046651,BP,GO:0046651,lymphocyte proliferation,0.834986159,"TICAM1,TNFRSF13C"
GO:0014065,BP,GO:0014065,phosphatidylinositol 3-kinase signaling,0.835237714,DAB2IP
GO:0050921,BP,GO:0050921,positive regulation of chemotaxis,0.835237714,TMEM102
GO:0071426,BP,GO:0071426,ribonucleoprotein complex export from nucleus,0.835237714,NXF2
GO:1902904,BP,GO:1902904,negative regulation of supramolecular fiber organization,0.835237714,TRIOBP
GO:0051648,BP,GO:0051648,vesicle localization,0.835237714,"IKBKG,TRAPPC1"
GO:0032943,BP,GO:0032943,mononuclear cell proliferation,0.835621036,"TICAM1,TNFRSF13C"
GO:0044262,BP,GO:0044262,cellular carbohydrate metabolic process,0.835621036,"FBP2,GALK1"
GO:0035296,BP,GO:0035296,regulation of tube diameter,0.835621036,KEL
GO:0045807,BP,GO:0045807,positive regulation of endocytosis,0.835621036,CALY
GO:0071166,BP,GO:0071166,ribonucleoprotein complex localization,0.835621036,NXF2
GO:0097746,BP,GO:0097746,regulation of blood vessel diameter,0.835621036,KEL
GO:0060828,BP,GO:0060828,regulation of canonical Wnt signaling pathway,0.835901517,"BMP2,DAB2IP"
GO:0007006,BP,GO:0007006,mitochondrial membrane organization,0.835901517,TMEM102
GO:0031333,BP,GO:0031333,negative regulation of protein-containing complex assembly,0.835901517,TRIOBP
GO:0034605,BP,GO:0034605,cellular response to heat,0.835901517,DNAJB6
GO:0051250,BP,GO:0051250,negative regulation of lymphocyte activation,0.835901517,IFNL1
GO:0060048,BP,GO:0060048,cardiac muscle contraction,0.835901517,CALM3
GO:1902850,BP,GO:1902850,microtubule cytoskeleton organization involved in mitosis,0.835901517,BIRC5
GO:0006354,BP,GO:0006354,"DNA-templated transcription, elongation",0.838629851,CTDP1
GO:0007062,BP,GO:0007062,sister chromatid cohesion,0.838838883,BIRC5
GO:0007586,BP,GO:0007586,digestion,0.838838883,PGA3
GO:0030048,BP,GO:0030048,actin filament-based movement,0.838838883,MYH14
GO:0042737,BP,GO:0042737,drug catabolic process,0.838838883,RENBP
GO:0048813,BP,GO:0048813,dendrite morphogenesis,0.838838883,SHANK2
GO:0051053,BP,GO:0051053,negative regulation of DNA metabolic process,0.838838883,PAPD5
GO:0061041,BP,GO:0061041,regulation of wound healing,0.838838883,HPSE
GO:0006090,BP,GO:0006090,pyruvate metabolic process,0.840667817,GALK1
GO:0008203,BP,GO:0008203,cholesterol metabolic process,0.840667817,LIPE
GO:0061351,BP,GO:0061351,neural precursor cell proliferation,0.840667817,SPINT1
GO:0010632,BP,GO:0010632,regulation of epithelial cell migration,0.842876154,"VASH1,DAB2IP"
GO:0006633,BP,GO:0006633,fatty acid biosynthetic process,0.842876154,FA2H
GO:0051494,BP,GO:0051494,negative regulation of cytoskeleton organization,0.845051254,TRIOBP
GO:1903900,BP,GO:1903900,regulation of viral life cycle,0.845051254,SNF8
GO:0010977,BP,GO:0010977,negative regulation of neuron projection development,0.846363311,EFNB3
GO:0030879,BP,GO:0030879,mammary gland development,0.846363311,BSX
GO:0045814,BP,GO:0045814,"negative regulation of gene expression, epigenetic",0.846363311,H2AFB2
GO:1903364,BP,GO:1903364,positive regulation of cellular protein catabolic process,0.846363311,DAB2IP
GO:0005996,BP,GO:0005996,monosaccharide metabolic process,0.848056688,"FBP2,GALK1"
GO:0007030,BP,GO:0007030,Golgi organization,0.848056688,CIT
GO:0018210,BP,GO:0018210,peptidyl-threonine modification,0.848056688,CALM3
GO:0035150,BP,GO:0035150,regulation of tube size,0.850132458,KEL
GO:0042133,BP,GO:0042133,neurotransmitter metabolic process,0.850132458,TICAM1
GO:0051258,BP,GO:0051258,protein polymerization,0.851760603,"UBE2C,TRIOBP"
GO:1902652,BP,GO:1902652,secondary alcohol metabolic process,0.851760603,LIPE
GO:2000736,BP,GO:2000736,regulation of stem cell differentiation,0.851760603,HES5
GO:0006754,BP,GO:0006754,ATP biosynthetic process,0.8536747,GALK1
GO:0010770,BP,GO:0010770,positive regulation of cell morphogenesis involved in differentiation,0.8536747,TRIOBP
GO:0051961,BP,GO:0051961,negative regulation of nervous system development,0.8536747,"HES5,EFNB3"
GO:0070661,BP,GO:0070661,leukocyte proliferation,0.8536747,"TICAM1,TNFRSF13C"
GO:0001764,BP,GO:0001764,neuron migration,0.8536747,DAB2IP
GO:0006606,BP,GO:0006606,protein import into nucleus,0.8536747,SPRN
GO:0009132,BP,GO:0009132,nucleoside diphosphate metabolic process,0.8536747,GALK1
GO:0048660,BP,GO:0048660,regulation of smooth muscle cell proliferation,0.8536747,HES5
GO:0051384,BP,GO:0051384,response to glucocorticoid,0.8536747,PAPPA
GO:0048592,BP,GO:0048592,eye morphogenesis,0.85520727,FJX1
GO:1903169,BP,GO:1903169,regulation of calcium ion transmembrane transport,0.85520727,CALM3
GO:2001056,BP,GO:2001056,positive regulation of cysteine-type endopeptidase activity,0.85520727,DAP
GO:0030258,BP,GO:0030258,lipid modification,0.858404777,"ST3GAL2,FA2H"
GO:0002377,BP,GO:0002377,immunoglobulin production,0.858404777,IL27RA
GO:0048659,BP,GO:0048659,smooth muscle cell proliferation,0.858404777,HES5
GO:0050806,BP,GO:0050806,positive regulation of synaptic transmission,0.858404777,SHANK2
GO:1902600,BP,GO:1902600,proton transmembrane transport,0.858404777,ATP6V0B
GO:0071824,BP,GO:0071824,protein-DNA complex subunit organization,0.858404777,"H2AFB2,GRWD1"
GO:0006405,BP,GO:0006405,RNA export from nucleus,0.859621198,NXF2
GO:0007338,BP,GO:0007338,single fertilization,0.859621198,BPY2C
GO:0008643,BP,GO:0008643,carbohydrate transport,0.859621198,ASPSCR1
GO:0009451,BP,GO:0009451,RNA modification,0.861448069,ADAT3
GO:0045931,BP,GO:0045931,positive regulation of mitotic cell cycle,0.861448069,UBE2C
GO:0042129,BP,GO:0042129,regulation of T cell proliferation,0.862830075,TNFRSF13C
GO:0043535,BP,GO:0043535,regulation of blood vessel endothelial cell migration,0.862830075,VASH1
GO:0051028,BP,GO:0051028,mRNA transport,0.862830075,NXF2
GO:0032103,BP,GO:0032103,positive regulation of response to external stimulus,0.866312873,"TICAM1,TMEM102"
GO:0046394,BP,GO:0046394,carboxylic acid biosynthetic process,0.866621445,"GALK1,ASPG,FA2H"
GO:0006261,BP,GO:0006261,DNA-dependent DNA replication,0.866756913,ORC6
GO:0016053,BP,GO:0016053,organic acid biosynthetic process,0.867381586,"GALK1,ASPG,FA2H"
GO:0016579,BP,GO:0016579,protein deubiquitination,0.867636071,"IKBKG,HGS"
GO:0006626,BP,GO:0006626,protein targeting to mitochondrion,0.867636071,MTX1
GO:0030856,BP,GO:0030856,regulation of epithelial cell differentiation,0.867636071,HES5
GO:0009206,BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,0.868487624,GALK1
GO:0016125,BP,GO:0016125,sterol metabolic process,0.868487624,LIPE
GO:0035821,BP,GO:0035821,modulation of process of other organism,0.868487624,CTDP1
GO:0048754,BP,GO:0048754,branching morphogenesis of an epithelial tube,0.868487624,BMP2
GO:0042742,BP,GO:0042742,defense response to bacterium,0.869225851,"SPINK5,IL27RA"
GO:0002695,BP,GO:0002695,negative regulation of leukocyte activation,0.869728098,IFNL1
GO:0009145,BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,0.869728098,GALK1
GO:0030336,BP,GO:0030336,negative regulation of cell migration,0.873041674,"VASH1,DAB2IP"
GO:0072330,BP,GO:0072330,monocarboxylic acid biosynthetic process,0.873041674,"GALK1,FA2H"
GO:0051897,BP,GO:0051897,positive regulation of protein kinase B signaling,0.874963914,HPSE
GO:0000209,BP,GO:0000209,protein polyubiquitination,0.874963914,"UBE2T,UBE2C"
GO:0007568,BP,GO:0007568,aging,0.874963914,"VASH1,TACR3"
GO:0051188,BP,GO:0051188,cofactor biosynthetic process,0.874963914,"GALK1,NMRK2"
GO:0003205,BP,GO:0003205,cardiac chamber development,0.875671108,XIRP2
GO:0048015,BP,GO:0048015,phosphatidylinositol-mediated signaling,0.875671108,DAB2IP
GO:0055067,BP,GO:0055067,monovalent inorganic cation homeostasis,0.875671108,ATP6V0B
GO:0000723,BP,GO:0000723,telomere maintenance,0.876361315,PAPD5
GO:0009201,BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,0.876361315,GALK1
GO:0050821,BP,GO:0050821,protein stabilization,0.876361315,GPIHBP1
GO:0120032,BP,GO:0120032,regulation of plasma membrane bounded cell projection assembly,0.876361315,PALM
GO:0031960,BP,GO:0031960,response to corticosteroid,0.877666857,PAPPA
GO:0043488,BP,GO:0043488,regulation of mRNA stability,0.877666857,YBX1
GO:0030216,BP,GO:0030216,keratinocyte differentiation,0.877666857,"SPINK5,KRT32"
GO:0006470,BP,GO:0006470,protein dephosphorylation,0.877666857,"CTDP1,CALM3"
GO:0007088,BP,GO:0007088,regulation of mitotic nuclear division,0.877666857,UBE2C
GO:0048017,BP,GO:0048017,inositol lipid-mediated signaling,0.877666857,DAB2IP
GO:0060491,BP,GO:0060491,regulation of cell projection assembly,0.877666857,PALM
GO:1903034,BP,GO:1903034,regulation of response to wounding,0.877666857,HPSE
GO:0030833,BP,GO:0030833,regulation of actin filament polymerization,0.879531051,TRIOBP
GO:0009416,BP,GO:0009416,response to light stimulus,0.880036286,"SYNPO,GUCY2D"
GO:0021543,BP,GO:0021543,pallium development,0.880889592,DAB2IP
GO:0070646,BP,GO:0070646,protein modification by small protein removal,0.880889592,"IKBKG,HGS"
GO:0071496,BP,GO:0071496,cellular response to external stimulus,0.881009519,"DAP,GAS2L1"
GO:0003018,BP,GO:0003018,vascular process in circulatory system,0.881009519,KEL
GO:0008361,BP,GO:0008361,regulation of cell size,0.881009519,KEL
GO:0051170,BP,GO:0051170,import into nucleus,0.881009519,SPRN
GO:0009127,BP,GO:0009127,purine nucleoside monophosphate biosynthetic process,0.881009519,GALK1
GO:0009168,BP,GO:0009168,purine ribonucleoside monophosphate biosynthetic process,0.881009519,GALK1
GO:0048469,BP,GO:0048469,cell maturation,0.881009519,HES5
GO:0043687,BP,GO:0043687,post-translational protein modification,0.881009519,"GPIHBP1,SPRN,DCAF4"
GO:0009205,BP,GO:0009205,purine ribonucleoside triphosphate metabolic process,0.881009519,"GTPBP1,GALK1"
GO:0009166,BP,GO:0009166,nucleotide catabolic process,0.881009519,GALK1
GO:0010565,BP,GO:0010565,regulation of cellular ketone metabolic process,0.881009519,BMP2
GO:0062013,BP,GO:0062013,positive regulation of small molecule metabolic process,0.881009519,CALM3
GO:0008202,BP,GO:0008202,steroid metabolic process,0.881009519,"LIPE,BMP2"
GO:0033044,BP,GO:0033044,regulation of chromosome organization,0.881009519,"UBE2C,PAPD5"
GO:0070372,BP,GO:0070372,regulation of ERK1 and ERK2 cascade,0.881009519,"BMP2,DAB2IP"
GO:2000146,BP,GO:2000146,negative regulation of cell motility,0.881009519,"VASH1,DAB2IP"
GO:0030324,BP,GO:0030324,lung development,0.881009519,JMJD6
GO:0031345,BP,GO:0031345,negative regulation of cell projection organization,0.881009519,EFNB3
GO:0046890,BP,GO:0046890,regulation of lipid biosynthetic process,0.881009519,BMP2
GO:0070613,BP,GO:0070613,regulation of protein processing,0.881009519,BIRC5
GO:0002703,BP,GO:0002703,regulation of leukocyte mediated immunity,0.881899118,IL27RA
GO:0043487,BP,GO:0043487,regulation of RNA stability,0.881899118,YBX1
GO:0002040,BP,GO:0002040,sprouting angiogenesis,0.881899118,JMJD6
GO:0043534,BP,GO:0043534,blood vessel endothelial cell migration,0.881899118,VASH1
GO:0046328,BP,GO:0046328,regulation of JNK cascade,0.881899118,DAB2IP
GO:0048771,BP,GO:0048771,tissue remodeling,0.881899118,BSX
GO:1903317,BP,GO:1903317,regulation of protein maturation,0.881899118,BIRC5
GO:0002460,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.881899118,"IL27RA,TNFRSF13C"
GO:0051235,BP,GO:0051235,maintenance of location,0.881899118,"MCOLN1,CALM3"
GO:0009199,BP,GO:0009199,ribonucleoside triphosphate metabolic process,0.881948563,"GTPBP1,GALK1"
GO:0009144,BP,GO:0009144,purine nucleoside triphosphate metabolic process,0.881948563,"GTPBP1,GALK1"
GO:0070997,BP,GO:0070997,neuron death,0.881948563,"IKBKG,CIT"
GO:0009142,BP,GO:0009142,nucleoside triphosphate biosynthetic process,0.881948563,GALK1
GO:0010950,BP,GO:0010950,positive regulation of endopeptidase activity,0.881948563,DAP
GO:0021953,BP,GO:0021953,central nervous system neuron differentiation,0.881948563,HES5
GO:0030177,BP,GO:0030177,positive regulation of Wnt signaling pathway,0.881948563,BMP2
GO:0030323,BP,GO:0030323,respiratory tube development,0.881948563,JMJD6
GO:0071346,BP,GO:0071346,cellular response to interferon-gamma,0.881948563,IRF5
GO:0001959,BP,GO:0001959,regulation of cytokine-mediated signaling pathway,0.881948563,IKBKG
GO:0032200,BP,GO:0032200,telomere organization,0.881948563,PAPD5
GO:0035265,BP,GO:0035265,organ growth,0.881948563,CTDP1
GO:0043901,BP,GO:0043901,negative regulation of multi-organism process,0.881948563,SPINK5
GO:1901292,BP,GO:1901292,nucleoside phosphate catabolic process,0.881948563,GALK1
GO:0050866,BP,GO:0050866,negative regulation of cell activation,0.882728642,IFNL1
GO:0061136,BP,GO:0061136,regulation of proteasomal protein catabolic process,0.882728642,DAB2IP
GO:2000377,BP,GO:2000377,regulation of reactive oxygen species metabolic process,0.882728642,TICAM1
GO:0042098,BP,GO:0042098,T cell proliferation,0.884305094,TNFRSF13C
GO:0043902,BP,GO:0043902,positive regulation of multi-organism process,0.885861132,CTDP1
GO:0002685,BP,GO:0002685,regulation of leukocyte migration,0.886167881,TMEM102
GO:0019083,BP,GO:0019083,viral transcription,0.886167881,CTDP1
GO:0030041,BP,GO:0030041,actin filament polymerization,0.886167881,TRIOBP
GO:2001235,BP,GO:2001235,positive regulation of apoptotic signaling pathway,0.886167881,DAB2IP
GO:0010631,BP,GO:0010631,epithelial cell migration,0.887216872,"VASH1,DAB2IP"
GO:0009156,BP,GO:0009156,ribonucleoside monophosphate biosynthetic process,0.889176716,GALK1
GO:0038095,BP,GO:0038095,Fc-epsilon receptor signaling pathway,0.889238775,IKBKG
GO:0090132,BP,GO:0090132,epithelium migration,0.889238775,"VASH1,DAB2IP"
GO:0070371,BP,GO:0070371,ERK1 and ERK2 cascade,0.889238775,"BMP2,DAB2IP"
GO:0006479,BP,GO:0006479,protein methylation,0.889238775,EEF2KMT
GO:0008213,BP,GO:0008213,protein alkylation,0.889238775,EEF2KMT
GO:0015698,BP,GO:0015698,inorganic anion transport,0.889238775,SLC34A1
GO:0022900,BP,GO:0022900,electron transport chain,0.889238775,AOC2
GO:0060759,BP,GO:0060759,regulation of response to cytokine stimulus,0.889238775,IKBKG
GO:0071478,BP,GO:0071478,cellular response to radiation,0.889238775,GUCY2D
GO:0006611,BP,GO:0006611,protein export from nucleus,0.890671911,NXF2
GO:0006898,BP,GO:0006898,receptor-mediated endocytosis,0.890873571,"ASGR2,SNX9"
GO:0007051,BP,GO:0007051,spindle organization,0.893071986,BIRC5
GO:0009566,BP,GO:0009566,fertilization,0.893071986,BPY2C
GO:0090130,BP,GO:0090130,tissue migration,0.893789476,"VASH1,DAB2IP"
GO:0051783,BP,GO:0051783,regulation of nuclear division,0.894038799,UBE2C
GO:0030278,BP,GO:0030278,regulation of ossification,0.895396585,BMP2
GO:0007178,BP,GO:0007178,"transmembrane receptor protein serine,threonine kinase signaling pathway",0.895670645,"HES5,BMP2"
GO:0006694,BP,GO:0006694,steroid biosynthetic process,0.895670645,BMP2
GO:0031099,BP,GO:0031099,regeneration,0.895670645,BCL9
GO:0009141,BP,GO:0009141,nucleoside triphosphate metabolic process,0.895670645,"GTPBP1,GALK1"
GO:0050907,BP,GO:0050907,detection of chemical stimulus involved in sensory perception,0.895670645,"CST1,OR9A2,OR7C2"
GO:0031348,BP,GO:0031348,negative regulation of defense response,0.895670645,SPINK5
GO:0060348,BP,GO:0060348,bone development,0.895670645,BMP2
GO:0006338,BP,GO:0006338,chromatin remodeling,0.895670645,TOP1
GO:0010952,BP,GO:0010952,positive regulation of peptidase activity,0.895670645,DAP
GO:0031032,BP,GO:0031032,actomyosin structure organization,0.895670645,MYH14
GO:0044272,BP,GO:0044272,sulfur compound biosynthetic process,0.895670645,ST3GAL2
GO:1901215,BP,GO:1901215,negative regulation of neuron death,0.895670645,IKBKG
GO:0051056,BP,GO:0051056,regulation of small GTPase mediated signal transduction,0.895670645,"IQSEC3,DAB2IP"
GO:0006006,BP,GO:0006006,glucose metabolic process,0.895747329,FBP2
GO:0009124,BP,GO:0009124,nucleoside monophosphate biosynthetic process,0.895747329,GALK1
GO:0051271,BP,GO:0051271,negative regulation of cellular component movement,0.895747329,"VASH1,DAB2IP"
GO:0019080,BP,GO:0019080,viral gene expression,0.896999938,CTDP1
GO:0010810,BP,GO:0010810,regulation of cell-substrate adhesion,0.897839363,TRIOBP
GO:0034341,BP,GO:0034341,response to interferon-gamma,0.897839363,IRF5
GO:0050679,BP,GO:0050679,positive regulation of epithelial cell proliferation,0.898403272,BMP2
GO:0072655,BP,GO:0072655,establishment of protein localization to mitochondrion,0.898403272,MTX1
GO:0030111,BP,GO:0030111,regulation of Wnt signaling pathway,0.898403272,"BMP2,DAB2IP"
GO:0060541,BP,GO:0060541,respiratory system development,0.899466437,JMJD6
GO:0062012,BP,GO:0062012,regulation of small molecule metabolic process,0.899575641,"PALM,BMP2,CALM3"
GO:0001666,BP,GO:0001666,response to hypoxia,0.899675034,"BMP2,P2RX3"
GO:0006913,BP,GO:0006913,nucleocytoplasmic transport,0.899804878,"SPRN,NXF2"
GO:0006413,BP,GO:0006413,translational initiation,0.899804878,EIF4E2
GO:0007623,BP,GO:0007623,circadian rhythm,0.899804878,TOP1
GO:0070585,BP,GO:0070585,protein localization to mitochondrion,0.899804878,MTX1
GO:1902905,BP,GO:1902905,positive regulation of supramolecular fiber organization,0.899804878,SYNPO
GO:0032591,CC,GO:0032591,dendritic spine membrane,0.040794358,"PALM,SHISA9,KCNC3"
GO:0032002,CC,GO:0032002,interleukin-28 receptor complex,0.040794358,"IFNLR1,IFNL1"
GO:0032590,CC,GO:0032590,dendrite membrane,0.040794358,"PALM,TACR3,SHISA9,KCNC3"
GO:0098862,CC,GO:0098862,cluster of actin-based cell projections,0.040794358,"SLC34A1,MYO15A,MYH14,PDZD7,SHANK2,TRIOBP,CDHR2"
GO:0032809,CC,GO:0032809,neuronal cell body membrane,0.072319525,"TACR3,DAB2IP,KCNC3"
GO:0044298,CC,GO:0044298,cell body membrane,0.072319525,"TACR3,DAB2IP,KCNC3"
GO:0032589,CC,GO:0032589,neuron projection membrane,0.088442362,"PALM,TACR3,SHISA9,KCNC3"
GO:0043197,CC,GO:0043197,dendritic spine,0.138710229,"PALM,SHISA9,P2RX3,SYNPO,SHANK2,KCNC3"
GO:0044309,CC,GO:0044309,neuron spine,0.138710229,"PALM,SHISA9,P2RX3,SYNPO,SHANK2,KCNC3"
GO:0098802,CC,GO:0098802,plasma membrane signaling receptor complex,0.233126204,"IFNLR1,IFNL1,APBB1IP,SHISA9,BMP2,SHANK2"
GO:0005639,CC,GO:0005639,integral component of nuclear inner membrane,0.233126204,"P2RX5,P2RX3"
GO:0031229,CC,GO:0031229,intrinsic component of nuclear inner membrane,0.233126204,"P2RX5,P2RX3"
GO:0032420,CC,GO:0032420,stereocilium,0.233126204,"MYO15A,PDZD7,TRIOBP"
GO:0031674,CC,GO:0031674,I band,0.233126204,"FBP2,XIRP2,SYNPO,DNAJB6,CACNA1S"
GO:0030017,CC,GO:0030017,sarcomere,0.233126204,"FBP2,XIRP2,SYNPO,DNAJB6,CALM3,CACNA1S"
GO:0031526,CC,GO:0031526,brush border membrane,0.233126204,"SLC34A1,SHANK2,CDHR2"
GO:0032421,CC,GO:0032421,stereocilium bundle,0.233126204,"MYO15A,PDZD7,TRIOBP"
GO:0005903,CC,GO:0005903,brush border,0.233126204,"SLC34A1,MYH14,SHANK2,CDHR2"
GO:0031253,CC,GO:0031253,cell projection membrane,0.233126204,"SLC34A1,PALM,TACR3,SHISA9,SHANK2,GUCY2D,KCNC3,CDHR2"
GO:0001725,CC,GO:0001725,stress fiber,0.233126204,"XIRP2,SYNPO,MYH14"
GO:0097517,CC,GO:0097517,contractile actin filament bundle,0.233126204,"XIRP2,SYNPO,MYH14"
GO:0030016,CC,GO:0030016,myofibril,0.23965696,"FBP2,XIRP2,SYNPO,DNAJB6,CALM3,CACNA1S"
GO:0009330,CC,GO:0009330,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex",0.23965696,TOP1
GO:0044301,CC,GO:0044301,climbing fiber,0.23965696,DAB2IP
GO:0070724,CC,GO:0070724,BMP receptor complex,0.23965696,BMP2
GO:1990696,CC,GO:1990696,USH2 complex,0.23965696,PDZD7
GO:0032432,CC,GO:0032432,actin filament bundle,0.239988692,"XIRP2,SYNPO,MYH14"
GO:0043292,CC,GO:0043292,contractile fiber,0.251856229,"FBP2,XIRP2,SYNPO,DNAJB6,CALM3,CACNA1S"
GO:0042641,CC,GO:0042641,actomyosin,0.251856229,"XIRP2,SYNPO,MYH14"
GO:0043235,CC,GO:0043235,receptor complex,0.251856229,"IFNLR1,IFNL1,APBB1IP,MCOLN1,SHISA9,BMP2,P2RX3,SHANK2"
GO:0005770,CC,GO:0005770,late endosome,0.251856229,"RILP,MON1A,MCOLN1,SNF8,PGA3,HGS"
GO:0000814,CC,GO:0000814,ESCRT II complex,0.251856229,SNF8
GO:0005588,CC,GO:0005588,collagen type V trimer,0.251856229,COL5A3
GO:0033565,CC,GO:0033565,ESCRT-0 complex,0.251856229,HGS
GO:0097513,CC,GO:0097513,myosin II filament,0.251856229,MYH14
GO:1990597,CC,GO:1990597,AIP1-IRE1 complex,0.251856229,DAB2IP
GO:0043025,CC,GO:0043025,neuronal cell body,0.251856229,"TACR3,P2RX3,SYNPO,CIT,SHANK2,DAB2IP,S100A5,TOP1,KCNC3"
GO:0036452,CC,GO:0036452,ESCRT complex,0.251856229,"SNF8,HGS"
GO:0030670,CC,GO:0030670,phagocytic vesicle membrane,0.263357566,"RILP,MCOLN1,ATP6V0B"
GO:0030018,CC,GO:0030018,Z disc,0.263357566,"FBP2,XIRP2,SYNPO,DNAJB6"
GO:0031902,CC,GO:0031902,late endosome membrane,0.263444578,"RILP,MCOLN1,SNF8,HGS"
GO:0002141,CC,GO:0002141,stereocilia ankle link,0.274312835,PDZD7
GO:0002142,CC,GO:0002142,stereocilia ankle link complex,0.274312835,PDZD7
GO:0035658,CC,GO:0035658,Mon1-Ccz1 complex,0.274312835,MON1A
GO:0097209,CC,GO:0097209,epidermal lamellar body,0.274312835,SPINK5
GO:0098858,CC,GO:0098858,actin-based cell projection,0.289754553,"PALM,MYO15A,PDZD7,TRIOBP,CDHR2"
GO:0032040,CC,GO:0032040,small-subunit processome,0.289754553,"UTP14A,PDCD11"
GO:0002139,CC,GO:0002139,stereocilia coupling link,0.289754553,PDZD7
GO:0030061,CC,GO:0030061,mitochondrial crista,0.289754553,COX6B2
GO:0032133,CC,GO:0032133,chromosome passenger complex,0.289754553,BIRC5
GO:0032437,CC,GO:0032437,cuticular plate,0.289754553,TRIOBP
GO:0042272,CC,GO:0042272,nuclear RNA export factor complex,0.289754553,NXF2
GO:0044300,CC,GO:0044300,cerebellar mossy fiber,0.289754553,DAB2IP
GO:0000220,CC,GO:0000220,"vacuolar proton-transporting V-type ATPase, V0 domain",0.31622785,ATP6V0B
GO:0044214,CC,GO:0044214,spanning component of plasma membrane,0.31622785,CDHR2
GO:0070937,CC,GO:0070937,CRD-mediated mRNA stability complex,0.31622785,YBX1
GO:0071204,CC,GO:0071204,histone pre-mRNA 3'end processing complex,0.31622785,YBX1
GO:0097342,CC,GO:0097342,ripoptosome,0.31622785,TICAM1
GO:0005771,CC,GO:0005771,multivesicular body,0.338897279,"PGA3,HGS"
GO:0097486,CC,GO:0097486,multivesicular body lumen,0.349131494,PGA3
GO:1990454,CC,GO:1990454,L-type voltage-gated calcium channel complex,0.349131494,CACNA1S
GO:0098794,CC,GO:0098794,postsynapse,0.360015811,"PALM,P2RX5,SHISA9,P2RX3,IQSEC3,SYNPO,SHANK2,KCNC3"
GO:0001917,CC,GO:0001917,photoreceptor inner segment,0.367841089,"PDZD7,SHANK2"
GO:0031965,CC,GO:0031965,nuclear membrane,0.367841089,"YBX1,P2RX5,MRGPRF,P2RX3,DNAJB12,GUCY2D"
GO:0005883,CC,GO:0005883,neurofilament,0.367841089,SHANK2
GO:0031256,CC,GO:0031256,leading edge membrane,0.367841089,"PALM,TACR3,SHISA9,KCNC3"
GO:0030496,CC,GO:0030496,midbody,0.36865981,"CTDP1,CIT,TRIOBP,BIRC5"
GO:0008328,CC,GO:0008328,ionotropic glutamate receptor complex,0.368736109,"SHISA9,SHANK2"
GO:0000808,CC,GO:0000808,origin recognition complex,0.368736109,ORC6
GO:0005664,CC,GO:0005664,nuclear origin of replication recognition complex,0.368736109,ORC6
GO:0031298,CC,GO:0031298,replication fork protection complex,0.368736109,TOP1
GO:0031906,CC,GO:0031906,late endosome lumen,0.368736109,PGA3
GO:0097060,CC,GO:0097060,synaptic membrane,0.368736109,"PALM,SHISA9,IQSEC3,SYNPO,SHANK2,KCNC3"
GO:0097731,CC,GO:0097731,9+0 non-motile cilium,0.368736109,"PDZD7,SHANK2,GUCY2D"
GO:0097733,CC,GO:0097733,photoreceptor cell cilium,0.368736109,"PDZD7,SHANK2,GUCY2D"
GO:0098878,CC,GO:0098878,neurotransmitter receptor complex,0.368736109,"SHISA9,SHANK2"
GO:0033179,CC,GO:0033179,"proton-transporting V-type ATPase, V0 domain",0.384571901,ATP6V0B
GO:0034663,CC,GO:0034663,endoplasmic reticulum chaperone complex,0.384571901,SDF2L1
GO:0008385,CC,GO:0008385,IkappaB kinase complex,0.400504969,IKBKG
GO:0032585,CC,GO:0032585,multivesicular body membrane,0.400504969,HGS
GO:0089717,CC,GO:0089717,spanning component of membrane,0.400504969,CDHR2
GO:1990907,CC,GO:1990907,beta-catenin-TCF complex,0.400504969,BCL9
GO:0043204,CC,GO:0043204,perikaryon,0.41045344,"SYNPO,TOP1,KCNC3"
GO:0005583,CC,GO:0005583,fibrillar collagen trimer,0.41177353,COL5A3
GO:0008250,CC,GO:0008250,oligosaccharyltransferase complex,0.41177353,KRTCAP2
GO:0098643,CC,GO:0098643,banded collagen fibril,0.41177353,COL5A3
GO:0005637,CC,GO:0005637,nuclear inner membrane,0.41177353,"P2RX5,P2RX3"
GO:0045335,CC,GO:0045335,phagocytic vesicle,0.432118668,"RILP,MCOLN1,ATP6V0B"
GO:0005845,CC,GO:0005845,mRNA cap binding complex,0.452903772,EIF4E2
GO:0030008,CC,GO:0030008,TRAPP complex,0.452903772,TRAPPC1
GO:0031089,CC,GO:0031089,platelet dense granule lumen,0.452903772,ITIH4
GO:0034704,CC,GO:0034704,calcium channel complex,0.45654003,"CALM3,CACNA1S"
GO:0000177,CC,GO:0000177,cytoplasmic exosome (RNase complex),0.45783523,GTPBP1
GO:0030126,CC,GO:0030126,COPI vesicle coat,0.45783523,ARCN1
GO:0031235,CC,GO:0031235,intrinsic component of the cytoplasmic side of the plasma membrane,0.45783523,DAB2IP
GO:0060077,CC,GO:0060077,inhibitory synapse,0.45783523,IQSEC3
GO:0097730,CC,GO:0097730,non-motile cilium,0.468315405,"PDZD7,SHANK2,GUCY2D"
GO:0034518,CC,GO:0034518,RNA cap binding complex,0.468315405,EIF4E2
GO:0010008,CC,GO:0010008,endosome membrane,0.468315405,"RILP,TICAM1,MCOLN1,SNF8,ATP6V0B,HGS,TMEM150B"
GO:0016459,CC,GO:0016459,myosin complex,0.468315405,"MYO15A,MYH14"
GO:0005666,CC,GO:0005666,RNA polymerase III complex,0.468315405,POLR3D
GO:0008074,CC,GO:0008074,"guanylate cyclase complex, soluble",0.468315405,GUCY2D
GO:0031527,CC,GO:0031527,filopodium membrane,0.468315405,PALM
GO:0034702,CC,GO:0034702,ion channel complex,0.468315405,"SHISA9,SHANK2,CALM3,KCNC3,CACNA1S"
GO:0034703,CC,GO:0034703,cation channel complex,0.468315405,"SHISA9,CALM3,KCNC3,CACNA1S"
GO:0030663,CC,GO:0030663,COPI-coated vesicle membrane,0.468315405,ARCN1
GO:0031362,CC,GO:0031362,anchored component of external side of plasma membrane,0.468315405,GPIHBP1
GO:0032426,CC,GO:0032426,stereocilium tip,0.468315405,PDZD7
GO:0045121,CC,GO:0045121,membrane raft,0.468315405,"SLC34A1,LIPE,P2RX3,HPSE,CBLC"
GO:0031252,CC,GO:0031252,cell leading edge,0.468315405,"PALM,APBB1IP,TACR3,SNX9,SHISA9,KCNC3"
GO:0098857,CC,GO:0098857,membrane microdomain,0.468315405,"SLC34A1,LIPE,P2RX3,HPSE,CBLC"
GO:0016327,CC,GO:0016327,apicolateral plasma membrane,0.468315405,PALM
GO:0042101,CC,GO:0042101,T cell receptor complex,0.468315405,APBB1IP
GO:0042599,CC,GO:0042599,lamellar body,0.468315405,SPINK5
GO:0030684,CC,GO:0030684,preribosome,0.468315405,"UTP14A,PDCD11"
GO:0014069,CC,GO:0014069,postsynaptic density,0.468315405,"PALM,SHISA9,SYNPO,SHANK2"
GO:0098644,CC,GO:0098644,complex of collagen trimers,0.468315405,COL5A3
GO:0099572,CC,GO:0099572,postsynaptic specialization,0.468315405,"PALM,SHISA9,SYNPO,SHANK2"
GO:0000922,CC,GO:0000922,spindle pole,0.468315405,"CTDP1,IKBKG,CALM3"
GO:0005680,CC,GO:0005680,anaphase-promoting complex,0.468315405,UBE2C
GO:0042827,CC,GO:0042827,platelet dense granule,0.468315405,ITIH4
GO:0097225,CC,GO:0097225,sperm midpiece,0.468315405,TACR3
GO:0032279,CC,GO:0032279,asymmetric synapse,0.468315405,"PALM,SHISA9,SYNPO,SHANK2"
GO:0098589,CC,GO:0098589,membrane region,0.468315405,"SLC34A1,LIPE,P2RX3,HPSE,CBLC"
GO:0098984,CC,GO:0098984,neuron to neuron synapse,0.468315405,"PALM,SHISA9,SYNPO,SHANK2"
GO:0032982,CC,GO:0032982,myosin filament,0.468315405,MYH14
GO:0001750,CC,GO:0001750,photoreceptor outer segment,0.468315405,"SHANK2,GUCY2D"
GO:1902495,CC,GO:1902495,transmembrane transporter complex,0.468315405,"SHISA9,SHANK2,CALM3,KCNC3,CACNA1S"
GO:0031225,CC,GO:0031225,anchored component of membrane,0.468315405,"GPIHBP1,SPRN,CEACAM6"
GO:0060170,CC,GO:0060170,ciliary membrane,0.468315405,"SHANK2,GUCY2D"
GO:0000178,CC,GO:0000178,exosome (RNase complex),0.468315405,GTPBP1
GO:0001891,CC,GO:0001891,phagocytic cup,0.468315405,MCOLN1
GO:0005682,CC,GO:0005682,U5 snRNP,0.468315405,DCAF4
GO:0031233,CC,GO:0031233,intrinsic component of external side of plasma membrane,0.468315405,GPIHBP1
GO:0031528,CC,GO:0031528,microvillus membrane,0.468315405,CDHR2
GO:0033177,CC,GO:0033177,"proton-transporting two-sector ATPase complex, proton-transporting domain",0.468315405,ATP6V0B
GO:0097381,CC,GO:0097381,photoreceptor disc membrane,0.468315405,GUCY2D
GO:1905354,CC,GO:1905354,exoribonuclease complex,0.468315405,GTPBP1
GO:0005819,CC,GO:0005819,spindle,0.468315405,"SLC34A1,CTDP1,IKBKG,CALM3,BIRC5"
GO:0030666,CC,GO:0030666,endocytic vesicle membrane,0.468315405,"RILP,MCOLN1,ATP6V0B"
GO:0035327,CC,GO:0035327,transcriptionally active chromatin,0.472327933,H2AFB2
GO:0045211,CC,GO:0045211,postsynaptic membrane,0.472327933,"SHISA9,IQSEC3,SYNPO,SHANK2"
GO:0005774,CC,GO:0005774,vacuolar membrane,0.472327933,"RILP,MCOLN1,HPSE,ATP6V0B,CEACAM6,TMEM150B"
GO:1990351,CC,GO:1990351,transporter complex,0.47321757,"SHISA9,SHANK2,CALM3,KCNC3,CACNA1S"
GO:0005640,CC,GO:0005640,nuclear outer membrane,0.479019832,GUCY2D
GO:0030137,CC,GO:0030137,COPI-coated vesicle,0.479019832,ARCN1
GO:0005776,CC,GO:0005776,autophagosome,0.489162321,"TICAM1,TMEM150B"
GO:0033176,CC,GO:0033176,proton-transporting V-type ATPase complex,0.489162321,ATP6V0B
GO:0072686,CC,GO:0072686,mitotic spindle,0.489162321,"SLC34A1,IKBKG"
GO:0005775,CC,GO:0005775,vacuolar lumen,0.489162321,"NEU4,HPSE,TRAPPC1"
GO:0005689,CC,GO:0005689,U12-type spliceosomal complex,0.489162321,YBX1
GO:0032281,CC,GO:0032281,AMPA glutamate receptor complex,0.489162321,SHISA9
GO:0034364,CC,GO:0034364,high-density lipoprotein particle,0.489162321,GPIHBP1
GO:0043202,CC,GO:0043202,lysosomal lumen,0.489908694,"NEU4,HPSE"
GO:0009898,CC,GO:0009898,cytoplasmic side of plasma membrane,0.502063612,"SNX9,DAB2IP,ASPSCR1"
GO:0031301,CC,GO:0031301,integral component of organelle membrane,0.504175529,"P2RX5,P2RX3,PET100"
GO:0044322,CC,GO:0044322,endoplasmic reticulum quality control compartment,0.507348395,ASGR2
GO:0000777,CC,GO:0000777,condensed chromosome kinetochore,0.540566381,"BIRC5,GPATCH11"
GO:0000421,CC,GO:0000421,autophagosome membrane,0.540566381,TMEM150B
GO:0051233,CC,GO:0051233,spindle midzone,0.540566381,CTDP1
GO:0000786,CC,GO:0000786,nucleosome,0.540566381,"H2AFB2,GLYR1"
GO:0005635,CC,GO:0005635,nuclear envelope,0.542714554,"YBX1,P2RX5,MRGPRF,P2RX3,DNAJB12,GUCY2D"
GO:0016460,CC,GO:0016460,myosin II complex,0.542714554,MYH14
GO:0071011,CC,GO:0071011,precatalytic spliceosome,0.542714554,DCAF4
GO:0045177,CC,GO:0045177,apical part of cell,0.542739027,"SLC34A1,GPIHBP1,VASH1,SHANK2,CDHR2"
GO:0031904,CC,GO:0031904,endosome lumen,0.549925246,PGA3
GO:0031300,CC,GO:0031300,intrinsic component of organelle membrane,0.55165977,"P2RX5,P2RX3,PET100"
GO:0036064,CC,GO:0036064,ciliary basal body,0.55256638,"RILP,RTTN"
GO:0031985,CC,GO:0031985,Golgi cisterna,0.555885351,"ST3GAL2,CIT"
GO:0044815,CC,GO:0044815,DNA packaging complex,0.555885351,"H2AFB2,GLYR1"
GO:0032391,CC,GO:0032391,photoreceptor connecting cilium,0.555885351,PDZD7
GO:0080008,CC,GO:0080008,Cul4-RING E3 ubiquitin ligase complex,0.555885351,DCAF4
GO:0032993,CC,GO:0032993,protein-DNA complex,0.555885351,"H2AFB2,GLYR1,TOP1"
GO:0098562,CC,GO:0098562,cytoplasmic side of membrane,0.555885351,"SNX9,DAB2IP,ASPSCR1"
GO:0031941,CC,GO:0031941,filamentous actin,0.555885351,XIRP2
GO:0016607,CC,GO:0016607,nuclear speck,0.555885351,"SLC34A1,GLYR1,TATDN2,POLR3D,SURF2"
GO:0030139,CC,GO:0030139,endocytic vesicle,0.555885351,"RILP,MCOLN1,DAB2IP,ATP6V0B"
GO:0031968,CC,GO:0031968,organelle outer membrane,0.555885351,"MTX1,GUCY2D,SPATA19"
GO:0019867,CC,GO:0019867,outer membrane,0.55639782,"MTX1,GUCY2D,SPATA19"
GO:0000779,CC,GO:0000779,"condensed chromosome, centromeric region",0.55639782,"BIRC5,GPATCH11"
GO:0031304,CC,GO:0031304,intrinsic component of mitochondrial inner membrane,0.55639782,PET100
GO:0031305,CC,GO:0031305,integral component of mitochondrial inner membrane,0.55639782,PET100
GO:0034358,CC,GO:0034358,plasma lipoprotein particle,0.55639782,GPIHBP1
GO:1990777,CC,GO:1990777,lipoprotein particle,0.55639782,GPIHBP1
GO:0000788,CC,GO:0000788,nuclear nucleosome,0.564372253,H2AFB2
GO:0016324,CC,GO:0016324,apical plasma membrane,0.564372253,"SLC34A1,GPIHBP1,SHANK2,CDHR2"
GO:0000152,CC,GO:0000152,nuclear ubiquitin ligase complex,0.564372253,UBE2C
GO:0032994,CC,GO:0032994,protein-lipid complex,0.564372253,GPIHBP1
GO:1990391,CC,GO:1990391,DNA repair complex,0.564372253,PHF21A
GO:0043596,CC,GO:0043596,nuclear replication fork,0.572527857,TOP1
GO:0005891,CC,GO:0005891,voltage-gated calcium channel complex,0.580492463,CACNA1S
GO:0010494,CC,GO:0010494,cytoplasmic stress granule,0.595864512,YBX1
GO:0030315,CC,GO:0030315,T-tubule,0.595864512,CACNA1S
GO:0000776,CC,GO:0000776,kinetochore,0.611188884,"BIRC5,GPATCH11"
GO:0001650,CC,GO:0001650,fibrillar center,0.611188884,"ORC6,TOP1"
GO:0046658,CC,GO:0046658,anchored component of plasma membrane,0.617586693,GPIHBP1
GO:0016469,CC,GO:0016469,proton-transporting two-sector ATPase complex,0.654016914,ATP6V0B
GO:0005795,CC,GO:0005795,Golgi stack,0.663138918,"ST3GAL2,CIT"
GO:0005871,CC,GO:0005871,kinesin complex,0.663138918,KIF19
GO:0032154,CC,GO:0032154,cleavage furrow,0.663138918,CIT
GO:0030120,CC,GO:0030120,vesicle coat,0.665561175,ARCN1
GO:0055029,CC,GO:0055029,nuclear DNA-directed RNA polymerase complex,0.665561175,"CTDP1,POLR3D"
GO:0000428,CC,GO:0000428,DNA-directed RNA polymerase complex,0.665561175,"CTDP1,POLR3D"
GO:0005875,CC,GO:0005875,microtubule associated complex,0.665561175,"KIF19,BIRC5"
GO:0005667,CC,GO:0005667,transcription regulator complex,0.670742572,"MAFB,BCL9,BSX,SNF8"
GO:0005876,CC,GO:0005876,spindle microtubule,0.670742572,CALM3
GO:0030880,CC,GO:0030880,RNA polymerase complex,0.671573664,"CTDP1,POLR3D"
GO:0035577,CC,GO:0035577,azurophil granule membrane,0.673010478,CEACAM6
GO:0030426,CC,GO:0030426,growth cone,0.675918949,"MYH14,SHANK2"
GO:0005766,CC,GO:0005766,primary lysosome,0.675918949,"TRAPPC1,CEACAM6"
GO:0042582,CC,GO:0042582,azurophil granule,0.675918949,"TRAPPC1,CEACAM6"
GO:0005765,CC,GO:0005765,lysosomal membrane,0.675918949,"RILP,MCOLN1,HPSE,CEACAM6"
GO:0098852,CC,GO:0098852,lytic vacuole membrane,0.675918949,"RILP,MCOLN1,HPSE,CEACAM6"
GO:0000118,CC,GO:0000118,histone deacetylase complex,0.675918949,PHF21A
GO:0101003,CC,GO:0101003,ficolin-1-rich granule membrane,0.675918949,SIGLEC14
GO:0035580,CC,GO:0035580,specific granule lumen,0.676344398,HPSE
GO:0030427,CC,GO:0030427,site of polarized growth,0.676344398,"MYH14,SHANK2"
GO:0005801,CC,GO:0005801,cis-Golgi network,0.676344398,BCL9
GO:0035869,CC,GO:0035869,ciliary transition zone,0.676344398,PDZD7
GO:0097525,CC,GO:0097525,spliceosomal snRNP complex,0.676344398,DCAF4
GO:0150034,CC,GO:0150034,distal axon,0.702257961,"P2RX3,MYH14,SHANK2"
GO:0033116,CC,GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,0.705840294,ASPSCR1
GO:0005657,CC,GO:0005657,replication fork,0.705840294,TOP1
GO:0030532,CC,GO:0030532,small nuclear ribonucleoprotein complex,0.705840294,DCAF4
GO:0032592,CC,GO:0032592,integral component of mitochondrial membrane,0.705840294,PET100
GO:0098793,CC,GO:0098793,presynapse,0.705840294,"P2RX3,SYN2,NRXN2,KCNC3"
GO:0043195,CC,GO:0043195,terminal bouton,0.705840294,P2RX3
GO:0098573,CC,GO:0098573,intrinsic component of mitochondrial membrane,0.705840294,PET100
GO:0099023,CC,GO:0099023,vesicle tethering complex,0.705840294,TRAPPC1
GO:0061695,CC,GO:0061695,"transferase complex, transferring phosphorus-containing groups",0.705840294,"CTDP1,IKBKG,POLR3D"
GO:0015629,CC,GO:0015629,actin cytoskeleton,0.708606207,"XIRP2,MYO15A,SYNPO,MYH14,TRIOBP"
GO:0070821,CC,GO:0070821,tertiary granule membrane,0.712051033,SIGLEC14
GO:0005741,CC,GO:0005741,mitochondrial outer membrane,0.715878918,"MTX1,SPATA19"
GO:0030864,CC,GO:0030864,cortical actin cytoskeleton,0.719192701,TRIOBP
GO:0005925,CC,GO:0005925,focal adhesion,0.724656195,"XIRP2,APBB1IP,TRIOBP,CASS4"
GO:0005811,CC,GO:0005811,lipid droplet,0.724656195,LIPE
GO:0005758,CC,GO:0005758,mitochondrial intermembrane space,0.724656195,COX6B2
GO:0005901,CC,GO:0005901,caveola,0.724656195,LIPE
GO:0042734,CC,GO:0042734,presynaptic membrane,0.724656195,KCNC3
GO:0030055,CC,GO:0030055,cell-substrate junction,0.724656195,"XIRP2,APBB1IP,TRIOBP,CASS4"
GO:0031461,CC,GO:0031461,cullin-RING ubiquitin ligase complex,0.724656195,"UBE2C,DCAF4"
GO:0005938,CC,GO:0005938,cell cortex,0.724656195,"SPINK5,TRIOBP,KCNC3"
GO:0032153,CC,GO:0032153,cell division site,0.724656195,CIT
GO:0120114,CC,GO:0120114,Sm-like protein family complex,0.724656195,DCAF4
GO:0005788,CC,GO:0005788,endoplasmic reticulum lumen,0.724656195,"RCN3,SDF2L1,COL5A3"
GO:0005681,CC,GO:0005681,spliceosomal complex,0.724656195,"YBX1,DCAF4"
GO:0036464,CC,GO:0036464,cytoplasmic ribonucleoprotein granule,0.725485487,"YBX1,TOP1"
GO:0005902,CC,GO:0005902,microvillus,0.725558144,CDHR2
GO:0000932,CC,GO:0000932,P-body,0.725558144,TOP1
GO:0000775,CC,GO:0000775,"chromosome, centromeric region",0.725558144,"BIRC5,GPATCH11"
GO:1902554,CC,GO:1902554,"serine,threonine protein kinase complex",0.725558144,IKBKG
GO:0031970,CC,GO:0031970,organelle envelope lumen,0.725558144,COX6B2
GO:0036126,CC,GO:0036126,sperm flagellum,0.725558144,TACR3
GO:0097729,CC,GO:0097729,9+2 motile cilium,0.725558144,TACR3
GO:0005882,CC,GO:0005882,intermediate filament,0.727794878,"KRT32,SHANK2"
GO:0005581,CC,GO:0005581,collagen trimer,0.728273735,COL5A3
GO:0035770,CC,GO:0035770,ribonucleoprotein granule,0.728273735,"YBX1,TOP1"
GO:0000151,CC,GO:0000151,ubiquitin ligase complex,0.728273735,"UBE2C,IKBKG,DCAF4"
GO:0005791,CC,GO:0005791,rough endoplasmic reticulum,0.731893449,P2RX3
GO:0032580,CC,GO:0032580,Golgi cisterna membrane,0.731893449,ST3GAL2
GO:0035578,CC,GO:0035578,azurophil granule lumen,0.731893449,TRAPPC1
GO:0008076,CC,GO:0008076,voltage-gated potassium channel complex,0.734092681,KCNC3
GO:0034774,CC,GO:0034774,secretory granule lumen,0.739504105,"ITIH4,HPSE,TRAPPC1"
GO:0016323,CC,GO:0016323,basolateral plasma membrane,0.739504105,"PALM,GPIHBP1"
GO:0030117,CC,GO:0030117,membrane coat,0.739504105,ARCN1
GO:0030175,CC,GO:0030175,filopodium,0.739504105,PALM
GO:0030672,CC,GO:0030672,synaptic vesicle membrane,0.739504105,SYN2
GO:0044853,CC,GO:0044853,plasma membrane raft,0.739504105,LIPE
GO:0048475,CC,GO:0048475,coated membrane,0.739504105,ARCN1
GO:0099501,CC,GO:0099501,exocytic vesicle membrane,0.739504105,SYN2
GO:0034705,CC,GO:0034705,potassium channel complex,0.739504105,KCNC3
GO:1902911,CC,GO:1902911,protein kinase complex,0.739504105,IKBKG
GO:0000793,CC,GO:0000793,condensed chromosome,0.739658566,"BIRC5,GPATCH11"
GO:0005884,CC,GO:0005884,actin filament,0.740203717,XIRP2
GO:0071013,CC,GO:0071013,catalytic step 2 spliceosome,0.740203717,DCAF4
GO:0060205,CC,GO:0060205,cytoplasmic vesicle lumen,0.747299019,"ITIH4,HPSE,TRAPPC1"
GO:0031983,CC,GO:0031983,vesicle lumen,0.747299019,"ITIH4,HPSE,TRAPPC1"
GO:0030863,CC,GO:0030863,cortical cytoskeleton,0.749068027,TRIOBP
GO:0031234,CC,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,0.76325629,SNX9
GO:0005930,CC,GO:0005930,axoneme,0.76325629,KIF19
GO:0099568,CC,GO:0099568,cytoplasmic region,0.76325629,"SPINK5,KIF19,TRIOBP,KCNC3"
GO:0097014,CC,GO:0097014,ciliary plasm,0.76325629,KIF19
GO:0000790,CC,GO:0000790,nuclear chromatin,0.76325629,"H2AFB2,KLF1,POLR3D"
GO:0030660,CC,GO:0030660,Golgi-associated vesicle membrane,0.76325629,ARCN1
GO:0045111,CC,GO:0045111,intermediate filament cytoskeleton,0.76325629,"KRT32,SHANK2"
GO:0005923,CC,GO:0005923,bicellular tight junction,0.786256479,SYNPO
GO:0005793,CC,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,0.786256479,ASPSCR1
GO:0016591,CC,GO:0016591,"RNA polymerase II, holoenzyme",0.786256479,CTDP1
GO:0043679,CC,GO:0043679,axon terminus,0.786256479,P2RX3
GO:0070160,CC,GO:0070160,tight junction,0.786860638,SYNPO
GO:0042383,CC,GO:0042383,sarcolemma,0.797059,CACNA1S
GO:0031901,CC,GO:0031901,early endosome membrane,0.82438847,HGS
GO:0044306,CC,GO:0044306,neuron projection terminus,0.824413816,P2RX3
GO:0043296,CC,GO:0043296,apical junction complex,0.824413816,SYNPO
GO:0030135,CC,GO:0030135,coated vesicle,0.825184409,"SNX9,ARCN1"
GO:0005874,CC,GO:0005874,microtubule,0.831196876,"KIF19,CALM3,BIRC5"
GO:0030176,CC,GO:0030176,integral component of endoplasmic reticulum membrane,0.837347916,DNAJB12
GO:0009897,CC,GO:0009897,external side of plasma membrane,0.837997561,"GPIHBP1,TNFRSF13C"
GO:0019898,CC,GO:0019898,extrinsic component of membrane,0.83887193,"SNX9,ASPSCR1"
GO:0031227,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,0.838905497,DNAJB12
GO:0031514,CC,GO:0031514,motile cilium,0.845158122,TACR3
GO:0090575,CC,GO:0090575,RNA polymerase II transcription regulator complex,0.845158122,BCL9
GO:0042581,CC,GO:0042581,specific granule,0.84609586,HPSE
GO:0030667,CC,GO:0030667,secretory granule membrane,0.84609586,"SIGLEC14,CEACAM6"
GO:0001726,CC,GO:0001726,ruffle,0.84609586,SNX9
GO:0043209,CC,GO:0043209,myelin sheath,0.84609586,MYH14
GO:0070820,CC,GO:0070820,tertiary granule,0.84609586,SIGLEC14
GO:0055037,CC,GO:0055037,recycling endosome,0.84609586,SNF8
GO:0019897,CC,GO:0019897,extrinsic component of plasma membrane,0.852756001,SNX9
GO:0030662,CC,GO:0030662,coated vesicle membrane,0.852756001,ARCN1
GO:0005798,CC,GO:0005798,Golgi-associated vesicle,0.85579658,ARCN1
GO:0008021,CC,GO:0008021,synaptic vesicle,0.856804607,SYN2
GO:0030136,CC,GO:0030136,clathrin-coated vesicle,0.85858888,SNX9
GO:0032838,CC,GO:0032838,plasma membrane bounded cell projection cytoplasm,0.85858888,KIF19
GO:0072562,CC,GO:0072562,blood microparticle,0.861097077,ITIH4
GO:0101002,CC,GO:0101002,ficolin-1-rich granule,0.861767234,SIGLEC14
GO:0030027,CC,GO:0030027,lamellipodium,0.861803041,APBB1IP
GO:0070382,CC,GO:0070382,exocytic vesicle,0.861803041,SYN2
GO:0031012,CC,GO:0031012,extracellular matrix,0.861803041,"ADAMTS14,HPSE,COL5A3"
GO:0098687,CC,GO:0098687,chromosomal region,0.866518786,"BIRC5,GPATCH11"
GO:0005813,CC,GO:0005813,centrosome,0.867579246,"CTDP1,RTTN,CALM3"
GO:0005802,CC,GO:0005802,trans-Golgi network,0.870265299,SNX9
GO:0030658,CC,GO:0030658,transport vesicle membrane,0.870265299,SYN2
GO:0030133,CC,GO:0030133,transport vesicle,0.890835221,"SYN2,ARCN1"
GO:0004832,MF,GO:0004832,valine-tRNA ligase activity,0.111870782,"VARS,VARS2"
GO:0004931,MF,GO:0004931,extracellularly ATP-gated cation channel activity,0.229467162,"P2RX5,P2RX3"
GO:0035381,MF,GO:0035381,ATP-gated ion channel activity,0.229467162,"P2RX5,P2RX3"
GO:0019211,MF,GO:0019211,phosphatase activator activity,0.229467162,"BMP2,CALM3"
GO:0002161,MF,GO:0002161,aminoacyl-tRNA editing activity,0.229467162,"VARS,VARS2"
GO:0004866,MF,GO:0004866,endopeptidase inhibitor activity,0.229467162,"CST1,SPINK5,SPINT1,ITIH4,RENBP,BIRC5"
GO:0003688,MF,GO:0003688,DNA replication origin binding,0.229467162,"GRWD1,ORC6"
GO:0061135,MF,GO:0061135,endopeptidase regulator activity,0.229467162,"CST1,SPINK5,SPINT1,ITIH4,RENBP,BIRC5"
GO:0030414,MF,GO:0030414,peptidase inhibitor activity,0.229467162,"CST1,SPINK5,SPINT1,ITIH4,RENBP,BIRC5"
GO:0004812,MF,GO:0004812,aminoacyl-tRNA ligase activity,0.229467162,"VARS,VARS2,PARS2"
GO:0016875,MF,GO:0016875,"ligase activity, forming carbon-oxygen bonds",0.229467162,"VARS,VARS2,PARS2"
GO:0016854,MF,GO:0016854,racemase and epimerase activity,0.229467162,"RENBP,YJEFN3"
GO:0044389,MF,GO:0044389,ubiquitin-like protein ligase binding,0.229467162,"UBE2T,UBE2C,SNX9,IKBKG,TNFRSF14,TRIOBP,EIF4E2,HGS"
GO:0051087,MF,GO:0051087,chaperone binding,0.229467162,"SDF2L1,DNAJB6,BIRC5,HSCB"
GO:0001614,MF,GO:0001614,purinergic nucleotide receptor activity,0.229467162,"P2RX5,P2RX3"
GO:0016502,MF,GO:0016502,nucleotide receptor activity,0.229467162,"P2RX5,P2RX3"
GO:0061134,MF,GO:0061134,peptidase regulator activity,0.229467162,"CST1,SPINK5,SPINT1,ITIH4,RENBP,BIRC5"
GO:0003827,MF,GO:0003827,"alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity",0.229467162,POMGNT1
GO:0004067,MF,GO:0004067,asparaginase activity,0.229467162,ASPG
GO:0004335,MF,GO:0004335,galactokinase activity,0.229467162,GALK1
GO:0004873,MF,GO:0004873,asialoglycoprotein receptor activity,0.229467162,ASGR2
GO:0018479,MF,GO:0018479,benzaldehyde dehydrogenase (NAD+) activity,0.229467162,ALDH3A1
GO:0030305,MF,GO:0030305,heparanase activity,0.229467162,HPSE
GO:0031750,MF,GO:0031750,D3 dopamine receptor binding,0.229467162,PALM
GO:0042132,MF,GO:0042132,"fructose 1,6-bisphosphate 1-phosphatase activity",0.229467162,FBP2
GO:0045509,MF,GO:0045509,interleukin-27 receptor activity,0.229467162,IL27RA
GO:0050262,MF,GO:0050262,ribosylnicotinamide kinase activity,0.229467162,NMRK2
GO:0052593,MF,GO:0052593,tryptamine:oxygen oxidoreductase (deaminating) activity,0.229467162,AOC2
GO:0052594,MF,GO:0052594,aminoacetone:oxygen oxidoreductase(deaminating) activity,0.229467162,AOC2
GO:0052595,MF,GO:0052595,aliphatic-amine oxidase activity,0.229467162,AOC2
GO:0052596,MF,GO:0052596,phenethylamine:oxygen oxidoreductase (deaminating) activity,0.229467162,AOC2
GO:0052856,MF,GO:0052856,NADHX epimerase activity,0.229467162,YJEFN3
GO:0052857,MF,GO:0052857,NADPHX epimerase activity,0.229467162,YJEFN3
GO:0061769,MF,GO:0061769,ribosylnicotinate kinase activity,0.229467162,NMRK2
GO:0005031,MF,GO:0005031,tumor necrosis factor-activated receptor activity,0.250401541,"RELT,TNFRSF14"
GO:0005035,MF,GO:0005035,death receptor activity,0.250401541,"RELT,TNFRSF14"
GO:0001671,MF,GO:0001671,ATPase activator activity,0.253193258,"DNAJB6,HSCB"
GO:0061631,MF,GO:0061631,ubiquitin conjugating enzyme activity,0.253193258,"UBE2T,UBE2C"
GO:0004566,MF,GO:0004566,beta-glucuronidase activity,0.253193258,HPSE
GO:0004616,MF,GO:0004616,phosphogluconate dehydrogenase (decarboxylating) activity,0.253193258,GLYR1
GO:0004827,MF,GO:0004827,proline-tRNA ligase activity,0.253193258,PARS2
GO:0004995,MF,GO:0004995,tachykinin receptor activity,0.253193258,TACR3
GO:0031997,MF,GO:0031997,N-terminal myristoylation domain binding,0.253193258,CALM3
GO:0032399,MF,GO:0032399,HECT domain binding,0.253193258,BPY2C
GO:0047223,MF,GO:0047223,"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity",0.253193258,POMGNT1
GO:0047288,MF,GO:0047288,monosialoganglioside sialyltransferase activity,0.253193258,ST3GAL2
GO:0061650,MF,GO:0061650,ubiquitin-like protein conjugating enzyme activity,0.256192738,"UBE2T,UBE2C"
GO:0031625,MF,GO:0031625,ubiquitin protein ligase binding,0.256854536,"UBE2T,UBE2C,SNX9,IKBKG,TNFRSF14,TRIOBP,EIF4E2"
GO:0017124,MF,GO:0017124,SH3 domain binding,0.27236851,"CIT,SHANK2,DAB2IP,CBLC"
GO:0003917,MF,GO:0003917,"DNA topoisomerase type I (single strand cut, ATP-independent) activity",0.275983551,TOP1
GO:0030160,MF,GO:0030160,synaptic receptor adaptor activity,0.275983551,SHANK2
GO:0035368,MF,GO:0035368,selenocysteine insertion sequence binding,0.275983551,SECISBP2
GO:0052794,MF,GO:0052794,exo-alpha-(2->3)-sialidase activity,0.275983551,NEU4
GO:0052795,MF,GO:0052795,exo-alpha-(2->6)-sialidase activity,0.275983551,NEU4
GO:0052796,MF,GO:0052796,exo-alpha-(2->8)-sialidase activity,0.275983551,NEU4
GO:0070815,MF,GO:0070815,peptidyl-lysine 5-dioxygenase activity,0.275983551,JMJD6
GO:0004857,MF,GO:0004857,enzyme inhibitor activity,0.276040763,"CST1,SPINK5,SPINT1,ITIH4,LRRC3C,RENBP,FAM212B,BIRC5"
GO:0003847,MF,GO:0003847,1-alkyl-2-acetylglycerophosphocholine esterase activity,0.310109692,ASPG
GO:0004169,MF,GO:0004169,dolichyl-phosphate-mannose-protein mannosyltransferase activity,0.310109692,SDF2L1
GO:0005534,MF,GO:0005534,galactose binding,0.310109692,GALK1
GO:0097100,MF,GO:0097100,supercoiled DNA binding,0.310109692,TOP1
GO:0097109,MF,GO:0097109,neuroligin family protein binding,0.310109692,NRXN2
GO:0052689,MF,GO:0052689,carboxylic ester hydrolase activity,0.323414129,"LIPE,VARS,VARS2,ASPG"
GO:0043394,MF,GO:0043394,proteoglycan binding,0.323414129,"HPSE,COL5A3"
GO:0030165,MF,GO:0030165,PDZ domain binding,0.323414129,"SLC34A1,SHISA9,CIT"
GO:0004308,MF,GO:0004308,exo-alpha-sialidase activity,0.323414129,NEU4
GO:0008131,MF,GO:0008131,primary amine oxidase activity,0.323414129,AOC2
GO:0016997,MF,GO:0016997,alpha-sialidase activity,0.323414129,NEU4
GO:0035473,MF,GO:0035473,lipase binding,0.323414129,GPIHBP1
GO:0045159,MF,GO:0045159,myosin II binding,0.323414129,TRIOBP
GO:0045545,MF,GO:0045545,syndecan binding,0.323414129,HPSE
GO:0004867,MF,GO:0004867,serine-type endopeptidase inhibitor activity,0.333277869,"SPINK5,SPINT1,ITIH4"
GO:0060590,MF,GO:0060590,ATPase regulator activity,0.333277869,"DNAJB6,HSCB"
GO:0003836,MF,GO:0003836,"beta-galactoside (CMP) alpha-2,3-sialyltransferase activity",0.333277869,ST3GAL2
GO:0003916,MF,GO:0003916,DNA topoisomerase activity,0.333277869,TOP1
GO:0004030,MF,GO:0004030,aldehyde dehydrogenase [NAD(P)+] activity,0.333277869,ALDH3A1
GO:0032051,MF,GO:0032051,clathrin light chain binding,0.333277869,CALY
GO:0034046,MF,GO:0034046,poly(G) binding,0.333277869,DAZAP1
GO:0043184,MF,GO:0043184,vascular endothelial growth factor receptor 2 binding,0.333277869,DAB2IP
GO:0072345,MF,GO:0072345,NAADP-sensitive calcium-release channel activity,0.333277869,MCOLN1
GO:0004028,MF,GO:0004028,3-chloroallyl aldehyde dehydrogenase activity,0.361031197,ALDH3A1
GO:0008420,MF,GO:0008420,RNA polymerase II CTD heptapeptide repeat phosphatase activity,0.361031197,CTDP1
GO:0030368,MF,GO:0030368,interleukin-17 receptor activity,0.361031197,IL27RA
GO:0072542,MF,GO:0072542,protein phosphatase activator activity,0.361031197,CALM3
GO:0005231,MF,GO:0005231,excitatory extracellular ligand-gated ion channel activity,0.373509008,"P2RX5,P2RX3"
GO:0004652,MF,GO:0004652,polynucleotide adenylyltransferase activity,0.390297858,PAPD5
GO:0071933,MF,GO:0071933,"Arp2,3 complex binding",0.390297858,SNX9
GO:0003697,MF,GO:0003697,single-stranded DNA binding,0.390974605,"YBX1,SSBP3,TOP1"
GO:0099094,MF,GO:0099094,ligand-gated cation channel activity,0.391150448,"P2RX5,MCOLN1,P2RX3"
GO:0005381,MF,GO:0005381,iron ion transmembrane transporter activity,0.391150448,MCOLN1
GO:0005436,MF,GO:0005436,sodium:phosphate symporter activity,0.391150448,SLC34A1
GO:0019203,MF,GO:0019203,carbohydrate phosphatase activity,0.391150448,FBP2
GO:0030957,MF,GO:0030957,Tat protein binding,0.391150448,CTDP1
GO:0036312,MF,GO:0036312,phosphatidylinositol 3-kinase regulatory subunit binding,0.391150448,DAB2IP
GO:0050308,MF,GO:0050308,sugar-phosphatase activity,0.391150448,FBP2
GO:0070513,MF,GO:0070513,death domain binding,0.391150448,DAP
GO:0004222,MF,GO:0004222,metalloendopeptidase activity,0.393762145,"PAPPA,ADAMTS14,KEL"
GO:0005172,MF,GO:0005172,vascular endothelial growth factor receptor binding,0.41273923,DAB2IP
GO:0016888,MF,GO:0016888,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters",0.41273923,TATDN2
GO:0005507,MF,GO:0005507,copper ion binding,0.41273923,"AOC2,S100A5"
GO:0004869,MF,GO:0004869,cysteine-type endopeptidase inhibitor activity,0.413301218,"CST1,BIRC5"
GO:0003777,MF,GO:0003777,microtubule motor activity,0.413301218,"KIF19,MYO15A,MYH14"
GO:0008093,MF,GO:0008093,cytoskeletal anchor activity,0.413301218,GAS2L1
GO:0008331,MF,GO:0008331,high voltage-gated calcium channel activity,0.413301218,CACNA1S
GO:0016857,MF,GO:0016857,"racemase and epimerase activity, acting on carbohydrates and derivatives",0.413301218,RENBP
GO:0030898,MF,GO:0030898,actin-dependent ATPase activity,0.413301218,MYH14
GO:0042975,MF,GO:0042975,peroxisome proliferator activated receptor binding,0.413301218,IKBKG
GO:0070700,MF,GO:0070700,BMP receptor binding,0.413301218,BMP2
GO:0016616,MF,GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",0.41490296,"GLYR1,BMP2,ALDH3A1"
GO:0051082,MF,GO:0051082,unfolded protein binding,0.41490296,"DNAJB6,PET100,DNAJC4"
GO:0140101,MF,GO:0140101,"catalytic activity, acting on a tRNA",0.41490296,"VARS,VARS2,PARS2"
GO:0008017,MF,GO:0008017,microtubule binding,0.41490296,"KIF19,MYO15A,MYH14,BIRC5,GAS2L1"
GO:0042393,MF,GO:0042393,histone binding,0.41490296,"PHF21A,GRWD1,GLYR1,PHF13"
GO:0008179,MF,GO:0008179,adenylate cyclase binding,0.41490296,CALM3
GO:0015114,MF,GO:0015114,phosphate ion transmembrane transporter activity,0.41490296,SLC34A1
GO:0039706,MF,GO:0039706,co-receptor binding,0.41490296,BMP2
GO:0035064,MF,GO:0035064,methylated histone binding,0.425103635,"GLYR1,PHF13"
GO:0140034,MF,GO:0140034,methylation-dependent protein binding,0.425103635,"GLYR1,PHF13"
GO:0031432,MF,GO:0031432,titin binding,0.429895807,CALM3
GO:0050780,MF,GO:0050780,dopamine receptor binding,0.429895807,PALM
GO:0140030,MF,GO:0140030,modification-dependent protein binding,0.440104885,"GLYR1,IKBKG,PHF13"
GO:0001056,MF,GO:0001056,RNA polymerase III activity,0.440104885,POLR3D
GO:0004029,MF,GO:0004029,aldehyde dehydrogenase (NAD+) activity,0.440104885,ALDH3A1
GO:0005545,MF,GO:0005545,1-phosphatidylinositol binding,0.440104885,SNX9
GO:0035613,MF,GO:0035613,RNA stem-loop binding,0.440104885,DAZAP1
GO:0016247,MF,GO:0016247,channel regulator activity,0.443492477,"SNF8,FXYD6,NRXN2"
GO:0003724,MF,GO:0003724,RNA helicase activity,0.443492477,"DDX49,DDX51"
GO:0008186,MF,GO:0008186,RNA-dependent ATPase activity,0.443492477,"DDX49,DDX51"
GO:0001091,MF,GO:0001091,RNA polymerase II general transcription initiation factor binding,0.447581007,CTDP1
GO:0031435,MF,GO:0031435,mitogen-activated protein kinase kinase kinase binding,0.447581007,DAB2IP
GO:0003774,MF,GO:0003774,motor activity,0.447581007,"KIF19,MYO15A,MYH14"
GO:0016614,MF,GO:0016614,"oxidoreductase activity, acting on CH-OH group of donors",0.447581007,"GLYR1,BMP2,ALDH3A1"
GO:0004383,MF,GO:0004383,guanylate cyclase activity,0.447581007,GUCY2D
GO:0005005,MF,GO:0005005,transmembrane-ephrin receptor activity,0.447581007,EFNB3
GO:0005123,MF,GO:0005123,death receptor binding,0.447581007,DAB2IP
GO:0008320,MF,GO:0008320,protein transmembrane transporter activity,0.447581007,GPIHBP1
GO:0016641,MF,GO:0016641,"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",0.447581007,AOC2
GO:0048038,MF,GO:0048038,quinone binding,0.447581007,AOC2
GO:0140098,MF,GO:0140098,"catalytic activity, acting on RNA",0.45219929,"VARS,VARS2,PARS2,POLR3D,DDX49,DDX51"
GO:0001618,MF,GO:0001618,virus receptor activity,0.455204587,"EFNB3,TNFRSF14"
GO:0000339,MF,GO:0000339,RNA cap binding,0.455204587,EIF4E2
GO:0004016,MF,GO:0004016,adenylate cyclase activity,0.455204587,GUCY2D
GO:0004745,MF,GO:0004745,retinol dehydrogenase activity,0.455204587,BMP2
GO:0005230,MF,GO:0005230,extracellular ligand-gated ion channel activity,0.458996228,"P2RX5,P2RX3"
GO:0015276,MF,GO:0015276,ligand-gated ion channel activity,0.458996228,"P2RX5,MCOLN1,P2RX3"
GO:0022834,MF,GO:0022834,ligand-gated channel activity,0.458996228,"P2RX5,MCOLN1,P2RX3"
GO:0005003,MF,GO:0005003,ephrin receptor activity,0.458996228,EFNB3
GO:0008266,MF,GO:0008266,poly(U) RNA binding,0.458996228,DAZAP1
GO:0022884,MF,GO:0022884,macromolecule transmembrane transporter activity,0.458996228,GPIHBP1
GO:0016853,MF,GO:0016853,isomerase activity,0.467608617,"RENBP,YJEFN3,TOP1"
GO:0003746,MF,GO:0003746,translation elongation factor activity,0.467608617,GTPBP1
GO:0005086,MF,GO:0005086,ARF guanyl-nucleotide exchange factor activity,0.467608617,IQSEC3
GO:0070696,MF,GO:0070696,"transmembrane receptor protein serine,threonine kinase binding",0.467608617,BMP2
GO:0003727,MF,GO:0003727,single-stranded RNA binding,0.467608617,"JMJD6,DAZAP1"
GO:0004622,MF,GO:0004622,lysophospholipase activity,0.467608617,ASPG
GO:0008373,MF,GO:0008373,sialyltransferase activity,0.467608617,ST3GAL2
GO:0017049,MF,GO:0017049,GTP-Rho binding,0.467608617,TRIOBP
GO:0046961,MF,GO:0046961,"proton-transporting ATPase activity, rotational mechanism",0.467608617,ATP6V0B
GO:0070530,MF,GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,0.467608617,IKBKG
GO:0005261,MF,GO:0005261,cation channel activity,0.467608617,"P2RX5,MCOLN1,P2RX3,KCNC3,CACNA1S"
GO:0000146,MF,GO:0000146,microfilament motor activity,0.467608617,MYH14
GO:0008106,MF,GO:0008106,alcohol dehydrogenase (NADP+) activity,0.467608617,ALDH3A1
GO:0016638,MF,GO:0016638,"oxidoreductase activity, acting on the CH-NH2 group of donors",0.467608617,AOC2
GO:0016849,MF,GO:0016849,phosphorus-oxygen lyase activity,0.467608617,GUCY2D
GO:0019200,MF,GO:0019200,carbohydrate kinase activity,0.467608617,GALK1
GO:0033612,MF,GO:0033612,"receptor serine,threonine kinase binding",0.467608617,BMP2
GO:0070034,MF,GO:0070034,telomerase RNA binding,0.467608617,PAPD5
GO:0016874,MF,GO:0016874,ligase activity,0.469723998,"VARS,VARS2,PARS2"
GO:0008187,MF,GO:0008187,poly-pyrimidine tract binding,0.469723998,DAZAP1
GO:0009975,MF,GO:0009975,cyclase activity,0.469723998,GUCY2D
GO:0015278,MF,GO:0015278,calcium-release channel activity,0.469723998,MCOLN1
GO:0070717,MF,GO:0070717,poly-purine tract binding,0.469723998,DAZAP1
GO:0140103,MF,GO:0140103,"catalytic activity, acting on a glycoprotein",0.469723998,POMGNT1
GO:0030159,MF,GO:0030159,signaling receptor complex adaptor activity,0.485077357,SHANK2
GO:0008135,MF,GO:0008135,"translation factor activity, RNA binding",0.487747631,"GTPBP1,EIF4E2"
GO:0016811,MF,GO:0016811,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",0.487747631,"PHF21A,ASPG"
GO:0000030,MF,GO:0000030,mannosyltransferase activity,0.487747631,SDF2L1
GO:0004190,MF,GO:0004190,aspartic-type endopeptidase activity,0.487747631,PGA3
GO:0070273,MF,GO:0070273,phosphatidylinositol-4-phosphate binding,0.487747631,DAB2IP
GO:0019208,MF,GO:0019208,phosphatase regulator activity,0.487747631,"BMP2,CALM3"
GO:0022839,MF,GO:0022839,ion gated channel activity,0.487747631,"P2RX5,MCOLN1,P2RX3,KCNC3,CACNA1S"
GO:0004806,MF,GO:0004806,triglyceride lipase activity,0.487747631,LIPE
GO:0070001,MF,GO:0070001,aspartic-type peptidase activity,0.487747631,PGA3
GO:0005216,MF,GO:0005216,ion channel activity,0.487747631,"P2RX5,MCOLN1,P2RX3,FXYD6,KCNC3,CACNA1S"
GO:0004896,MF,GO:0004896,cytokine receptor activity,0.487747631,"IFNLR1,IL27RA"
GO:0022836,MF,GO:0022836,gated channel activity,0.487747631,"P2RX5,MCOLN1,P2RX3,KCNC3,CACNA1S"
GO:0046875,MF,GO:0046875,ephrin receptor binding,0.487747631,EFNB3
GO:0051787,MF,GO:0051787,misfolded protein binding,0.487747631,SDF2L1
GO:0070566,MF,GO:0070566,adenylyltransferase activity,0.487747631,PAPD5
GO:0071813,MF,GO:0071813,lipoprotein particle binding,0.487747631,GPIHBP1
GO:0071814,MF,GO:0071814,protein-lipid complex binding,0.487747631,GPIHBP1
GO:0071889,MF,GO:0071889,14-3-3 protein binding,0.487747631,DAB2IP
GO:0004860,MF,GO:0004860,protein kinase inhibitor activity,0.488232362,"LRRC3C,FAM212B"
GO:0032452,MF,GO:0032452,histone demethylase activity,0.488232362,JMJD6
GO:0035255,MF,GO:0035255,ionotropic glutamate receptor binding,0.488232362,SHANK2
GO:0046966,MF,GO:0046966,thyroid hormone receptor binding,0.488232362,GAS2L1
GO:0051721,MF,GO:0051721,protein phosphatase 2A binding,0.488232362,DAB2IP
GO:1904680,MF,GO:1904680,peptide transmembrane transporter activity,0.488232362,GPIHBP1
GO:0003887,MF,GO:0003887,DNA-directed DNA polymerase activity,0.488546508,PAPD5
GO:0004033,MF,GO:0004033,aldo-keto reductase (NADP) activity,0.488546508,ALDH3A1
GO:0005251,MF,GO:0005251,delayed rectifier potassium channel activity,0.488546508,KCNC3
GO:0043548,MF,GO:0043548,phosphatidylinositol 3-kinase binding,0.488546508,DAB2IP
GO:0051959,MF,GO:0051959,dynein light intermediate chain binding,0.488546508,RILP
GO:0099604,MF,GO:0099604,ligand-gated calcium channel activity,0.488546508,MCOLN1
GO:0019210,MF,GO:0019210,kinase inhibitor activity,0.490333643,"LRRC3C,FAM212B"
GO:0015631,MF,GO:0015631,tubulin binding,0.494776866,"KIF19,MYO15A,MYH14,BIRC5,GAS2L1"
GO:0008574,MF,GO:0008574,"ATP-dependent microtubule motor activity, plus-end-directed",0.505093792,KIF19
GO:0030332,MF,GO:0030332,cyclin binding,0.505093792,KLHDC9
GO:0097718,MF,GO:0097718,disordered domain specific binding,0.505093792,CALM3
GO:0008237,MF,GO:0008237,metallopeptidase activity,0.510810439,"PAPPA,ADAMTS14,KEL"
GO:0004553,MF,GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",0.510810439,"NEU4,HPSE"
GO:0000987,MF,GO:0000987,cis-regulatory region sequence-specific DNA binding,0.51561416,"MAFB,YBX1,KLF1,DLX4,SSBP3,BATF3"
GO:0005154,MF,GO:0005154,epidermal growth factor receptor binding,0.51792125,CBLC
GO:0030291,MF,GO:0030291,"protein serine,threonine kinase inhibitor activity",0.51792125,FAM212B
GO:0043539,MF,GO:0043539,"protein serine,threonine kinase activator activity",0.51792125,CALM3
GO:0008536,MF,GO:0008536,Ran GTPase binding,0.523879487,BIRC5
GO:0044769,MF,GO:0044769,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism",0.523879487,ATP6V0B
GO:0051393,MF,GO:0051393,alpha-actinin binding,0.523879487,XIRP2
GO:0047485,MF,GO:0047485,protein N-terminus binding,0.525320892,"SNF8,CALM3"
GO:0001784,MF,GO:0001784,phosphotyrosine residue binding,0.526295189,CBLC
GO:0005217,MF,GO:0005217,intracellular ligand-gated ion channel activity,0.526295189,MCOLN1
GO:0016620,MF,GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",0.526295189,ALDH3A1
GO:0015267,MF,GO:0015267,channel activity,0.526295189,"P2RX5,MCOLN1,P2RX3,FXYD6,KCNC3,CACNA1S"
GO:0022803,MF,GO:0022803,passive transmembrane transporter activity,0.526968388,"P2RX5,MCOLN1,P2RX3,FXYD6,KCNC3,CACNA1S"
GO:0005246,MF,GO:0005246,calcium channel regulator activity,0.527004173,NRXN2
GO:0019239,MF,GO:0019239,deaminase activity,0.527004173,ADAT3
GO:0032266,MF,GO:0032266,phosphatidylinositol-3-phosphate binding,0.527004173,DAB2IP
GO:0140097,MF,GO:0140097,"catalytic activity, acting on DNA",0.527004173,"PAPD5,TATDN2,TOP1"
GO:0005516,MF,GO:0005516,calmodulin binding,0.529371314,"MYO15A,MYH14,CACNA1S"
GO:0017080,MF,GO:0017080,sodium channel regulator activity,0.53304594,FXYD6
GO:0019887,MF,GO:0019887,protein kinase regulator activity,0.534051351,"LRRC3C,FAM212B,CALM3"
GO:0032451,MF,GO:0032451,demethylase activity,0.540281581,JMJD6
GO:0030544,MF,GO:0030544,Hsp70 protein binding,0.549629841,DNAJB12
GO:0016893,MF,GO:0016893,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",0.55489232,TATDN2
GO:0046915,MF,GO:0046915,transition metal ion transmembrane transporter activity,0.55489232,MCOLN1
GO:0005262,MF,GO:0005262,calcium channel activity,0.55489232,"MCOLN1,CACNA1S"
GO:0003899,MF,GO:0003899,DNA-directed 5'-3' RNA polymerase activity,0.562245962,POLR3D
GO:0031072,MF,GO:0031072,heat shock protein binding,0.562245962,"DNAJB12,DNAJB6"
GO:0005245,MF,GO:0005245,voltage-gated calcium channel activity,0.562245962,CACNA1S
GO:0034061,MF,GO:0034061,DNA polymerase activity,0.562245962,PAPD5
GO:0035254,MF,GO:0035254,glutamate receptor binding,0.562245962,SHANK2
GO:0042805,MF,GO:0042805,actinin binding,0.562245962,XIRP2
GO:0004407,MF,GO:0004407,histone deacetylase activity,0.568356961,PHF21A
GO:0042887,MF,GO:0042887,amide transmembrane transporter activity,0.568356961,GPIHBP1
GO:0033558,MF,GO:0033558,protein deacetylase activity,0.568518505,PHF21A
GO:0034062,MF,GO:0034062,5'-3' RNA polymerase activity,0.568518505,POLR3D
GO:0045309,MF,GO:0045309,protein phosphorylated amino acid binding,0.568518505,CBLC
GO:0097747,MF,GO:0097747,RNA polymerase activity,0.568518505,POLR3D
GO:0046982,MF,GO:0046982,protein heterodimerization activity,0.568518505,"H2AFB2,MAFB,IKBKG,BMP2,PDZD7,DRAP1"
GO:0016298,MF,GO:0016298,lipase activity,0.568518505,"LIPE,ASPG"
GO:0016706,MF,GO:0016706,2-oxoglutarate-dependent dioxygenase activity,0.568518505,JMJD6
GO:0016903,MF,GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",0.568518505,ALDH3A1
GO:0031593,MF,GO:0031593,polyubiquitin modification-dependent protein binding,0.568518505,IKBKG
GO:0016798,MF,GO:0016798,"hydrolase activity, acting on glycosyl bonds",0.571734806,"NEU4,HPSE"
GO:0032813,MF,GO:0032813,tumor necrosis factor receptor superfamily binding,0.571734806,DAB2IP
GO:0003779,MF,GO:0003779,actin binding,0.571734806,"XIRP2,MYO15A,SYNPO,MYH14,TRIOBP"
GO:0019207,MF,GO:0019207,kinase regulator activity,0.571734806,"LRRC3C,FAM212B,CALM3"
GO:0061630,MF,GO:0061630,ubiquitin protein ligase activity,0.577093705,"UBE2T,UBE2C,CBLC"
GO:0070851,MF,GO:0070851,growth factor receptor binding,0.577093705,"DAB2IP,CBLC"
GO:0005160,MF,GO:0005160,transforming growth factor beta receptor binding,0.589300093,BMP2
GO:1990939,MF,GO:1990939,ATP-dependent microtubule motor activity,0.589300093,KIF19
GO:0061659,MF,GO:0061659,ubiquitin-like protein ligase activity,0.589300093,"UBE2T,UBE2C,CBLC"
GO:0004520,MF,GO:0004520,endodeoxyribonuclease activity,0.594290931,TATDN2
GO:0001227,MF,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",0.594456373,"HES5,DLX4,BATF3"
GO:0003743,MF,GO:0003743,translation initiation factor activity,0.594456373,EIF4E2
GO:0008188,MF,GO:0008188,neuropeptide receptor activity,0.594456373,TACR3
GO:0017112,MF,GO:0017112,Rab guanyl-nucleotide exchange factor activity,0.594456373,TRAPPC1
GO:0015085,MF,GO:0015085,calcium ion transmembrane transporter activity,0.599346489,"MCOLN1,CACNA1S"
GO:0016779,MF,GO:0016779,nucleotidyltransferase activity,0.60224743,"PAPD5,POLR3D"
GO:0035091,MF,GO:0035091,phosphatidylinositol binding,0.602880856,"SNX9,SNX22,DAB2IP"
GO:0022843,MF,GO:0022843,voltage-gated cation channel activity,0.602880856,"KCNC3,CACNA1S"
GO:0000978,MF,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,0.614424765,"MAFB,YBX1,DLX4,SSBP3,BATF3"
GO:0016810,MF,GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",0.622197847,"PHF21A,ASPG"
GO:0019213,MF,GO:0019213,deacetylase activity,0.622197847,PHF21A
GO:0051287,MF,GO:0051287,NAD binding,0.628244875,GLYR1
GO:0004386,MF,GO:0004386,helicase activity,0.629606197,"DDX49,DDX51"
GO:0004842,MF,GO:0004842,ubiquitin-protein transferase activity,0.629606197,"UBE2T,UBE2C,DTX4,CBLC,BIRC5"
GO:0030971,MF,GO:0030971,receptor tyrosine kinase binding,0.629606197,CBLC
GO:0097110,MF,GO:0097110,scaffold protein binding,0.635383391,CIT
GO:0001098,MF,GO:0001098,basal transcription machinery binding,0.636496021,CTDP1
GO:0001099,MF,GO:0001099,basal RNA polymerase II transcription machinery binding,0.636496021,CTDP1
GO:0008375,MF,GO:0008375,acetylglucosaminyltransferase activity,0.636496021,POMGNT1
GO:0016887,MF,GO:0016887,ATPase activity,0.647422281,"KIF19,MYH14,ATP6V0B,DDX49,DDX51"
GO:0016279,MF,GO:0016279,protein-lysine N-methyltransferase activity,0.647422281,EEF2KMT
GO:0005518,MF,GO:0005518,collagen binding,0.64816889,COL5A3
GO:0016278,MF,GO:0016278,lysine N-methyltransferase activity,0.64816889,EEF2KMT
GO:0017022,MF,GO:0017022,myosin binding,0.64816889,TRIOBP
GO:0005506,MF,GO:0005506,iron ion binding,0.655495646,"JMJD6,FA2H"
GO:0003730,MF,GO:0003730,mRNA 3'-UTR binding,0.660390553,SECISBP2
GO:0004714,MF,GO:0004714,transmembrane receptor protein tyrosine kinase activity,0.660390553,EFNB3
GO:0030246,MF,GO:0030246,carbohydrate binding,0.660390553,"ASGR2,GALK1,SIGLEC14"
GO:0019829,MF,GO:0019829,ATPase-coupled cation transmembrane transporter activity,0.660390553,ATP6V0B
GO:0019787,MF,GO:0019787,ubiquitin-like protein transferase activity,0.660390553,"UBE2T,UBE2C,DTX4,CBLC,BIRC5"
GO:0004536,MF,GO:0004536,deoxyribonuclease activity,0.660390553,TATDN2
GO:0022853,MF,GO:0022853,active ion transmembrane transporter activity,0.660390553,ATP6V0B
GO:0042625,MF,GO:0042625,ATPase-coupled ion transmembrane transporter activity,0.660390553,ATP6V0B
GO:0043130,MF,GO:0043130,ubiquitin binding,0.660390553,IKBKG
GO:0016791,MF,GO:0016791,phosphatase activity,0.660390553,"FBP2,HDHD2,CTDP1"
GO:0048029,MF,GO:0048029,monosaccharide binding,0.663998201,GALK1
GO:0031434,MF,GO:0031434,mitogen-activated protein kinase kinase binding,0.666282567,DAB2IP
GO:1990782,MF,GO:1990782,protein tyrosine kinase binding,0.666282567,CBLC
GO:0004722,MF,GO:0004722,"protein serine,threonine phosphatase activity",0.669203019,CTDP1
GO:0017048,MF,GO:0017048,Rho GTPase binding,0.669203019,"CIT,TRIOBP"
GO:0051015,MF,GO:0051015,actin filament binding,0.671090879,"MYH14,TRIOBP"
GO:0005126,MF,GO:0005126,cytokine receptor binding,0.671132408,"IFNL1,BMP2,DAB2IP"
GO:0030276,MF,GO:0030276,clathrin binding,0.67477882,CALY
GO:0030295,MF,GO:0030295,protein kinase activator activity,0.676693237,CALM3
GO:0046332,MF,GO:0046332,SMAD binding,0.676693237,BMP2
GO:0016757,MF,GO:0016757,"transferase activity, transferring glycosyl groups",0.678173005,"ST3GAL2,SDF2L1,POMGNT1"
GO:0015370,MF,GO:0015370,solute:sodium symporter activity,0.682457104,SLC34A1
GO:0051219,MF,GO:0051219,phosphoprotein binding,0.682457104,CBLC
GO:0005201,MF,GO:0005201,extracellular matrix structural constituent,0.686307559,COL5A3
GO:0019888,MF,GO:0019888,protein phosphatase regulator activity,0.688450695,CALM3
GO:0017137,MF,GO:0017137,Rab GTPase binding,0.688450695,"RILP,TRAPPC1"
GO:0051117,MF,GO:0051117,ATPase binding,0.691559957,SDF2L1
GO:0019209,MF,GO:0019209,kinase activator activity,0.70089789,CALM3
GO:0008013,MF,GO:0008013,beta-catenin binding,0.702134198,BCL9
GO:0035591,MF,GO:0035591,signaling adaptor activity,0.702134198,DAB2IP
GO:0060090,MF,GO:0060090,molecular adaptor activity,0.7033011,"DAB2IP,GAS2L1"
GO:0019199,MF,GO:0019199,transmembrane receptor protein kinase activity,0.7033011,EFNB3
GO:0038024,MF,GO:0038024,cargo receptor activity,0.712026696,ASGR2
GO:0032182,MF,GO:0032182,ubiquitin-like protein binding,0.714938119,IKBKG
GO:0001046,MF,GO:0001046,core promoter sequence-specific DNA binding,0.714938119,TOP1
GO:0005244,MF,GO:0005244,voltage-gated ion channel activity,0.714938119,"KCNC3,CACNA1S"
GO:0022832,MF,GO:0022832,voltage-gated channel activity,0.714938119,"KCNC3,CACNA1S"
GO:0001228,MF,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",0.715343342,"MAFB,YBX1,IRF5,SSBP3"
GO:0008276,MF,GO:0008276,protein methyltransferase activity,0.727669854,EEF2KMT
GO:0051213,MF,GO:0051213,dioxygenase activity,0.727669854,JMJD6
GO:0005249,MF,GO:0005249,voltage-gated potassium channel activity,0.740174529,KCNC3
GO:0099106,MF,GO:0099106,ion channel regulator activity,0.741095578,NRXN2
GO:0016758,MF,GO:0016758,"transferase activity, transferring hexosyl groups",0.741095578,"SDF2L1,POMGNT1"
GO:0005085,MF,GO:0005085,guanyl-nucleotide exchange factor activity,0.741095578,"MON1A,IQSEC3,TRAPPC1"
GO:0008170,MF,GO:0008170,N-methyltransferase activity,0.745407391,EEF2KMT
GO:0004620,MF,GO:0004620,phospholipase activity,0.752338855,ASPG
GO:0005125,MF,GO:0005125,cytokine activity,0.763402392,"IFNL1,BMP2"
GO:0015294,MF,GO:0015294,solute:cation symporter activity,0.774152607,SLC34A1
GO:0046873,MF,GO:0046873,metal ion transmembrane transporter activity,0.779176483,"SLC34A1,MCOLN1,KCNC3,CACNA1S"
GO:0003714,MF,GO:0003714,transcription corepressor activity,0.791248155,"DRAP1,BATF3"
GO:0009055,MF,GO:0009055,electron transfer activity,0.80366011,AOC2
GO:0004175,MF,GO:0004175,endopeptidase activity,0.804201641,"PAPPA,ADAMTS14,KEL,PGA3"
GO:0060589,MF,GO:0060589,nucleoside-triphosphatase regulator activity,0.804201641,"DNAJB6,DAB2IP,HSCB"
GO:0042626,MF,GO:0042626,ATPase-coupled transmembrane transporter activity,0.804201641,ATP6V0B
GO:0042578,MF,GO:0042578,phosphoric ester hydrolase activity,0.808226549,"FBP2,HDHD2,CTDP1"
GO:0019903,MF,GO:0019903,protein phosphatase binding,0.808226549,DAB2IP
GO:0044325,MF,GO:0044325,ion channel binding,0.808226549,CALM3
GO:0043021,MF,GO:0043021,ribonucleoprotein complex binding,0.809482308,SECISBP2
GO:0005525,MF,GO:0005525,GTP binding,0.815024447,"GTPBP1,ARL5C,GUCY2D"
GO:0050839,MF,GO:0050839,cell adhesion molecule binding,0.815024447,"SNX9,NRXN2,DAB2IP,CDHR2"
GO:0032550,MF,GO:0032550,purine ribonucleoside binding,0.817477322,"GTPBP1,ARL5C,GUCY2D"
GO:0015399,MF,GO:0015399,primary active transmembrane transporter activity,0.817477322,ATP6V0B
GO:0001883,MF,GO:0001883,purine nucleoside binding,0.819574062,"GTPBP1,ARL5C,GUCY2D"
GO:0032549,MF,GO:0032549,ribonucleoside binding,0.819574062,"GTPBP1,ARL5C,GUCY2D"
GO:0005267,MF,GO:0005267,potassium channel activity,0.819853338,KCNC3
GO:0043492,MF,GO:0043492,"ATPase activity, coupled to movement of substances",0.819853338,ATP6V0B
GO:0015078,MF,GO:0015078,proton transmembrane transporter activity,0.819853338,ATP6V0B
GO:0020037,MF,GO:0020037,heme binding,0.819853338,FA2H
GO:0001882,MF,GO:0001882,nucleoside binding,0.819962868,"GTPBP1,ARL5C,GUCY2D"
GO:0002020,MF,GO:0002020,protease binding,0.819962868,CST1
GO:0008528,MF,GO:0008528,G protein-coupled peptide receptor activity,0.819962868,TACR3
GO:0001653,MF,GO:0001653,peptide receptor activity,0.819962868,TACR3
GO:0032561,MF,GO:0032561,guanyl ribonucleotide binding,0.819962868,"GTPBP1,ARL5C,GUCY2D"
GO:0004519,MF,GO:0004519,endonuclease activity,0.819962868,TATDN2
GO:0019001,MF,GO:0019001,guanyl nucleotide binding,0.819962868,"GTPBP1,ARL5C,GUCY2D"
GO:0015077,MF,GO:0015077,monovalent inorganic cation transmembrane transporter activity,0.819962868,"SLC34A1,ATP6V0B,KCNC3"
GO:0046906,MF,GO:0046906,tetrapyrrole binding,0.827192897,FA2H
GO:0001085,MF,GO:0001085,RNA polymerase II transcription factor binding,0.827192897,CTDP1
GO:0015293,MF,GO:0015293,symporter activity,0.827192897,SLC34A1
GO:0005543,MF,GO:0005543,phospholipid binding,0.838647017,"SNX9,SNX22,DAB2IP"
GO:1901981,MF,GO:1901981,phosphatidylinositol phosphate binding,0.838647017,DAB2IP
GO:0008194,MF,GO:0008194,UDP-glycosyltransferase activity,0.8389407,POMGNT1
GO:0035257,MF,GO:0035257,nuclear hormone receptor binding,0.844192613,GAS2L1
GO:0008201,MF,GO:0008201,heparin binding,0.856279659,COL5A3
GO:0008757,MF,GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,0.856279659,EEF2KMT
GO:0016705,MF,GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",0.858458373,JMJD6
GO:0015081,MF,GO:0015081,sodium ion transmembrane transporter activity,0.858458373,SLC34A1
GO:0008083,MF,GO:0008083,growth factor activity,0.860552664,BMP2
GO:0015079,MF,GO:0015079,potassium ion transmembrane transporter activity,0.862374344,KCNC3
GO:0015103,MF,GO:0015103,inorganic anion transmembrane transporter activity,0.862374344,SLC34A1
GO:0019902,MF,GO:0019902,phosphatase binding,0.864235892,DAB2IP
GO:0030674,MF,GO:0030674,protein-macromolecule adaptor activity,0.86600826,GAS2L1
GO:0045296,MF,GO:0045296,cadherin binding,0.87588322,"SNX9,DAB2IP"
GO:0004721,MF,GO:0004721,phosphoprotein phosphatase activity,0.87588322,CTDP1
GO:0051427,MF,GO:0051427,hormone receptor binding,0.87588322,GAS2L1
GO:0016829,MF,GO:0016829,lyase activity,0.87588322,GUCY2D
GO:0004713,MF,GO:0004713,protein tyrosine kinase activity,0.877162705,EFNB3
GO:0008022,MF,GO:0008022,protein C-terminus binding,0.886769747,SNF8
GO:0000287,MF,GO:0000287,magnesium ion binding,0.895547369,CIB3
GO:0048037,MF,GO:0048037,cofactor binding,0.896550477,"GLYR1,FA2H,AOC2"